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Cellular function hinges on the ability to process information from the outside envi-
ronment into speciﬁc decisions. Ultimately these processes decide cell fate, whether
it be to undergo proliferation, apoptosis, diﬀerentiation, migration and other cellu-
lar functions. These processes can be thought of as ﬁnely tuned programs evolved
to maintain robust function in spite of environmental perturbations. Malfunctions
in these programs can lead to improper cellular function and various disease states.
To develop more eﬀective, personalized and even preventative therapeutics we must
attain a better, more detailed, understanding of the programs involved. To this
end we have employed mechanistic mathematical modeling to a variety of complex
cellular programs. In Chapter 1, we review a variety of computational methods
have have been used successfully in diﬀerent areas of biotechnology. In Chapter 2,
we present the software platform UNIVERSAL, which was developed in our lab.
UNIVERSAL is an extensible code generation framework for Mac OS X which pro-
duces editable, fully commented platform-independent physiochemical model code
in several common programming languages from a variety of inputs. UNIVERSAL
generates mass-action ODE models of intracellular signal transduction processes
and model analysis code, such as adjoint sensitivity balances. We employed the
mass-action ODE framework, as generated by UNIVERSAL, commonly through-
out the studies presented here. In Chapter 3, we introduce a variety of modeling
strategies in the context of EGF-induced Eukaryotic transcription. We demon-strated the ability to make meaningful and statistically consistent model predic-
tions despite considerable parametric uncertainty. In Chapter 4, we constructed a
mathematical model to study a mechanism for androgen independent proliferation
in prostate cancer. Analysis of the model provided insight into the importance
of network components as a function of androgen dependence. Translation be-
came progressively more important in androgen independent cells. Moreover, the
analysis suggested that direct targeting of the translational machinery, speciﬁcally
eIF4E, could be eﬃcacious in androgen independent prostate cancers. In Chap-
ter 5, A mathematical model of RA-induced cell-cycle arrest and diﬀerentiation
was formulated and tested against BLR1 wild-type (wt) knock-out and knock-in
HL-60 cell lines with and without RA. The ensemble of HL-60 models recapitu-
lated the positive feedback between BLR1 and MAPK signaling. We investigated
the robustness of the HL-60 network architecture to structural perturbations and
generated experimentally testable hypotheses for future study. In Chapter 6, we
carried out experimental studies to reduce the structural uncertainty of the HL-
60 model. Result from the HL-60 model cRaf as the most critical component of
the MAPK cascade. To investigate the role of cRaf in RA-induced diﬀerentiation
we observed the eﬀect of cRaf kinase inhibition. Furthermore, we interrogated
a panel of proteins to identify RA responsive cRaf binding partner. We found
that cRaf kinase activity was necessary for functional ROS response, but not for
RA-induced growth arrest. Based on our ﬁndings, we proposed a simpliﬁed ontrol
architecture for sustained MAPK activation. Computational modeling identiﬁed
a bistability suggesting that the MAPK activation was self-sustaining. This re-
sult was experimentally validated, and could explain previously observed cellular
memory eﬀects. Taken together, the results of these studies demonstrated that
computational modeling can identify therapeutically relevant targets for humandisease such as cancer. Furthermore, we demonstrated the ability of an iterative
strategy between computational and experimental analysis to provide insight on
key regulator circuits for complex programs involved in deciding cell fate.BIOGRAPHICAL SKETCH
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xxiCHAPTER 1
MATHEMATICAL MODELS IN BIOTECHNOLOGY
Biotechnology uses cellular systems to produce biomolecules that beneﬁt society.
One of the core challenges of biotechnology is the understanding of how cellular
mechanisms result in functional responses. Through evolution, cellular systems
have been optimized to overcome obstacles to survival including their purposeful
reprogramming. Thus, a major obstacle limiting biotechnology applications is the
complexity of the cellular systems involved. This obstacle arises from the intrinsic
complexity of the biomolecules involved (proteins, DNA, RNA, lipids, etc.) and the
large number of interactions between them [188]. These interactions are organized
into vast complex networks which sense and execute cellular programs important
for proliferation and survival. Therefore, to properly understand the operation of
cells, one must consider the properties of individual biomolecules and their role in
complex interaction networks.
Many have suggested that the integration of experimental and computational
research is required to unravel critical questions facing modern cell biology [9].
Toward this end, mathematical modeling has become an important tool to under-
stand biological complexity. A common method of modeling biological pathways
is to formulate coupled Ordinary Diﬀerential Equations (ODEs) or large stoichio-
metric network models. ODE models have been constructed for a range of signal
transduction processes [155, 111, 295, 323, 268, 209, 324, 316]. However, to formu-
late and solve these models both the network structure and parameter estimates
are required. Yeast Two-Hybrid (Y2H) [97, 38, 342, 163], Fluorescence Resonance
Energy Transfer (FRET) [388] or Chromatin Immunoprecipitation (ChIP)-DNA
microarray techniques [93, 114, 148, 204] have all been used to identify network in-
1Table 1.1: Listing of useful databases of observed and hypothesized biomolec-
ular interactions.
DataBase Name Description Website
In silico Organisms Genome scale metabolic networks  http://systemsbiology.ucsd.edu/
In\_Silico\_Organisms/Other\_
Organisms
BioModels Curated database of published mecha-
nistic models
http://www.ebi.ac.uk/biomodels
-main/
KEGG Pathway maps, and other protein/gene 
resources 
http://www.genome.jp/kegg/
Science Signaling Database of cell signaling pathways  http://stke.sciencemag.org/cm/
TRANSFAC Database of Transcription Factors  http://www.gene-regulation.com
/pub/databases.html
String Database of predicted protein interac-
tions and associations
 http://string-db.org/ 
NetworKIN Data on predicted in vivo kinase-
substrate relationships
http://networkin.info/search.php
teractions. Although error prone [96, 353], these techniques along with traditional
low-throughput Immunoprecipitation have been the basis for most experimental
network discovery. Computational motif discovery [233, 373, 175], high-throughput
network reconstruction [387, 333, 126, 215] or text processing [5], have also con-
tributed signiﬁcantly to network identiﬁcation. The integration of these studies
has led to comprehensive on-line network databases (Table 1.1). However, while
network structural knowledge continues to evolve, the challenge shifts towards
identifying strategies to properly make use of the data. Due to the dimensionality
of the problem, computational methods are perfect candidates for data assimila-
tion and interpretation as well as the synthesis of new hypotheses (see Table 1.2
for examples of avalible software).
2Table 1.2: Listing of useful simulation packages and tools for biomolecular
interaction networks.
Package Name Description Website
SBML A verity of tools for SBML formatted 
networks 
http://sbml.org/Main\_Page 
Systems Biology 
Workbench 
Software framework for applications 
in systems biology 
http://sbw.sourceforge.net/
COBRA ToolBox  COnstraint-Based Reconstruction 
and Analysis Toolbox
http://gcrg.ucsd.edu/Download
s/Cobra\_Toolbox
Universal Code 
Generator
Tool for generating mathematical 
code for mechanistic modeling
http://code.google.com/p/unive
rsal-code-generator/
Sloppy Cell  Software environment for parametric 
ensemble analysis
http://sloppycell.sourceforge.n
et/
StochKit C++ software for solving stochastic 
and hybrid simulations
http://engineering.ucsb.edu/~c
se/StochKit/
Snoopy  Tool to model and execute hierar-
chical graph-based systems.
http://www-dssz.informatik.tu-c
ottbus.de/index.html?/software
/snoopy.html
1.1 Metabolic network models and Flux balance analysis
(FBA)
Stoichiometric models and Flux balance analysis (FBA) are probably the most per-
vasive tools for modeling metabolic interaction networks; see [270, 250]. Stoichio-
metric models have emerged as powerful analysis tools that couple extracellular
phenomena (uptake/production rates, growth rate, product and biomass yields,
etc.) with intracellular carbon and energy ﬂux distribution. Constraints-based
stoichiometric models do away with kinetics in favor of a pseudo-steady-state pic-
ture of metabolism. At the core of FBA is a description of the reaction network
stoichiometry available to the cell. All possible reactions are encoded in the stoi-
chiometric matrix which is to constrain how materials, such as glucose or oxygen,
can be processed by a cell (Fig. 1.1A). Each row of the stoichiometric corresponds
to a metabolite in the network, while each column corresponds to a reaction. Entry
ηi,j contains the stoichiometric coeﬃcient for metabolite i in reaction j. A negative
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Figure 1.1: Schematic of FBA analysis. (A) Top depicts ﬂow/ﬂux through
the metabolic network. Bottom is an example reaction to iden-
tify stoichiometric coeﬃcients negative values indicate reactants
in the example reaction and positive values indicate products.
(B) Bottom shows the FBA constraints and objective function.
Top shows the space identiﬁed by the given constraints. The ex-
treama of the space is searched via linear programing for optimal
solutions to the objective function.
value for ηi,j indicates that metabolite i is consumed by reaction j, while positive
values indicate the metabolite is produced.
FBA and stoichiometric models have been employed to calculate genomic-scale
snapshots of several organisms as well as portraits of key subnetworks such as
central carbon metabolism. One of the ﬁrst examples of what would evolve into
FBA was the analysis of butyric-acid bacteria by Papoutsakis [254, 255, 256].
Later, Varma, Palsson and coworkers employed a stoichiometric model of E.coli
W3110 to study oxygen limitation and byproduct secretion [346, 347]. Vallino and
Stephanopoulos employed FBA to exploreCorynebacterium glutamicum during ly-
4sine overproduction [345, 344], while Sauer et al., characterized the metabolic ca-
pabilities of riboﬂavin producing B.subtilis [287]. Pramanik and Keasling explored
the impact of time varying biomass composition and E.coli metabolism [264, 265]
while Maranas and coworkers explored the performance limits of E.coli subject to
gene additions or deletions [33], the coupling of metabolic ﬂuxes in large-scale net-
works [34], the generation of optimal gene deletion strategies [260], the production
of lactic acid in E.coli [102] and the computational identiﬁcation of reaction acti-
vation/inhibition or elimination candidates in metabolic networks [261]. Edwards,
Schilling, Palsson and coworkers extended FBA to genomic-scale metabolic recon-
structions of Helicobacter pylori 26695 (389 reactions) [291], E.coli MG1655 (740
reactions) [85, 84], E.coli K-12 (931 reactions) [273], S. cerevisiae (1173 reactions)
[103] and most recently to the human metabolic map with a genome scale recon-
struction consisting of 3,311 metabolic and transport reactions and 2,766 metabo-
lites [82]. An attractive feature of constraints-based models is the relative ease of
computation (solving a linear program or determining a matrix inverse) and the
ability to directly incorporate process information, for example on-line CO2, O2 or
cellmass measurements into the constraints (see Savinell and Palsson for discussion
of optimal measurement selection [290] or Becker et al., for FBA software [23]).
In addition to physiological measurements, 13C-NMR/GC-MS labeling techniques
have been employed by many groups to add additional constraints to the ﬂux cal-
culation [398, 325, 292, 286, 285, 293, 365, 68, 40, 220, 364, 360, 90, 98, 318, 99].
Sauer et al., (and others) have pushed 13C enhanced metabolic ﬂux estimation be-
yond serial experiments into the realm of parallel high-throughput data generation;
see [284]. FBA simulations have also been used to inform our understanding of the
underlying biology. For example, Nakahigahi and co-workers performed FBA sim-
ulations of multiple knockout E. coli strains under 12 diﬀerent growth conditions
5using a comprehensive network model [242]. They identiﬁed previously unknown
glycolytic enzymes activities that allowed transaldolase knockouts to grow. Thus,
by examining where simulations failed, Nakahigahi and co-workers suggested al-
ternative metabolic pathways which must have been functional but not included
in the initial comprehensive metabolic model.
Limitations of traditional FBA include the loss of dynamic metabolite infor-
mation, the inability to model dynamic transients and uncertainty concerning the
choice of objective function. Flux distributions estimated by FBA are calculated
by solving the mass balance equations at steady-state. Typically, FBA is posed
as a Linear Programming (LP) problem. A space of feasible solutions is deter-
mined by the mass-balances and ﬂux constraints (Fig. 1.1B). LP is then used to
identify a particular solution, or set of solutions, that maximize a given objective
function. Thus, because only the ﬂux distribution is estimated by FBA, time-
resolved metabolite trajectories are lost. However, the traditional FBA problem
can be re-formulated as an iterative optimization problem to model dynamic tran-
sients, e.g., the growth of E. coli in batch cultures. Dynamic ﬂux balance analysis
(dFBA), ﬁrst proposed by Doyle and coworkers [221], uses extracellular concen-
tration information to calculate the maximum allowable uptake and production
rates. These rates can then be used as constraints on FBA calculations solved
iteratively until a speciﬁed end-point is reached. Another challenge to traditional
FBA is the choice of objective function. In general, an inﬁnite number of objective
functions are possible. However, objective functions should be biologically moti-
vated and may be interpreted as a particular phenotype for the organism, e.g.,
the maximization of growth rate. The ultimate choice of objective function is de-
termined by the system and the type of analysis desired; see [296] for a study of
several diﬀerent objective functions in E. coli. Of course not all objective functions
6must be linear. One could assume that the organism works to minimize intracel-
lular ﬂuxes, e.g., the minimization of the Euclidean norm of the ﬂux vector v. In
these cases, the structure problem is no longer feasible as an LP, and alternative
optimization methods must be employed. Many packages are available for exe-
cuting sophisticated nonlinear optimization algorithms. For example, the LINDO
package (http://www.linod.com) is a commercially available package which can be
interfaced with COBRA for solving nonlinear FBA problems.
1.2 Modeling, Analysis and Reverse Engineering of Gene
Regulatory Networks (GRNs)
FBA has been successful in many studies; however, its predictive ability is limited
because it does not include gene expression information. In cellular systems the
level and activity of enzymes and other proteins are tightly regulated. Regulation
of proteins takes place at a genetic level where transcription factors bind the DNA
and promote, or inhibit, the transcription of speciﬁc proteins. This regulation
helps control the expression levels of enzymes, signaling molecules and even other
transcription factors. In a very real sense the regulation of genes leads to another
layer of gene regulation, and so on. It is, therefore, reasonable to construct gene
regulatory networks where nodes represent genes and the connecting edges repre-
sent regulatory interactions. Many computational methods have been developed
for studying such networks; see [174] for a review on modeling gene regulatory
networks.
A number of studies have been conducted and frameworks proposed to ex-
tract regulatory networks from gene expression data. Most early network inference
7methods relied primarily on clustering genes on the basis of their expression pro-
ﬁles [86, 359, 72, 80]. Recently, there has been considerable interest in developing
computational tools that go beyond answering the question of whether two or more
genes have similar expression proﬁles. Instead, the central question has become
whether we can uncover, hidden within gene expression data, the signature, extent
and directionality of interactions between diﬀerent genes. In other words, rather
than simply grouping genes with similar expression proﬁles, new methods have
attempted to learn gene regulatory patterns from expression data.
Broadly, these methods can be classiﬁed into two distinct categories based
on their fundamental treatment of gene interactions. Deterministic model-based
methods assume there exists a deterministic formalism Y = f(X) that captures
the eﬀect of expression level of gene X on gene Y. Diﬀerent choices for the function
f(x) (e.g., linear, sigmoidal, etc.) have given rise to many versions of model-based
methods [357, 72, 150, 74, 392]. Conversely, stochastic model-based methods start
by postulating that experimentally observed gene expression proﬁles correspond to
samples drawn from an unknown multivariate probability distribution. Bayesian
networks provide a popular alternative for achieving this objective by postulating
a multivariate joint conditional probability model that explains the observed ex-
pression data [105, 259]. In addition to classifying gene network inference methods
based upon the mathematical formalism used to model the control program, a
further distinction can be made based upon how gene expression is handled within
these formalisms. Boolean and logical networks were among the ﬁrst formalisms
proposed to model gene interactions [313, 3, 160, 207]. In logical models, the state
of a given system is described by discrete values at discrete time points. Thus,
logical models are time-invariant in the sense that the next state is determined
only by the current state. Boolean network models are a speciﬁc realization of
8the logical modeling paradigm. In the Boolean approach, genes are assumed to be
either ON or OFF and the input-output relationships between them are modeled
through deterministic logical functions (such as AND, OR, NOT, etc.).
A powerful use of gene regulatory networks is in combination with conven-
tional FBA. Covert and Palsson demonstrated the eﬀects of gene regulation in
the central metabolism of E. coli [63]. In this study, gene regulation was repre-
sented as a logical boolean network using the logical operators AND OR NOT.
Using experimental data, various logical rules were developed which deﬁned the
regulation function for 149 genes that represented both regulatory proteins and
enzymes. If the gene of a particular enzyme was not active (a value of 0) then the
corresponding reaction column was removed from the stoichiometric matrix. Stan-
dard FBA optimization was then performed using the new stoichiometric matrix.
This gene regulatory FBA (rFBA) method was capable of predicting phenotipic
growth responses that conventional FBA could not. Of course, gene expression
is not limited to discrete values. Continuous dynamic models of gene regulatory
networks have also been considered. More recently, an extension of this approach
to account for uncertainty in expression data has been proposed in the form of
probabilistic Boolean networks [4, 305, 306]. However, in most real gene expres-
sion settings, Boolean idealizations may not be appropriate as genes are expressed
at continuously varying intermediate expression levels [169]. Consequently, more
general approaches have been proposed which model mRNA expression level as
a continuously varying quantity. These include linear weight modeling [72, 357],
linear and nonlinear ordinary diﬀerential equations [47, 67, 126], graph-theoretic
and hierarchal models [77, 24, 53] and S-systems [289, 4, 223, 180].
91.3 Continuous ordinary diﬀerential equation based dy-
namic models
The deepest level of network analysis ultimately culminating in the prediction
of dynamics, for example, the metabolic reprogramming observed in the seminal
work of Brown and coworkers during the diauxie shift in Saccharomyces cerevisiae
[71], requires that stoichiometry and kinetics be married with regulation and con-
trol. Constructing multiscale or hierarchal models of physiology is not new; Shuler
and coworkers in the late 1970s and early 1980s formulated dynamic single cell
models of Escherichia coli [309, 308, 78, 79], Chinese Hamster Ovary (CHO) cells
[366, 367] and S. cerevisiae [320]. These models were capable of predicting physi-
ological characteristics ranging from the dependence of cell geometry upon growth
rate and the impact of nutrient conditions [78, 201, 11] to plasmid replication and
host-plasmid interactions [182, 12, 181]. Many examples of the single cell model
paradigm can be found in the literature, see Shuler [307]. While arguably being the
best formalism to describe cell growth and physiology, single cell models are com-
putationally expensive, require a large number of kinetic parameters and detailed
biological knowledge [307]. Reuss and coworkers have developed structured unseg-
regated dynamic models (state averaged over the population) of both S. cerevisiae
[278, 222] and E.coli [46] and have studied the in-vivo dynamics of key pathways
such as the Pentose Phosphate Pathway (PPP) and sugar transport in S.cerevisiae
[348, 37]. Dynamic models of varying complexity has also been constructed to
study the penicillin biosynthetic pathway [246, 393, 334], threonine pathway dy-
namics [45, 44], regulatory architectures in metabolic reaction networks [137, 136],
red-blood cell metabolic pathways [170, 171, 202, 164, 177] and plant metabolic
pathways [66, 263, 237].
10As with other modeling strategies, continuous dynamic models are centered
around modeling the time-evolution of the protein-protein and protein-DNA in-
teraction networks. These networks can also be formulated as a stoichiometric
matrix which links species through protein-protein or protein-DNA interactions.
Unlike FBA, however, the form of the reaction kinetics is explicitly assumed (Fig.
1.2). A variety of physically motivated rate formulations have been considered.
The most common formulations are mass-action, which considers the reaction
rate to be proportional to the product of the reactants, and Michaelis-Menten
kinetics, which assumes quasi steady-state to simplify the mass-action formal-
ism. The stoichiometric matrix and rate formulations are combined to form a
system of ordinary diﬀerential equations (ODEs) that describe the mass balances
around each species in the network. Typically such systems are coupled and non-
linear, and must be solved numerically. Several software packages, including li-
braries and integrated stand alone platforms, are available for solving nonlinear
ODEs (Matlab, The Mathworks Inc. Natick MA; Octave, http://www.octave.org;
Sundials, https://computation.llnl.gov/casc/sundials/main.html; GSL-GNU Sci-
entiﬁc Library, http://www.gnu.org/software/gsl/). There also exists soft-
ware packages designed speciﬁcally for modeling biochemical reaction net-
works. The Systems Biology Workbench is an SBML-based software frame-
work for assembling models, performing simulations and conducting analysis
(http://sbw.sourceforge.net). Doyle and coworkers developed the BioSens pack-
age (part of the BioSpice program) which provides a sensitivity analysis toolkit for
model analysis (http://www.thedoylegroup.org/research/ software.html). Varner
and co-workers developed UNIVERSAL, a free source software package that allows
for automatic code generation in several common programming languages (Matlab-
M, Octave-M/C++, GSL-C,Sundials-C, Scilab-M etc) from ﬂat-ﬁle of SBML in-
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Figure 1.2: Schematic of continuous ODE analysis. Left depicts signal trans-
duction network. The network is formulated into a stoichiometric
matrix, S, which is combined with the rate vector, r, to deter-
mine the rate of change of the network species, x. Right shows
an example of continuos protein trajectories, ERK and pETS,
from an external response, EGF. Trajectories may be bounded
to represent variations due to parametric uncertainty.
puts (http://code.google.com/p/universal-codegenerator/).
Continuous dynamic models are well suited for modeling signal transduction
through cellular interaction networks. One of the most extensively modeled cellu-
lar networks is the Epidermal Growth Factor Receptor (EGFR)/ Mitogen Activate
Protein Kinase (MAPK) cascade [362]. EGFR-MAPK is a prime example of a com-
mon cellular control circuit, in which extracellular signals are sensed by transmem-
brane receptors. These signals are then propagated through the cellular network
via a series of enzymatic reactions ultimately resulting in regulation of protein
expression proﬁles. The central enzyme in MAPK is the Extracellular Regulated
Kinase (ERK) which activates a variety of Transcription Factors[337, 139, 200].
Wiley and Cunningham [361] developed an early system of rate equations to model
binding, internalization and degradation of the EGFR ligand, Epidermal Growth
12Factor (EGF). Although the analysis was predominantly at steady-state, they pre-
dicted that experimentally observed down-regulation of EGFR activity was due
to preferential internalization of bound EGFR opposed to the previously held hy-
pothesis of a change in EGFR recycling dynamics. Starbuck and Lauﬀenburger
[319] later developed a more detailed model of the dynamic EGF response which
supported the internalization hypothesis and was eventually experimentally con-
ﬁrmed. Recently, Chen et al. [48] compiled a large mass-action kinetic model of
multiple ErbB receptors signaling through various kinase pathways. The model,
which consisted of 499 nonlinear coupled ODEs, described the activation of ERK
and AKT kinases via the EGF and HRG ligands. Model analysis showed that ki-
nase sensitivity was strongly dependent on ligand choice and further demonstrated
the necessity of considering biological functions from a systems level point of view
as opposed to isolated modules. The previously deﬁned EGFR/MAPK networks
has been used in conjunction with other subsystems to study speciﬁc biological
functions. Tasseﬀ et al. [331] developed a mass-action kinetic model of signaling in
androgen-dependent/independent prostate cancer cells. The model included sub-
systems of EGFR HER2 receptor signaling, MAPK, AKT, androgen signaling and
transcriptional/translation regulation. The prostate cancer model recapitulated
experimental observations including the synergistic eﬀect of ERK and AKT on
proliferative regulation and further to suggested that the positive synergy resulted
from the above additive activation of the translational machinery. Continuous dy-
namic models have also successfully described cell cycle regulation. Tyson, Novak
and coworkers used nonlinear dynamic analysis techniques analyze increasingly
complex cell cycle models [339, 340, 247]. They identiﬁed dynamic behavior such
as hysteresis, bistability and various bifurcations along with irreversible switching
motifs that provide directionality to cell cycle.
13Although the mass-action formulation allows for dynamic calculation of all
model species, it is dependent on a large number of typically unknown kinetic
parameters. Initial dynamic models relied on experimentally determined kinetic
parameters. However, due to limited experimental data very few parameters are
known. Furthermore, experimentally determined in vitro rate constants do not
necessarily equate to the corresponding in vivo constants. Other strategies have
focused on identifying the “best ﬁt” rate constants that minimize the diﬀerence
between simulation and experimental data. However, the high dimensionality of
physically relevant interaction networks makes it impossible to uniquely identify
all model parameters. Given the issue of parametric uncertainty, ensemble ap-
proaches have become increasingly important. Ensemble approaches, which use
uncertain model families, have emerged to deal with uncertainty in systems biol-
ogy and other ﬁelds like weather prediction [21, 195, 31, 253]. Their central value
has been the ability to quantify simulation uncertainty and to constrain model pre-
dictions (Fig. 1.2). For example, Gutenkunst et al. showed that predictions were
possible using ensembles of signal transduction models despite sometimes only
order of magnitude parameter estimates [128]. Beyond their ability to robustly
describe data, uncertain deterministic ensembles might be a course-grained strat-
egy to explore population dynamics when stochastic simulation is too expensive.
There are several techniques to generate parameter ensembles. Battogtokh et al.
and later Brown et al. generated experimentally constrained parameter ensembles
using a Metropolis-type random walk through parameter space [21, 31]. In these
studies, an initial parameter guess p0 was iteratively reﬁned to maximize the likeli-
hood of describing experimental training data. Parameter sets were admitted into
the ensemble depending upon the autocorrelation function of the model trajecto-
ries. Sloppy Cell, the software package used for their analysis, is freely available
14(http://SloppyCell.sourceforge.net/). Other strategies, for example Pareto Opti-
mal Ensemble Techniques (POETs), have also been used to identify ensembles of
model parameters [316]. Multiple objective ensembles are particularly attractive
when considering data from multiple sources as discrepancies and even contradic-
tions are not uncommon even when experimental protocols diﬀer only slightly.
Kinetic parameters also oﬀer another handle for analysis. One powerful method
is parametric sensitivity analysis which considers the eﬀect of parameter perturba-
tions on model species concentration proﬁles. Many studies have linked parameter
sensitivity to physiological properties. Stelling et al. computed overall sensitiv-
ity coeﬃcients to explore the fragility and robustness of circadian rhythm [321].
By analyzing two dynamic models of the circadian clock they concluded that the
networks robustness could be contributed to a hierarchical network structure. Ro-
bustness, the ability to maintain function in the face of perturbation, is a common
feature of cellular networks. It is likely that the complexity of such systems is due,
in part, by the requirement of maintaining robust features. Doyle and coworkers
explored robustness from the stand point of highly optimized tolerance, which sug-
gests that networks have evolved to eﬃciently deal with expected perturbations
[322]. Overall sensitivity coeﬃcients can also identify fragile points within the
network structures. Both Luan et al. and Nayak et al. observed that fragile net-
work mechanisms were consistent with therapeutic targets in coagulation and cell
cycle networks [218, 244]. Kholodenko et al. employed a variation of sensitivity
analysis to calculate response coeﬃcients to identify physical network connections
[179]. By comparing global and local responses they were able to predict the phys-
ical interactions between modular components within signaling a gene regulatory
networks.
151.4 Single cell models and stochastic simulations
Continuous deterministic models rely on continuum mathematics and ignore dis-
crete events. However, molecular reactions occur in a discrete manner between
individual molecules. If the number of molecules present is large enough then the
continuum assumption is valid. However, in instances where only a few molecules
are interacting the continuum assumption breaks down. For example, Elowitz and
coworkers constructed a synthetic gene network, the Repressilator, which under-
goes noisy oscillatory behavior [88]. They later quantiﬁed the “noisiness” of gene
expression at a single cell level to identify both intrinsic and extrinsic ﬂuctuations
[89]. In such systems alternative simulation methods may be necessary. The Gille-
spie stochastic simulation algorithm (SSA) is a kinetic Monte Carlo method that
simulates dynamics one reaction at a time [117] for a review on SSA and other
stochastic methods see [119]). In SSA we again have a system of species which
can be described by a state vector (number of molecules for each species). These
species interact with one another through several reaction channels. The reactions
can be described in a similar manner to the continuous system, by a stoichiometric
matrix and a propensity function. The propensity function is analogous to the
rate equation, but instead of a rate describing a given reaction, it quantiﬁes the
probability that a reaction will occur given the current state between t and t+dt.
Because SSA considers the occurrence of every reaction event in the system, the
algorithm is slow. Many methods have been developed to improve the speed of
the SSA algorithm. One of the most popular methods is τ-leaping, which is an
approximation to SSA [118]. The τ-leaping algorithm works by pre-selecting a
value for τ and using random numbers to identify what reactions occurred in that
interval. If there is approximately no change in the state, x, over the interval
[t,t + τ] then x at time t can be used to evaluate the propensity for all reactions
16within the interval. The reactions which occurred in the interval are described by
a Poisson distribution. The speed up of τ-leaping comes from solving for several
possible reactions in a single iteration. However if τ is too large then the state
may change considerably over the interval and the approximation will fail.
SSA and variations on SSA have been employed to model a variety of biological
systems. For example, Hemberg and Barahona used a variation on SSA to study a
synthetic regulator circuit [145]. Arkin and coworkers demonstrated that stochastic
ﬂuctuations in gene expression promoted population heterogeneity and ultimately
host evasion in lambda phage [7]. Gonze and Goldbeter produced a stochastic
analysis of a simple core model for circadian rhythms. They observed that ro-
bust oscillations of the circadian clock were possible with only tens of regulatory
molecules, far bellow the continuous limit [121]. Schultz et al. used molecular-level
stochastic simulations to model the transition between vegetation and competence
in Bacillus subtilis [297]. They demonstrated that such a transition can occur
in the absence of bistability when stochastic ﬂuctuations are present which drive
the system to an excitable unstable ﬁxed point of competence. Although simple
cases where stochastic eﬀects are important have been identiﬁed, many biologically
relevant systems are considerably larger. Due to ineﬃciency, even using approx-
imations like τ-leaping, full stochastic models may not be feasible. Fortunately,
such large systems are heterogeneous in the sense that some species at certain
time s may require stochastic simulations while other species may not. Recently
several methods have been developed to partition systems into sub-systems where
the fastest and most appropriate algorithm can be employed. Harris and Clancy
developed one such algorithm termed partitioned leaping [133]. Here the system of
reactions is separated into multiple groups ranging from low frequency (employing
exact SSA) to high frequency (employing standard deterministic ODE methods).
17Rates that fell between these two extremes were modeled with various approx-
imations to SSA including τ-leaping. They were able to capture the stochastic
behavior of various systems but at a reduced computational cost. Gillespie, Pet-
zold and co-workers have assembled a toolkit, StochKit, of stochastic methods
(http://engineering.ucsb.edu/cse/StochKit/). The software toolkit is freely avail-
able and open source. StochKit can be used to carry out the methods described
here along with many others [208].
1.5 Qualitative models: fuzzy logic and petri nets
The dimensionality and nonlinearity of biologically relevant interaction networks
makes it diﬃcult to predict many features using intuition. As model sizes increase
towards the genome-scale, structural and parametric uncertainty makes models
intractable to identify even with complex computational methods. To this end,
strategies need to be be developed to formulate qualitative predictions.
Fuzzy logic is one method of incorporating qualitative or semiquantitative rules
into biochemical models. Similar to boolean networks, fuzzy logic relies on logical
statements like IF THEN. However, variable values are not restricted to boolean
TRUE FALSE values. Instead variables can have many values and can belong to
multiple groups or sets at the same time (Fig. 1.3). Lee et al. established a set
of fuzzy logic rules to describe diﬀerent regions of enzymatic activity in the core
metabolism of Escherichia coli [138]. Fuzzy logic rules supplemented a standard
kinetic formulation and resulted in better ﬁts to data. Aldridge and coworkers
recently presented a complete fuzzy logic formulation of a TNF/EGF signaling
network in colon carcinoma cells Aldridge2009. In this formulation logical gates
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Figure 1.3: Schematic of fuzzy versus boolean logic analysis. Left depicts
signal transduction as a logical gate. Based on the gate inputs
the sate of pERK is determined to be low or high. Boolean
species are members of one and only one group well fuzzy logic
allows members to be partially in multiple groups, as depicted
by the continuous trajectory at top right.
connect input to output species. The species were members of groups represented
using membership functions (ie. High Medium Low). The membership function
determined a variables degree of membership. Therefore, it was possible to have
a variable at some degree of ‘on’ as opposed to on/oﬀ TRUE/FALSE values. Fur-
thermore, the logical rules were weighted so one rule had a higher impact on a
species degree of membership as compared to other rules. The TNF/EGF model
recapitulated kinase crosstalk and predicted inhibition of IKK via EGF. More-
over, the authors discussed the relative ease and the intuitive nature of modeling
biological networks using fuzzy logic.
Petri Nets are another way of modeling a distribution of states for a system
19of interacting elements. A petri net is formed by a collection of passive nodes,
places, connected via edges, arcs, through active nodes, transitions. The concept
of tokens are used to quantify the state over the collection of places in the model. At
each turn, transitions may move tokens from one place to another based on a set of
rules and the current state. Petri nets are straightforward abstractions of biological
interaction networks. For example, Heiner, Koch and Will constructed a large petri
net model of apoptosis [141]. Sackmann, Heiner and Kock demonstrated the ability
of petri nets to predict qualitative behavior of mating pheromone response pathway
in Saccharomyces cerevisiae. Finally, Heiner and coworkers developed a software
platform, termed Snoopy, which provides a systematic framework for modeling
qualitative, stochastic and continuous petri nets (http://www-dssz.informatik.tu-
cottbus.de/snoopy.html).
1.6 Conclusion
In this chapter we outlined modeling techniques to simulate cellular networks and
systems. Ultimately the choice of method depends upon both the system in ques-
tion and the goal of the analysis. For example, steady-state bioreactor optimization
for a speciﬁc metabolic process may be done entirely using Flux Balance Analysis
(FBA). FBA has beneﬁted from genome-level descriptions of metabolic networks.
However, conventional FBA tends to fail for cases in which gene regulation is
critical. In these cases, FBA should be augmented using regulatory ﬂux balance
analysis (rFBA). The inclusion of even simple boolean gene regulator networks sig-
niﬁcantly improves the predictive power of FBA. In instances when a steady-state
analysis is insuﬃcient, continuous deterministic simulations can be implemented.
Similar to FBA, continuous simulations are based on a ﬁxed interaction network,
20but also include kinetic information as well. Of course, chemical reactions are not
truly continuous processes. On occasions where rates are limited or species concen-
trations are low, stochastic simulations may be necessary. Stochastic simulations
can be important in gene regulatory or single cell dynamics. With networks in-
creasing in size and complexity, the most powerful models may be hybrid models
that combine the beneﬁts of diﬀerent simulation techniques. Simulation schemes
augmented with qualitative methods, e.g., fuzzy logic or petri nets, beneﬁt from
the wealth of qualitative biological information in the literature.
21CHAPTER 2
UNIVERSAL: AN EXTENSIBLE PHYSIOCHEMICAL MODEL
GENERATION AND ANALYSIS FRAMEWORK FOR MAC OS X
2.1 Summary
Physiochemical models which describe system-level responses can prioritize exper-
imental directions, generate testable hypotheses and perhaps identify therapeutic
targets. However, the construction and analysis of these models is challenging be-
cause of their scale and complexity. Automatic code generation, which minimizes
human coding errors and improves model throughput, is essential for large-scale
model development. To address these challenges, we developed UNIVERSAL.
UNIVERSAL is an extensible code generation framework for Mac OS X which pro-
duces editable, fully commented platform-independent physiochemical model code
in several common programming languages from a variety of inputs. By default,
UNIVERSAL generates mass-action ODE models of intracellular signal transduc-
tion processes and model analysis code, such as adjoint sensitivity balances. How-
ever, UNIVERSAL is also highly extensible; through its plug-in architecture it can
generate multiple simulation types, e.g., ﬂux balance or kinetic metabolic models,
in addition to ODE signal transduction models. UNIVERSAL is a client-server
application; the client graphical user interface (GUI) is written in the Objective-C
programming language and uses the Cocoa application framework. The UNIVER-
SAL code generation engine (CGE) is written in Java. Thus, while the GUI is
limited to Mac OS X, the CGE can run on multiple platforms. UNIVERSAL is
open source and free for academic and industrial users (available under an MIT li-
cense). The source code and compiled versions of UNIVERSAL can be downloaded
22from the UNIVERSAL Google Code page (http://code.google.com/p/universal-
code-generator/).
2.2 Introduction
Construction and analysis of large-scale physiochemical models is challenging be-
cause of their scale and complexity. Automatic code generation, which minimizes
human coding errors and improves model throughput, is essential for large-scale
model development. Many software packages facilitate model construction, e.g.,
CellDesigner [110] or VirtualCell [216]. Typically, these packages interface with
model description ﬁles e.g., Systems Biology Markup Language (SBML) [157], or
Systems Biology Graphical Notation (SBGN) to generate and solve model equa-
tions [110]. However, these packages are sometimes opaque in terms of the imple-
mentation and solution of the model equations. Thus, while unparalleled in their
ease of use, they may not meet the needs of power users who are comfortable di-
rectly interacting with source code or require advanced simulation scenarios such as
parallel or GPU-accelerated computing. To address these challenges, we developed
UNIVERSAL. UNIVERSAL is an extensible source code generation framework for
Mac OS X. UNIVERSAL produces fully commented, platform-independent phys-
iochemical model code in multiple programming languages from a variety of inputs
(Table S1). The primary objective of UNIVERSAL is the generation of mass-action
ordinary diﬀerential equation (ODE) models of intracellular signal transduction
networks. However, UNIVERSAL also generates model analysis code (e.g., analyt-
ical adjoint sensitivity balances) along with model identiﬁcation code (compatible
with both single and multiobjective problem formulations). Lastly, UNIVERSAL
is highly extensible; through its plug-in architecture, UNIVERSAL generates mul-
23tiple simulation types in addition to code in common programming languages. For
example, UNIVERSAL generates Flux Balance Analysis (FBA), dynamic FBA
(dFBA), or kinetic metabolic model code from SBML network descriptions through
its simple plug-in architecture. Additionally, UNIVERSAL generates visualization
formats used by common programs such as GraphViz (www.graphviz.org) or the
SIF format used by Cytoscape [57].
2.3 Architecture
UNIVERSAL is a client-server application; the client graphical user interface
(GUI) is written in the Objective-C programming language and uses the Cocoa
application framework (Apple, Cupertino CA). The UNIVERSAL code genera-
tion engine (CGE) is written in Java (Oracle, Redwood Shores CA). Thus, the
GUI is limited to Mac OS X, while the CGE can be run on multiple platforms.
The GUI facilitates graphical editing of XML speciﬁcation ﬁles (.uxml extension)
used by the CGE (Fig. 2.1). Transformation properties, e.g., paths to input
ﬁles or code generation options such as memory optimizations, are deﬁned in the
speciﬁcation ﬁle edited by the GUI. Each instance of the GUI manages a single
speciﬁcation ﬁle from which a CGE process can be initiated. In addition to UNI-
VERSAL speciﬁcation ﬁles, the GUI can edit generic XML tree structures where
data is contained in attributes e.g., SBML. The central architectural requirement
of the CGE is that all input and output handlers produce and consume a common
data structure (currently SBML). While this is a strict requirement to interface
with the built-in CGE code types, it is not a requirement for custom code types.
Classes implementing the IInputHandler interface transform raw-input ﬁle types
to SBML, while IOutputHandler implementations read the SBML tree in memory
24Toolbar: Open specification (*.uxml), save specification, check specification, execute job, quit
Problem specific properties:
Information about what files will get created and where
Properties window: set the values for CGE and problem attributes
Code Generation Engine (CGE) properties:
Paths and jar files (locations the CGE needs to know about)
Add, delete and action: Add/delete 
attributes, automate setting the value for 
attributes
Add, delete and action: Add/delete properties nodes, change 
node name
Console window: Debug information sent 
here. Supports cut/paste
Figure 2.1: Screen shot of the UNIVERSAL graphical user interface (GUI)
running on Mac OS X 10.6.6. The user selects property nodes
from the speciﬁcation tree on the left-hand panel. The upper-
right hand panel displays context speciﬁc property-value pairs
for the selected speciﬁcation, which the user can edit. Both the
speciﬁcation tree and the property-value pairs are fully editable.
Thus, the user can deﬁne custom nodes/ attributes on the spec-
iﬁcation tree. Once all required properties have been entered by
the user, the speciﬁcation tree can be saved to disk and used to
generate model code.
and generate code.
The UNIVERSAL architecture allows for easy plug-in development. Custom
XML speciﬁcations can be created in the GUI by selecting the custom speciﬁcation
option from the drop-down list. Alternatively, custom speciﬁcations can be loaded
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Figure 2.2: Simpliﬁed layout for the UXML speciﬁcation tree.
from disk. To be understood by the CGE, custom speciﬁcation ﬁles need only
include two XML blocks which deﬁne paths and class information required by the
CGE (see Fig. 2.2 for the expected tree layout). Likewise, Java CGE plug-ins must
implement either the IInputHandler or IOutputHandler interface, depending upon
their role. Once compiled, plug-in jar ﬁles can be placed in the plug-ins folder of
the CGE package to be placed on the CGE classpath. Alternatively, the plug-in
classpath can be explicitly speciﬁed in the speciﬁcation tree.
2.4 Models
UNIVERSAL generates models of the form:
dx
dt
= N · v(x,k) x(to) = xo (2.1)
26where x denotes the species concentration vector (M×1), k denotes the parameter
vector (R×1) and v(x,k) denotes the vector of reaction rates (R×1). The symbol
N denotes the stoichiometric or connectivity matrix (M × R) which encodes the
biological interactions included the model. By default, UNIVERSAL generates
mass-action kinetics of the form:
vq (x,kq) = kq
Y
j∈{Rq}
x
−ηjq
j (2.2)
The quantity {Rq} denotes the reactants for reaction q, while kq denotes the rate
constant governing reaction q. The symbols ηjq denote the stoichiometric coeﬃ-
cients (elements of N) for the reactants involved with reaction q. Other model
types, e.g. kinetic metabolic models, are generated with multiple saturation ki-
netics. More specialized kinetics, e.g. Hill functions, can also be generated by
including kinetic laws in the SBML input ﬁle.
2.5 Availability and Requirements
UNIVERSAL is open source and free for academic and industrial users
(available under a MIT license). The source code and compiled version
of the GUI and CGE are available at the UNIVERSAL Google Code site
(http://code.google.com/p/universal-code-generator/). The source code is man-
aged using Subversion. The GUI was developed using XCode 4.0 on Mac OSX
10.6.6. The CGE was developed using Eclipse 3.4.2 on Mac OSX 10.6.6. The
CGE has two external dependencies: libSBML v4.2.0 (compiled using the –
enabled-universal-binary and –with-java options) is used for parsing and ma-
nipulation of SBML [27]. Additionally, the CGE uses the paxtools package
(http://www.biopax.org/paxtools) to interact with BioPAX level 3 ﬁles. Sam-
27ple ﬁles for a prototypical signaling network [315] are included in the Universal
archive. In addition, video tutorials (and other documentation) are available at
Varnerlab.org or from the UNIVERSAL Google Code page.
2.6 Conclusion
UNIVERSAL is an open source physiochemical model generation platform for
Mac OS X. UNIVERSAL generates intracellular ODE signal transduction models,
along with supporting model analysis code, in common programming languages.
UNIVERSAL can also generate other model and simulation types, e.g., ﬂux bal-
ance analysis code. During the upcoming development cycle the UNIVERSAL
programming team will enhance support for BioPAX level 3 documents, as well
as enhancing support of other online database formats. Lastly, we are exploring
the generation of GPU-accelerated model code using the OpenCL framework on
Mac OS X. Lastly, UNIVERSAL also supports the generation of other calculation
types e.g., FBA/dFBA code (Table 2.1).
28Table 2.1: Top: UNIVERSAL version 1.0 feature matrix. Bottom: Calcu-
lation type matrix. Legend:black dot - Implemented, gray dot -
Testing, white dot - Development. Abbreviations: MA - Mass Ac-
tion, BCX - Biochemical experiment ﬁles, SO - Single objective
model identiﬁcation code, MO - Multi-objective model identiﬁ-
cation code, MEMO - Memory optimized code (sparse array),
GPUO - GPU Optimized Code (OpenCL), OC - Objective C
Code, SSC - Sensitivity analysis code.
Output programming and visualization languages Output programming and visualization languages Output programming and visualization languages Output programming and visualization languages Output programming and visualization languages Output programming and visualization languages Output programming and visualization languages
Input FFile SBML Octave-C Octave-M Matlab-M GSL Sundials Scilab GraphViz SIF
FFile
SBML
SIF
BioPAX
Supported Output Capability Supported Output Capability Supported Output Capability Supported Output Capability Supported Output Capability
MA FBA DFBA BCX SO MO MEMO GPUO SSC
Octave-C N/A N/A
Octave-M
Matlab-M
Sundials-C N/A N/A
GSL-C N/A N/A
Obj-C v2.0 N/A N/A
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A COMPUTATIONAL STUDY OF EUKARYOTIC GROWTH
FACTOR-INDUCED TRANSCRIPTIONAL REGULATION
3.1 Summary
Transcriptional regulation is an important aspect of the cellular decision making-
process. In this study, we constructed a mechanistic mathematical model of tran-
scriptional regulation in the context of growth factor-induced protein expression. In
total, the network consisted of 264 model species interconnected by 423 reactions.
We employed ordinary diﬀerential equations (ODEs) as the mathematical frame-
work. We identiﬁed an ensemble of parameter sets that qualitatively described
early EGF-induced gene expression. As a result of the high dimensional parameter
space and limited training data, we identiﬁed a number of statistically uncorrelated
parameter sets that described the training data. However, we observed statistically
consistent model predictions for both structural as well as dynamic perturbations
across the parameter ensemble. We observed the early EGF-induced expression to
be near saturation resulting in a particularly robust signal. Furthermore, we iden-
tiﬁed escape from abortive initiation and P-TEFb-regulated escape from proximal
pausing to be critical rate-limiting steps in EGF-induced but not basal protein
expression. Finally, we demonstrated that simple graph centrality measures did
not correlate with the functional dynamic analysis. We believe that the general
features of the analysis will hold true for genes with qualitatively similar expression
proﬁles. Furthermore, the network architecture and analysis strategies can easily
be adapted to other systems.
303.2 Introduction
Cells have evolved to process information from the outside environment to make
various decisions. At a phenotypic level, these decisions could be to undergo pro-
liferation, apoptosis, diﬀerentiation, migration and other cellular functions. Ex-
tracellular stimuli can also take a variety of forms including chemical, mechani-
cal, thermal and electrical. Arguably the most important way in which the cell
translates a stimulus into a cellular decision is through complex biochemical re-
action networks. Intracellular reaction networks encode ﬁnely tuned programs to
maintain robust function in spite of environmental perturbations [322, 187, 240].
Malfunctions in these programs can lead to improper cellular function and various
disease states [70, 282]. To develop more eﬀective, personalized and even preven-
tative therapeutics we must attain a better, more detailed, understanding of the
programs responsible for deciding cell fate. Transcriptional regulation is a promi-
nent feature of programed cell response and is linked to multiple complex diseases
[61]. A mechanistic understanding of transcriptional regulation provides obvious
beneﬁts in the study of human health.
Sequence-speciﬁc DNA-binding proteins, transcription factors, are a well rec-
ognized aspect of transcriptional regulation [235, 251, 198]. Transcription fac-
tors (TFs) may assume an activated state as a result of a stimulus such as small
molecules or proteins. Once activated, TFs bind to promoter regions of the DNA
associated with speciﬁc target genes and facilitate or inhibit transcriptional ini-
tiation. Furthermore, TFs often control other TFs, promoting waves of tran-
scriptional regulation and a hierarchical network structure [390]. An assortment
of proteins, beyond TFs, are also involved in transcriptional regulation including
cofactors, histone modiﬁers and chromatin remodelers [94, 206]. Furthermore, reg-
31ulation is not restricted to initiation at the promoter and can occur at many points
along the gene. Many experimental studies have worked to identify large gene reg-
ulatory networks [271]. To supplement, experimental results several computational
approaches have been implemented and integrated with data [174, 140, 328]. Al-
though these approaches have oﬀered enormous advances in our understanding of
gene regulation, most employ relational modeling tools; few computational stud-
ies focus on the speciﬁc mechanisms of transcription, and fewer still consider the
multiple points at which regulation can occur. However, there have been many
experimental studies on the general mechanisms of transcription and the many as-
pects of its regulation (for a review of general transcription mechanisms see [106]).
A dynamic computational model with mechanistic detail may prove useful in the
investigation and diﬀerentiation of the many aspects of transcriptional regulation
in cellular function and disease.
An important transcriptional response is the expression of immediate early
genes (IEGs) in response to growth factors [146, 13]. Genes that are induced in
the absence of any intervening protein expression are considered IEGs; these genes
are expressed in the ﬁrst 45 minutes of response. Lau and Nathans ﬁrst observed
rapidly serum-induced genes in the regulation of the G1/S restriction point [199].
One example is the rapid expression of cFos in response to growth factors such as
epidermal growth factor (EGF) [193, 239, 120]. Transcription of cFos is, in part,
regulated by the TF serum response factor (SRF) which binds the cFos promoter
[336]. Furthermore, EGF stimulation has been shown to stimulate SRF phospho-
rylation and activity [266]. Growth factor signaling is transduced through the cell
via transmembrane receptors and enzymatic cascades. One such cascade that is
activated by EGF is the mitogen activated protein kinase (MAPK) cascade. The
central enzyme in MAPK is the Extracellular Regulated Kinase (ERK) which ac-
32tivates a variety of TFs [337, 139, 200]. The activation of ERK is one mechanism
the cell uses to interpret extracellular growth factor signaling into transcriptional
regulation and cellular response. Computational modeling may yield valuable in-
sight into this common yet complex signaling architecture. Although the MAPK
cascade has been extensively studied using computational modeling approaches
[362], the incorporation of MAPK signaling with detailed transcriptional regula-
tion has yet to be considered. In the following, we present a dynamic mechanistic
model of transcriptional regulation in the context of growth factor-induced MAPK
signaling. Several computational techniques were employed to investigate the sys-
tems behavior under dynamic and structural perturbations. We considered the
possible interpretations of diﬀering results between these strategies. Furthermore,
we identiﬁed the transcriptional mechanisms for promoter escape, the active pro-
cess in which the DNA stabilizes within RNA pol II, and escape from proximal
pausing, the state in which RNA pol II has stopped productive elongation near the
promoter, as rate-limiting steps in the growth factor-induced expression of protein.
3.3 Results
3.3.1 Network Connectivity
In this study, we constructed a mechanistic mathematical model of transcriptional
regulation in the context of growth factor-induced protein expression. Roughly,
the network architecture is comprised of four functional groups or subnetworks:
Receptors, MAPK, transcription and Translation (Fig. 3.1). Receptor and MAPK
signaling is responsible for transducing the EGF signal to the nucleus. Mechanisms
33are included for shc-dependent and -independent adaptor complexes, receptor in-
ternalization, ERK-mediated negative feedback and PLCγ/PKC-mediated positive
feedback. The Receptor and MAPK subnetworks considered were similar to those
previously published [331, 332]. The translation subnetwork focuses on the regula-
tion of translation initiation via the PI3K-AKT-mTOR signaling axis and includes
mechanisms for the construction of the translation initiation complex. The transla-
tion subnetwork considered was previously published [243]. Finally, the transcrip-
tional subnetwork was constructed from literature: We considered three discrete
gene locations; this approximates the ability of transcription to take place at dif-
ferent locations on the gene simultaneously. At the gene promoter tata binding
protein (TBP) binds and the general transcription factors undergo ordered assem-
bly to form the promoter initiation complex (PIC) which ultimately binds RNA
polymerase II (Pol2) [100, 329, 185]. The binding of activated transcription factor
attracts histone acetyltransferase (HAT) which catalyzes acetylation and facilitates
TBP binding and PIC assemble [124]. As a simpliﬁcation, we considered only a
generic gene / transcription factor pair and a prototypical expression proﬁle for
IEG in response to EGF. Initiation then begins with DNA melting, abortive initia-
tion, and promoter escape into the open reading frame (ORF) [149, 185, 288, 252].
Once in the ORF productive elongation occurs; however, this process can be halted
20 to 40 nucleotides up from the promoter in a process known as proximal pausing
[288]. Although the exact mechanism is unknown, proximal pausing requires the
association of DRB Sensitivity Inducing Factor (DSIF) and Negative Elongation
Factor (NELF), and does not depend on the presence of nucleosomes or DNA struc-
ture [50]. Escape from proximal pausing is facilitated by Positive Transcription
Elongation Factor b (P-TEFb), which phosphorylates NELF, DISF and RNA pol
II. Other aspects of regulation in the open reading frame include histone modiﬁca-
34tions, which alter DNA structure and can inhibit elongation. Here we consider the
methalation of H4, by SET domain-containing lysine methyltransferase 8 (Set8),
to block productive elongation [206]. Finally, transcription is terminated via 5’-3’
Exoribonuclease 2 (XRN2) [279], and recycling of the PIC can occur. In total, the
network consisted of 264 model species interconnected by 423 reactions. Although
the regulated gene in this study was arbitrary, we believe that the general features
of the analysis will hold true for genes with qualitatively similar expression pro-
ﬁles. Furthermore, the network architecture and analysis strategies can easily be
adapted to a speciﬁc instance.
3.3.2 Model Framework and Generation of Parameter En-
semble
We employed ordinary diﬀerential equations (ODEs) as the mathematical frame-
work by writing mass-balances around the 264 individual species. We assumed
mass-action kinetics to describe the reaction rates. Typical reactions describe as-
sociation, disassociation and catalytic events. This formalism produced a system
of coupled nonlinear ODEs with a single rate constant corresponding to each of
the 423 reactions. The 423 rate constants were considered to be unknown param-
eters. We adjusted an initial set of model parameters to reproduce an arbitrary
mRNA and protein expression proﬁle for an early, EGF-induced gene. Given the
underdetermined nature of the system we expected several diﬀerent parameter
sets to produce similar mRNA and protein expression proﬁles. Such parametric
uncertainty is common in mechanistic modeling of large systems. Even with iden-
tiﬁcation standards [116] and extensive data, it is typically not possible to identify
a unique parameter set [112]. Strategies have been developed to identify parameter
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Figure 3.1: Schematic overview of the interaction network used in modeling
EGF-induced MAPK activation, transcriptional regulation and
protein expression. The bottom ﬁgure depicts the graphical net-
work structure using a hierarchal layout.
36ensembles and cope with this uncertainty [21, 30]. These strategies have demon-
strated an ability to produce statistically meaningful predictions despites poor
parameter identiﬁcation [128]. The parameter identiﬁcation procedure employed
here used a Gaussian accept/reject method. We considered the mRNA and protein
proﬁles of the initial set to be the mean value, with a 10% standard deviation. A
semi random walk strategy was used to move through parameter space. The direc-
tion and step size was biased using local curvature approximations and eigenvector
decomposition [30] (Fig. 3.2 A).
The parameter identiﬁcation scheme accepted 8579 parameter sets. We cal-
culated the mean correlation coeﬃcient between ensembles as a function of step
number (Fig. 3.2 B). Many nearby sets in the ensemble were highly correlated and
would yield no new information and have no statistical value. To increase ensem-
ble diversity and reduce the required computational resources, we selected a subset
from this initial ensemble. Sets were chosen at regular intervals such that the av-
erage correlation coeﬃcient decreased below 0.5. The ﬁnal ensemble contained 29
parameter sets which were highly uncorrelated (Fig. 3.2 C). The relative standard
deviation further demonstrated that the individual parameter values were poorly
constrained (Fig. 3.2 D). More the 97% of the parameters had a deviation greater
then their mean value, with some varying 5 times their mean. However, all of the
sets in the ensemble reproduced the mRNA and protein expression proﬁles with a
limited variance as trained for (Fig. 3.3). This result conﬁrmed that signiﬁcantly
diﬀerent parameter sets could describe the same training data.
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Figure 3.2: Parameter identiﬁcation scheme and results. A) schematic of a
two dimensional parameter space approximated by the Hessian.
The major and minor axis identiﬁed by Eigenvector decomposi-
tion is depicted along with hypothetical random walk trajecto-
ries. B) The mean correlation coeﬃcient as a function of number
of steps for two trajectories used to generate the ensemble. The
corresponding R values are directly related to step size. C) Cor-
relation coeﬃcients between all members of the ﬁnal parameter
ensemble. D) Mean normalized standard deviation (or coeﬃcient
of variance) for the members of the ﬁnal parameter ensemble.
3.3.3 Model Behavior in Response to EGF and Histone
Modiﬁers
We considered the eﬀect of key network species on protein expression. In the
current network, EGF is required for TF activation and notable transcription ini-
tiation. We ran simulations of diﬀerent EGF dosages and observed the mean
protein expression over the ensemble (Fig. 3.4A). As expected, decreased EGF
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Figure 3.3: Trained model response to EGF. The model was run to an ap-
proximate steady-state for t = 0, 10µM of EGF was added at
10min. Top line indicates generic protein expression, scale on
the left. Bottom line indicates generic mRNA expression, scale
on the right. The dashed line depicts the mean value over the
ensemble and the shaded region describes the ensemble standard
error.
resulted in slower expression dynamics as well as decreased maximum values. We
observed that the trained dosage of 10nM produced a saturated expression proﬁle
over the ensemble. Increased EGF dosages produced no increased protein expres-
sion (results not shown). Given the diversity of the ensemble, we concluded that
the saturation was a result of the dynamic data for mRNA and protein expression
used in training and not a result of the initial parameter set.
Histone modiﬁers play a critical role in regulating transcription. These proteins
catalyze the attachment of chemicals such as methyl and acetyal groups to histones.
This modiﬁcation alters charges on the histone and changes the local structure of
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Figure 3.4: Predicted model response to EGF dosage and altered levels of
histone modiﬁers. The model was run to an approximate steady-
state for t = 0, 10µM of EGF was added at 10min. The simula-
tion was repeated with diﬀerent dosages of EGF (A) or diﬀerent
initial conditions for the histone modiﬁers histone acetyltrans-
ferase (HAT;B), Positive Transcription Elongation Factor b (P-
TEFb;C), or ET domain-containing lysine methyltransferase 8
(Set8;D). The ensemble mean for generic protein concentration
is plotted.
the DNA. Decreases in the histone acetyal transferase levels resulted in decreased
protein expression, while decreases in a histone methyl transferase, Set8, had the
opposite eﬀect (Fig. 3.4B and D). However, large changes in concentration were
required to achieve any notable diﬀerences in ﬁnal expression levels, which suggests
these modiﬁers are not limiting reagents in this particular system. We did note
that P-TEFb, a protein required to overcome proximal pausing, had a similar eﬀect
on protein expression as EGF (Fig. 3.4C). This result could be indicative of the
importance in the regulation of early pausing mechanisms.
403.3.4 Global Responses to Dynamic and Structural Per-
turbation
Next, we investigated a more global analysis by introducing perturbations over
the entire network and observing the eﬀect on each species in the network. We
considered two diﬀerent types of perturbations, a structural perturbation in which
we removed individual reactions from the network and dynamic perturbations in
which we issued an inﬁnitesimal delta to individual reaction rates. We deﬁned
response coeﬃcients as the normalized diﬀerence between the wild type simulation
and the structural perturbation, and we used normalized sensitivity coeﬃcients to
quantify the dynamic perturbation. We employed two diﬀerent scoring schemes to
rank the global impact of these perturbations. Scoring by magnitude was done by
taking the euclidean norm over the network species. Scoring by principle compo-
nent analysis (PCA) was done by performing PCA on the time-averaged coeﬃcient
matrix and weighting reactions by their appearance in the principal components.
Magnitude scoring identiﬁes reactions with the largest overall impact, while PCA
scoring identiﬁes reactions with eﬀects that vary greatly from one species to the
next.
Response coeﬃcients identiﬁed reactions involving TF initiated promoter as-
sembly to be important in both PCA and magnitude scoring (Fig. 3.5A and C).
We calculated the Spearman rank coeﬃcient between diﬀerent strategies to quan-
tify correlations (Table 3.1). The Spearman rank coeﬃcient is a statistical measure
for the correlation, between two observations, of how variables are monotonically
ranked; a value of 1 or −1 indicates that the variables were in the same or opposite
increasing order respectively. For response coeﬃcients, we found a 0.97 correlation
between PCA and magnitude scoring. This suggests that the two diﬀerent scor-
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Figure 3.5: Predicted global importance of model reactions using sensitivity
and response coeﬃcients. Response coeﬃcients, a metric for the
eﬀect of reaction removal, were scored by a maximum normal-
ized euclidean norm (A) or by the wighted appearance in the in
the principle components of the response matrix (C). Sensitiv-
ity coeﬃcients, a metric for the eﬀect of rate perturbation, were
also calculated and scored using a normalized euclidean norm
(B) or by the wighted appearance in the in the principle com-
ponents of the sensitivity matrix (D). The reactions are ordered
by functional groups as shown in the bottom legend. Signiﬁcant
transcription reactions are labeled. Coeﬃcients were calculated
under EGF stimulation as employed in training. The dots de-
pict the ensemble mean and the error bars depict the ensemble
standard error.
ing schemes resulted in nearly identical rankings for all reactions. From a global
perspective, sensitivity coeﬃcients displayed larger errors and a weaker ability to
identify important reactions (Fig. 3.5A and C). It is possible that dynamic pertur-
bations were more sensitive to the poorly constrained parameters of the ensemble.
423.3.5 Perturbation Eﬀect on Gain in Protein Levels
To concentrate our investigation on a more functional system output, we calculated
response and sensitivity coeﬃcients for the EGF-induced protein expression. We
measured EGF induction as a gain or the diﬀerence in protein expression at the
beginning of the simulation, before EGF, and the end of the simulation, after EGF.
For both structural and dynamic perturbations, we noted remarkably low variation
over the ensemble (Fig. 3.6). This suggested that statistically relevant predictions
for EGF-induced protein expression could be made despite signiﬁcant parametric
uncertainty.
We observed that the response coeﬃcients, in some sense, described the role
of various reactions in EGF signal ﬂow (Fig. 3.6A). A response coeﬃcient of −1
indicated a complete loss of signal ﬂow or gain and included reactions for EGF
binding EGFR, MAPK activation and reactions for TF activity. Values between
−1 and 0 resulted where gain was reduced, but not prevented, indicating network
redundancy, for example, in aspects of receptor signaling where reactions can take
place on the membrane but also once internalized. Values near zero show no
notable impact on gain, and consisted primarily of reverse reactions where signal
ﬂow was predominantly in the forward direction. Finally, values > 0 indicate
reactions that inhibited the EGF-induced protein expression; mRNA and protein
degradation were identiﬁed to be the predominant inhibitors.
Sensitivity coeﬃcients also produced interesting results (Fig. 3.6A). Small per-
turbations in the rates had little to no impact on gain for nearly all reactions. It is
likely that this robust characteristic of protein expression was the result of a highly
saturated signal. Although many dynamic perturbations failed to impact the gain,
some notable exceptions were observed. As expected, the degradation mechanisms
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Figure 3.6: Predicted functional importance of model reactions using sensi-
tivity and response coeﬃcients. The gain is the maximum in-
crease in generic protein concentration due to EGF stimulation.
A) Response coeﬃcients, a metric for the eﬀect of reaction re-
moval, for the gain were calculated for all reactions. Note: the
response coeﬃcient for protein degradation was 250 and is not
shown. B) Sensitivity coeﬃcients, a metric for the eﬀect of rate
perturbation, for the gain were also calculated for each reaction.
The reactions are ordered by functional groups as shown in the
bottom legend. Signiﬁcant reactions deﬁned by sensitivity are
labeled. Coeﬃcients were calculated under EGF stimulation as
employed in training. The dots depict the ensemble mean and
the error bars depict the ensemble standard error.
inversely, and signiﬁcantly aﬀected gain. Interestingly, three reactions were found
to be directly proportional to gain, with statistical signiﬁcance. In translation,
the binding of PABP to the mRNA cap region, which is required for recruitment
to the translation initiation complex, was a strong eﬀector of protein expression.
In transcription, the largest impact was observed in the mechanisms to escape
from abortive initiation and proximal pausing. As described above, we also found
that P-TEFb, a key regulator of proximal pausing, had a more signiﬁcant impact
then that of histone modiﬁers (Fig. 3.4C). This mechanism may be considered a
rate-limiting steps in EGF-induced protein expression.
443.3.6 Dynamic Shifting of Protein Fragility
Up to this point we have considered metrics for static properties, such as gain, or
introduced a time-averaging. However, perturbations have a dynamic eﬀect and
their impact can change as a function of time. We noted a shifting in sensitiv-
ity coeﬃcients as the network moved from low basal level protein expression to
high EGF-induced expression. To demonstrate this we considered the dynamic
sensitivity of protein concentration to four reactions that we found to have the
largest change over time (Fig. 3.7). The ﬁrst two reactions represented aspects
of the promoter initiation complex (PIC) assembly, and the second two reactions
were for escape from abortive initiation at the promoter and escape from proximal
pausing. During low basal expression, the bottle neck for transcription is PIC as-
sembly. Addition of EGF leads to TF activation, allowing the TF to facilitate PIC
assembly. As transcriptional activity increases mechanisms that halt productive
elongation become rate-limiting. Release from these mechanisms is independent
of TF and therefore EGF stimulation.
3.3.7 Comparison of Structural Perturbation to Non-
Parametric Graph Measures
Finally, we investigated non-parametric methods to identify critical reactions and
compared these results to calculated response coeﬃcients. Graph measures con-
sider the network connectivity, in the absence of any dynamic response. We rep-
resented the current network as a graph with reactions as nodes and species as
edges (Fig. 3.8B). Reaction A, for example, would be connected to reaction B if
a product of A is a reactant for B. One measure that can be considered is the de-
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Figure 3.7: The switching between rate-limiting steps in protein expression
as demonstrated by sensitivity. The model was run to an ap-
proximate steady-state for t = 0, 10µM of EGF was added at
10min. Sensitivity coeﬃcients, a metric for the eﬀect of rate per-
turbation, for generic protein concentration were calculated as
a function of time. Plotted are the trajectories for initially im-
portant reactions, promoter initiation complex (PIC) assembly
in the absence of transcription factor, and reactions important
in EGF response, PIC escape from the promoter and proximal
pausing. The lines depict the ensemble mean and the error bars
depict the ensemble standard error.
gree of a node, the number of edges connected to a node. We calculated the degree
distribution for the reactions in the network on a log-log plot and the distribu-
tion appears linear (Fig. 3.8B). Networks with an exponential degree distribution
have a ‘scale free’ or ‘hub and spoke’ architecture; examples of this architecture
have been identiﬁed in other biological networks have a ‘hub and spoke’ archi-
tecture [17]. It has been suggested that the hubs, nodes with many connections,
represent critical network components and that these networks have evolved to
46minimize the number of hubs while maintaining proper connectivity. Hubs, or
high degree nodes, have been linked to essential genes in some case [168]. How-
ever many theoretical and experimental counter examples exist [130, 343, 135]. In
this system, the correlation between degree and response coeﬃcients was consid-
erably low, -0.02 as determined by Spearman rank (Table 3.2). In this system,
there is almost no relationship between the direct connectivity of a node and the
functional consequences of its removal. We calculated two other graph metrics, or
centrality measures. ‘Closeness’ is the average shortest path between a node and
all other nodes. ‘Betweenness’ is the number of times a node is on any shortest
path. Each centrality measure resulted in low correlation to response coeﬃcients.
Furthermore, the diﬀerent centrality measures showed low correlation with each
other.
Simple graph measures such as centrality have multiple short comings beyond
ignoring the information contained in the parameters,. They consider the entire
graph to be accessible at all times; in reality, a system can be operating in diﬀerent
modes at diﬀerent times, for example ﬂux through an edge may be near zero
preventing access to parts of the network. More importantly, we have considered
a simple graph where any given edge makes a single connection from one node to
another and all edges are unrelated to each other. In our system, however, edges
represent species and a single species can connect multiple reactions or nodes.
This property, where one edge connects multiple nodes, exists in hyper-graphs.
Unfortunately solutions to hyper-graphs are NP hard; thus, the time to calculate
a solution increases exponentially as a function of inputs. Ultimately, we found
that centrality measures did not correlate well with our other dynamic, parametric
measures and that the true meaning of centrality values is diﬃcult to interpret.
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Figure 3.8: Graphical representation of the network reaction structure. Con-
sidering reactions as nodes and edges as species that connect
reactions the network was represented as a graph or an adja-
cency matrix. A) Log-log plot of the degree distribution for the
reactions in the network. Node degree is the number of edges
connected to that node. B) Graphical depiction of the reaction
adjacency matrix, nodes are color-coded by functional groups.
3.4 Conclusions
Cells have evolved to process information from the outside environment to make
various decisions. Transcriptional regulation is an important aspect of the cellular
decision making process. In this study, we constructed a mechanistic mathemat-
ical model of transcriptional regulation in the context of growth factor-induced
protein expression. In total, the network consisted of 264 model species intercon-
nected by 423 reactions. We employed ordinary diﬀerential equations (ODEs) as
the mathematical framework by writing mass-balances around the 264 individual
species. We assumed mass-action kinetics to describe the reaction rates. The 423
48rate constants were considered to be unknown parameters. We trained the model
against arbitrary mRNA and protein expression data chosen to qualitatively repre-
sent an early EGF-induced gene. Given the underdetermined nature of the system
we gathered an ensemble of parameter sets that described the training data. The
ensemble was generated by using a Gaussian acceptance criterion and parameter
space was explored using a random walk strategy. The accepted parameter sets
were ﬁltered on the basis of average correlation coeﬃcient. The ﬁnal ensemble
consisted of 29 sets of low correlation (Fig. 3.2).
We calculated response coeﬃcients, measuring the eﬀect of removing a reaction,
to assess the eﬀect of structural perturbations on species concentrations. We also
calculated sensitivity coeﬃcients to determine the eﬀect of dynamic perturbations.
From a global perspective, sensitivity produced high variance over the ensemble
(Fig. 3.5B and D). We contributed this variance to the poor constraint of the pa-
rameters. However, response coeﬃcients proved to be more robust to parametric
variation (Fig. 3.5A and C). We found that mechanisms involved in transcription
factor (TF)-induced promoter initiation complex (PIC) assembly produced a large
eﬀect over the entire network. Moreover, we found that these predictions were
consistent for diﬀerent ranking schemes, as determined by Spearman rank coeﬃ-
cients (Table 3.1). Next, we considered the eﬀect of perturbations speciﬁcally on
EGF-induced protein expression, referred to here as gain. When considering this
single functional aspect, we found the statistical variation to be considerably low
(Fig. 3.6). Consistent prediction across the ensemble suggested that statistically
relevant predictions, even for dynamic eﬀects, were indeed possible despite enor-
mous parametric uncertainty. We found response coeﬃcients provided insight on
network structure, what mechanisms were necessary, unnecessary, redundant, and
inhibitory (Fig. 3.6A). Interestingly, many reverse reactions, especially for receptor
49signaling, were found to be unnecessary for the function of EGF-induced protein
expression, at least in the time window considered. Furthermore, sensitivity pre-
dicted the gain to be incredibly robust (Fig. 3.6). We surmise that to recapitulate
this rapid protein expression proﬁle, the signal ﬂow was nearly saturated in the
forward direction, towards TF activation and eventual protein expression. Despite
robust signaling, sensitivity did identify two key rate-limiting steps in transcrip-
tional regulation. Both escape from abortive initiation and escape from proximal
pausing had a direct impact on protein expression. Considering the dynamics of
the sensitivity coeﬃcients we found these mechanisms to be unimportant during
low basal expression, but upon EGF induction they became a bottle neck for the
process (Fig. 3.7). Moreover, we found that P-TEFb, a key regulator of proxi-
mal pausing, had a more signiﬁcant impact then that of histone modiﬁers (Fig.
3.4). Interestingly, proximal pausing has been considered experimentally to be the
key regulatory mechanism in growth factor-induced immediate early gene expres-
sion [109, 132, 108, 194]. This observation is a prime example of the ability of
mechanistic modeling to provide relevant biological insights and predictions.
This study highlighted some of the tools and beneﬁts of computational, mech-
anistic modeling; however, this strategy is not without drawbacks. A major issue
with any computational analysis is uncertainty. Uncertainty comes in two pri-
mary forms, structural and parametric. We implemented an ensemble approach
to identify where parametric uncertainty limited prediction capability. Indeed, we
observed instances where variation over the ensemble prevented statistically sound
predictions, for example in the global response to dynamic perturbations. Un-
fortunately, this approach hinges on eﬀective investigation of a high dimensional
parameter space. The statistics corresponding to model predictions were an ap-
proximation based on the parameter ensemble and, therefore, biased by the method
50of ensemble generation. Ultimately, we would like to not only improve on statistics
for anticipating inaccurate predictions, but actually improve upon overall predic-
tion accuracy. To achieve this goal we require more relevant experimental data for
model training. Structural uncertainty also plays a major role. Such uncertainty
resides in the network connectivity and may be seen as false positives, incorrect
reactions in the network, or false negatives, missing reactions in the network. We
attempt to limit false positives by proposing mechanisms with experimental evi-
dence. However, detailed and conclusive experimental support for each reaction is
simply not available. To limit false negatives we attempt to include as much detail
for a given system as possible, but no system operates independently and inclusion
of all known cellular mechanisms is again computationally intractable. To over-
come this issue we require increased processing speed, improved parallelizations
schemes and more intelligent solution methods. Another drawback to mechanis-
tic modeling is the formulation of the model itself. Structural and parametric
accuracy depend on experimental data from a variety of sources. Compiling the
relevant information requires extensive time and human involvement and interven-
tion. However, with the use of online databases, modeling software, standards of
representation and exchange, and automated search and data mining, this issue
can, at least, be mitigated. Despite these shortcomings, computational modeling
plays, and will continue to play, a critical role in understanding the complexity
cellular function. When considering the nonlinearity and high dimension of the
systems involved a proper, synergistic relationship between computational and ex-
perimental strategies is an obvious necessity.
51Table 3.1: Comparison of diﬀerent perturbation types and scoring strategies
using Spearman rank correlation coeﬃcient. The symbols R and
S are for Response and Sensitivity, gain refers to the increase in
generic protein concentration due to EGF stimulus, mag stands
for the magnitude or maximum normalized euclidean norm scoring
and PCA stands for weighted principal component scoring.
R Gain S Gain R mag S mag R PCA S PCA
R Gain 1.00000 0.50575 0.71014 0.34084 0.69054 0.23695
S Gain 0.50575 1.00000 0.33402 0.23552 0.32691 0.22743
R mag 0.71014 0.33402 1.00000 0.22240 0.98028 0.13294
S mag 0.34084 0.23552 0.22240 1.00000 0.22535 0.17991
R PCA 0.69054 0.32691 0.98028 0.22535 1.00000 0.15161
S PCA 0.23695 0.22743 0.13294 0.17991 0.15161 1.00000
Table 3.2: Comparison of diﬀerent graph centrality measures and the mag-
nitude of the response coeﬃcients
degree closeness betweenness dX Mag
degree 1.000000 -0.547729 0.335925 -0.020437
closeness -0.547729 1.000000 -0.134862 0.103230
betweenness 0.335925 -0.134862 1.000000 0.169508
RC Mag -0.020437 0.103230 0.169508 1.000000
3.5 Materials and Methods
3.5.1 Formulation and solution of the model equations
The transcription model was formulated as a set of coupled Ordinary Diﬀerential
Equations (ODEs):
dx
dt
= N · v(x,k) x(to) = xo (3.1)
The symbol N denotes the stoichiometric matrix (264 × 423). The quantity x
denotes the species concentration (264 × 1). The term v(x,p) denotes the vector
of reaction rates (423 × 1). Each row in N described a species while each column
described the stoichiometry of network interactions. Thus, the (i,j) element of N,
52denoted by ηij, described how protein i was involved in rate j. If ηij < 0, then
protein i was consumed in vj. Conversely, if ηij > 0, protein i was produced by vj.
Lastly, if ηij = 0, protein i was not involved in rate j.
We assumed mass-action kinetics for each interaction in the network. The rate
expression for protein-protein interaction or catalytic reaction q:
X
j∈{Rq}
ηjqxj →
X
p∈{Pq}
ηpqxp (3.2)
was given by:
vq (x,kq) = kq
Y
j∈{Rq}
x
−ηjq
j (3.3)
The set {Rq} denotes reactants for reaction q. The quantity {Pq} denotes the
set of products for reaction q. The kq term denotes the rate constant govern-
ing the qth interaction. Lastly, ηjq,ηpq denote stoichiometric coeﬃcients (ele-
ments of the matrix N). We treated every interaction in the model as non-
negative. All reversible interactions were split into two irreversible steps. The
mass-action formulation, while expanding the dimension of the prostate model,
regularized the mathematical structure. The regular structure allowed auto-
matic generation of the model equations using the software patform UNIVERSAL
(http://code.google.com/p/universal-code-generator/). The calculations were car-
ried out in Octave (http://www.octave.org) with the mass-balance functions writ-
ten in the C programming languages. The LSODE stiﬀ solver with tolerances set
at 1E-8 was used to solve the systems ODEs.
3.5.2 Simulation protocol.
An approximate steady-state was used as the starting point (t = 0min). At
t = 10min 10nM EGF was added to the simulation. Although no individual
53cell is likely to be at steady-state we assumed that steady-state was a reasonable
approximation for cells growing in the exponential phase. The steady-state was
estimated numerically by repeatedly solving the model equations and estimating
the diﬀerence between two subsequent time points:
kx(t + ∆t) − x(t)k2 ≤ ² (3.4)
The quantities x(t) and x(t + ∆t) denote the simulated concentration vector at
time t and t+∆t, respectively. The quantity k·k2 denotes the L2 vector norm. In
this study, we used ∆t = 1000min of simulated time and ² = 0.01.
3.5.3 Generation of parameter ensemble
An initial set of kinetic parameters, denoted by k0, was chosen by hand to qual-
itatively replicate early EGF-induced protein expression of an abstract gene. We
used the mRNA and protein expression proﬁle from this initial set as training
data. First we investigated how simulation results for mRNA and protein expres-
sion would deviate from the training data as a function of the kinetic parameters.
The diﬀerence between the training data and simulated value of species j at time or
condition i, denoted by ˆ xi,j and x(kk)i,j respectively, was quantiﬁed by the residual
ˆ xi −x(kk)i). We then consider the deviation from the training data as the sum of
squared residual, ψ:
ψ (kk) =
1
2
X
i
(ˆ xi − x(kk)i)
2, (3.5)
where the sum was carried out over the points in the training data i. The residual,
and ψ at the initial set, k0, is, of course, zero and we can locally approximate the
eﬀect of parameter variation on ψ by considering the curvature at k0. The Hessian
54evaluated at k0 deﬁnes the local curvature and is:
Hi,j =
∂2ψ
∂ki∂kj
. (3.6)
Because the residual is zero we can solve for the Hessian using Jacobean or the
ﬁrst-order derivatives of the residual which simplify to:
Hi,j =
X
q
∂xq
∂ki
∂xq
∂kj
, (3.7)
which is the sum of the ﬁrst-order sensitivity coeﬃcient for all the training data
points q evaluated at k0. Locally, the Hessian approximates ψ in parameter space
as a hyperdimensional, elliptical bowl. Eigenvector decomposition allows us to
identify the primary axis of the ellipsoid and the corresponding Eigenvalues quan-
tify the extent of the curvature. Simply put, we can identify, locally, how fast
the simulation values will deviate from the training data in the various directions
of parameter space (Fig. 3.2 A). This treatment has been performed previously
[30]. Furthermore, it has been demonstrated that, due to large variations in the
magnitudes of the parameter values, the log sensitivities are more practical[128],
given by:
∂xq
∂log(ki)
∂xq
∂log(kj)
. (3.8)
Next, we interrogated parameter space to identify an ensemble that produced
similar results to the initial set. It should be noted that, although the initial
conditions were technically unknown parameters as well, we considered them to
be set at 100nM for molecular level species and 0nM for all else. We explored
the log of parameter space (form here on referred to as log space) using a random
walk strategy. To more eﬃciently explore log space, we weighted the steps of the
random walk using the directions and magnitudes of the curvature near the initial
55set:
∆log(ki) =
X
j
R
s
1
λj
wi,jNj (3.9)
where ∆log(ki) is the step size of the ith parameter in log space, λj is the jth
Eigenvalue, wi,j is the coeﬃcient corresponding to the ith parameter in the jth
Eigenvector, N is a normally distributed random number, and R is a tunning co-
eﬃcient. Here we considered diﬀerent values for R (Fig. 3.2 B). Steps along the
random walk trajectory, log(kk), were accepted or rejected based on the probabil-
ity
min
i
exp{−
(ˆ xi − x(kk)i)2
2σ2
i
} (3.10)
where i was a point in the training data and σi was taken to be 10% of ˆ xi. This ac-
ceptance criterion was chosen to produce an ensemble with a Gaussian distribution
around the training data and a 10% relative standard deviation. The parameter
identiﬁcation scheme accepted 8579 parameter sets. We calculated the mean corre-
lation coeﬃcient between ensembles as a function of step number (Fig. 3.2 B). Sets
were then chosen at regular intervals such that the average correlation coeﬃcient
decreased below 0.5. The ﬁnal ensemble contained 29 parameter set which were
highly uncorrelated (Fig. 3.2 C).
3.5.4 Calculation of sensitivity and response coeﬃcients
To study the eﬀect of dynamic perturbation, we considered ﬁrst-order sensitivity
coeﬃcients, s. At time tk s was deﬁned as:
sij (tk) =
∂xi
∂kj
¯
¯
¯
¯
¯
tk
(3.11)
First-order sensitivity coeﬃcients were computed by ﬁnite diﬀerence:
sij (tk) ≈
x(k,tk)i − x(k + ∆j,tk)i
∆j
(3.12)
56with the ∆j taken to kj × 1E − 5 with a minimum of 1E-6 and ∆j was a vector
with the jth element set to δj and zero for all else. Finally, we normalized the
sensitivity coeﬃcients as
kjsij
xi .
To study the eﬀect of structural perturbation, we considered ﬁrst response
coeﬃcients, r. At time tk r was deﬁned as:
rij (tk) =
x
j
i − xi
xi
¯
¯
¯
¯
¯
tk
(3.13)
where the superscript j indicates that the simulation was solved with the jth
kinetic parameter set to zero. Due to the assumption of mass-action kinetics a zero
kinetic parameter results in a reaction rate of zero and is equivalent to removing
the reaction.
3.5.5 Coeﬃcient scoring metrics
Two methods were employed to score the sensitivity or response coeﬃcients. Con-
sider C as the time-averaged coeﬃcient matrix, either sensitivity or response. The
elements ci,j are the time-averaged coeﬃcients for the ith species and the jth reac-
tion. For magnitude scoring, we considered the Euclidean norm of the columns for
all j reactions. We then normalized by the maximum and averaged over the en-
semble. For principal component (PC) scoring, we performed principal component
analysis (PCA) on C. PCA identiﬁes the directions of largest change and consists
of: centering the columns such that the mean is zero (referred to as ˆ C), com-
puting the covariance matrix ˆ CT ˆ C, and performing Eigenvector decomposition.
The Eigenvectors deﬁne the primary directions of variation and the corresponding
Eigenvalues deﬁne the magnitude of variation. We deﬁned the PCs as the ﬁrst n
Eigenvectors that account for 80% of the variance. The PCs comprise a matrix of
57size m×n where m is the number of reactions. We then took the Euclidean norm
of the rows of this matrix, and normalized by the max. Simply put, we consider
the contribution of a given reaction to each of the PCs. Finally, we averaged the
scores over the ensemble.
58CHAPTER 4
ANALYSIS OF THE MOLECULAR NETWORKS IN
ANDROGEN-DEPENDENT AND -INDEPENDENT PROSTATE
CANCER REVEALED FRAGILE AND ROBUST SUBSYSTEMS†
4.1 Summary
Androgen ablation therapy is currently the primary treatment for metastatic
prostate cancer. Unfortunately, in nearly all cases androgen ablation fails to per-
manently arrest cancer progression. As androgens like testosterone are withdrawn,
prostate cancer cells lose their androgen sensitivity and begin to proliferate without
hormone growth factors. In this study, we constructed and analyzed a mathemat-
ical model of the integration between hormone growth factor signaling, androgen
receptor activation and the expression of cyclin D and Prostate Speciﬁc Antigen
in human LNCaP prostate adenocarcinoma cells. The objective of the study was
to investigate which signaling systems were important in the loss of androgen de-
pendence. The model was formulated as a set of ordinary diﬀerential equations
which described 212 species and 384 interactions including both the mRNA and
protein levels for key species. An ensemble approach was chosen to constrain
model parameters and to estimate the impact of parametric uncertainty on model
predictions. Model parameters were identiﬁed using 14 steady-state and dynamic
LNCaP data sets taken from literature sources. Alterations in the rate of Prostatic
Acid Phosphatase expression were suﬃcient to capture varying levels of androgen
dependence. Analysis of the model provided insight into the importance of network
components as a function of androgen dependence. The importance of androgen
0† Reproduced from [331] with permission under the open-access Creative Commons Attribu-
tion License
59receptor availability and the MAPK/Akt signaling axes was-independent of an-
drogen status. Interestingly, androgen receptor was important even in androgen
independent LNCaP cells. Translation became progressively more important in
androgen independent LNCaP cells. Further analysis suggested a positive synergy
between the MAPK and Akt signaling axes and the translation of key prolifer-
ative markers like cyclin D in androgen-independent cells. Taken together, the
results support the targeting of both the Akt and MAPK pathways. Moreover,
the analysis suggested that direct targeting of the translational machinery, specif-
ically eIF4E, could be eﬃcacious in androgen-independent prostate cancers.
4.2 Introduction
Prostate cancer is the most common cancer in men and the second leading cause
of cancer-related death in the United States [166]. It has been known since the
1940s that androgens, such as testosterone, are required for prostate cancer growth
[158]. Accordingly, androgen ablation in combination with radiation or tradi-
tional chemotherapy remains the primary non-surgical treatment for androgen-
dependent prostate cancer. Androgen ablation initially leads to decreased tumor
growth and reduced secretion of biomarkers such as Prostate Speciﬁc Antigen
(PSA) [257, 197, 280]. However, in nearly all cases androgen ablation fails to per-
manently arrest cancer progression. As testosterone is withdrawn, malfunctioning
prostate cells lose their sensitivity to androgen and begin to proliferate without
hormone growth factor signals. These testosterone-insensitive cells can then lead
to Androgen-Independent Prostate Cancer (AIPC) [87]. The AIPC phenotype is
closely related to metastasis and decreased survival. Unfortunately, current treat-
ments for metastatic AIPC have demonstrated only modest survival advantages
60[330]. Thus, an eﬀective therepy for metastatic AIPC represents an unmet medical
need and an ideal target for systems biology.
AIPC is characterized by androgen action in the absence of androgen stim-
ulation. At the core of androgen action is the regulation of Androgen Receptor
(AR) by hormones such as testosterone. AR is a cytosolic steroid hormone recep-
tor belonging to the superfamily of ligand-activated transcription factors. Other
members of this family include Vitamin A/D, estrogen, progesterone and thy-
roid hormone receptors [92, 43]. In healthy prostate epithelial cells, androgens
activate AR and drive an AR-dependent gene expression program. Sexual an-
drogens such as testosterone typically circulate in the blood, bound to proteins
such as the Sex Hormone Binding Globulin (SHBG) protein. Free testosterone
enters prostate cells where the 5α-reductase enzyme converts it to activated di-
hydrotestosterone (DHT) [229]. Both cytosolic testosterone and DHT can bind
AR, however DHT has a higher aﬃnity for AR. Binding of DHT to AR promotes
cytosolic AR activation and the translocation of activated AR to the nucleus.
Nuclear AR drives the expression of target genes including PSA by binding to
AR-responsive promoter elements [276, 115]. Because of its ligand dependence,
one would expect AR activation and AR-driven gene expression to be absent with-
out hormone stimulation. However, AIPC often has higher PSA expression and
increased cell-proliferation compared to its androgen-dependent counterpart even
without stimulation [161, 203].
AIPC’s increased proliferation and PSA secretion in the absence of androgen
suggests a failure in the regulation of androgen receptor activation. Feldman and
Feldman reviewed several possible AR regulatory pathways perhaps responsible
for androgen action in the absence of hormone stimulation [95]. One hypothe-
61sis, referred to as the hypersensitivity pathway, suggests that AR may be more
sensitive to androgen in AIPC. This would allow AR activation and AR-driven
gene expression at much lower levels of extracellular testosterone signals. Another
hypothesis, referred to as the ‘promiscuous’ pathway, suggests that AR can be ac-
tivated by non-androgen antagonists. A third hypothesis, explored here, suggests
that AR can be activated by other pathways, for example, the Mitogen Activated
Protein Kinase (MAPK) cascade. Several studies support this cross-talk hypothe-
sis, sometimes referred to as the ‘outlaw’ pathway. Culig et al. showed in DU-145
human prostatic tumor cells that growth factors, e.g., IGF-I, KGF, and EGF could
drive AR activation without androgen [65]. Nazareth and Weigel showed in human
prostate PC-3 cells that AR could also be activated by the protein kinase A ac-
tivator, forskolin, in the absence of androgen [245]. Other studies have suggested
a connection between Her2-induced activation of the primary MAPK cascade and
AR activation [375]. For example, Her2 overexpression was positively correlated
with diminished sensitivity to androgen ablation, increased AR dependent PSA
expression, increased AR activation, increased tumor mass and shortened tumor
latency [64, 375, 230, 203]. Thus, one would expect regulators of Her2 activation,
for example the diﬀerent forms of the 100 kDa glycoprotein Prostatic Acid Phos-
phatase (PAcP), could be important factors in androgen dependence and tumor
grade [351, 211, 310, 281, 231, 349]. Intracellular PAcP (cPAcP) whose expres-
sion is AR-responsive, downregulates Her2 by dephosphorylation. On the other
hand, secreted PAcP (sPAcP) promotes modest Her2 activation by an unknown
mechanism [349].
624.3 Results
The objective of this study was to determine which signaling components were im-
portant in AI versus AD LNCaP cells. Toward this objective, we constructed and
analyzed a mechanistic mathematical model of the androgen response of three
diﬀerent LNCaP prostate adenocarcinoma sub-lines. We investigated MAPK-
dependent outlaw activation of AR in AD (C-33), mid-range (C-51) and AI (C-
81) LNCaP cells [153, 161]. Our network model included: nuclear hormone and
transmembrane growth factor receptor activation; transcriptional activity via the
MAPK subsystem [178, 155, 295] together with outlaw activation of AR via MAPK
[95, 375]; PI3K/AKT/TOR-mediated translation initiation [352, 275]; the tran-
scriptional and translational regulation of PSA, cyclin D and PAcP expression
[230, 203]; and the regulation of Her2 activity by PAcP [349] (Fig. 4.1). The
network described 212 species and 384 interactions. Transcription and translation
were modeled using elementary reactions based on literature (supplemental mate-
rials). Constitutive and regulated expression of PSA, cyclin D and the two forms of
PAcP were considered in the model. The total level of all other model proteins was
constant. We modeled the molecular interactions using mass-action kinetic pro-
cesses within an ordinary diﬀerential equation (ODE) framework. ODEs are a com-
mon method of modeling biological pathways and have been used to model a range
of signal transduction processes [155, 111, 295, 323, 268, 209, 324, 218, 316, 48].
Mass action kinetics have also been used extensively, for example, to model re-
ceptor tyrosine kinase signaling [48], blood coagulation [218], pain networks [316]
or Toll like receptor signaling [144, 301]. They have also been a key component
in the success of perturbation-response approaches which have shown that simple
linear rules often govern the response behavior of biological networks [302]. The
ODE model was deterministic and captured only population averaged behavior.
63While we assumed spatial homogeneity, we diﬀerentiated between cytosolic and
membrane localized processes. We used mass-action kinetics to describe the rate
of each molecular interaction. Thus, the 384 kinetic model parameters were mainly
association, dissociation or catalytic rate constants. With one exception, model
parameters were estimated and validated using LNCaP training data taken from
literature sources (Table A.1). However, we were unable to estimate unique model
parameters. Instead, we estimated a family or ensemble of parameters that was
consistent with the training data. The ensemble allowed us to estimate the model
uncertainty associated with the many poorly characterized parameters. We ana-
lyzed the model ensemble to better understand which architectural features were
important in androgen-dependent versus -independent cells.
4.3.1 Estimating the ensemble of prostate model parame-
ters.
Signal transduction models often exhibit complex behavior [10, 30, 228, 152]. It is
often not possible to identify model parameters, even with extensive training data
[112]. Thus, despite identiﬁcation standards [116] and the integration of model
identiﬁcation with experimental design [16], parameter estimation remains chal-
lenging. In this study, an ensemble of plausible model parameters was estimated
from AI and AD LNCaP sub-clones. Ensemble approaches have successfully ad-
dressed uncertainty in systems biology and other ﬁelds like weather prediction
[21, 195, 316, 31, 253]. Their central value is the ability to constrain model predic-
tions despite uncertainty. For example, Sethna and coworkers showed in a model
of growth factor signaling that predictions were possible using ensembles despite
incomplete parameter information (sometimes only order of magnitude estimates)
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Figure 4.1: Schematic overview of the interaction network used in modeling
the androgen response in prostate epithelial cells. The model
architecture was formulated by aggregating molecular modules
into a single network (see insert for high level details). The model
describes growth factor and hormone-induced expression of cyclin
D, PSA and the two forms of PAcP.
65[30]. They further showed that model ensembles were predictive using many dif-
ferent mathematical models [128].
The 420 unknown model parameters (384 kinetic constants and 36 non-zero
initial conditions) were estimated using 14 time-series and steady-state training sets
taken from literature sources (Table A.1). The parameter identiﬁcation procedure
used a maximum likelihood random-walk strategy with a correlation constraint
to identify a diverse family of likely parameter sets (Fig. 4.2C). We generated
3210 possible parameter sets and selected 107 of these for inclusion in the ﬁnal
ensemble. The selection was made to minimize the correlation between possible
sets (materials and methods). The majority of parameters had a Coeﬃcient of
Variation (CV) of greater than 100%. Thus, although the model qualitatively
recapitulated the training data, many of the parameters were poorly constrained
(Fig. 4.2B). However, parameters involved with key features such as cyclin-D and
PSA expression were relatively well constrained (CV ≤ 50%). The low deviation of
these parameters could be attributed to the abundance of PSA/cyclin D training
data. Alternatively, it may suggest that these mechanisms had a large impact on
model behavior. A single network structure described both Androgen Dependent
(AD) and Androgen Independent (AI) training data with only two experimentally
justiﬁed parameter changes. The parameters controlling the expression rate of
cellular PAcP (cPAcP) and secreted PAcP (sPAcP) were reduced by a factor of
0.01 and 0.5, respectively, for the C-81 and C-51 cell lines compared to C-33
(Fig. 4.2A). The PAcP expression scaling factors were chosen to correspond with
measured steady-state PAcP expression ratios for the diﬀerent cell lines [212].
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Figure 4.2: Identiﬁcation and properties of the prostate model ensemble. A:
Steady state PSA level as a function of cPAcP and sPAcP ex-
pression. The circles represent the values used to model the C-
51 and C-81 LNCaP clones. All values are relative to C-33. B:
Coeﬃcient of Variation (CV; standard deviation of a parameter
relative to its mean value) for the parameter ensemble used in
this study. A small CV suggested a parameter was tightly con-
strained by the training data used for model identiﬁcation. The
parameters with the three smallest CVs are listed. C: Parameter
identiﬁcation strategy. Multiple Monte-Carlo trajectories were
used to randomly explore parameter space. The simulation error
and the correlation between parameter sets was used to generate
the family of parameter sets used in the simulation study.
674.3.2 The ensemble of AI/AD LNCaP models recapitu-
lated androgen action and the activity of the outlaw
pathway.
AR can be activated by both hormone-dependent and-independent pathways. In
this study, we considered both the traditional hormone dependent and MAPK-
mediated AR activation. We selected training data sets to constrain each mode
of AR activation and the subsequent AR-driven gene expression program. The
data of Lee et al., was used to constrain the relationship between PSA expression
and AR activation in AI and AD cells [203]. Activated AR was modeled as both
a transcriptional activator of PSA expression [184] and a transcriptional represser
of PAcP expression [230]. The model recapitulated the qualitative features of
PSA expression at the protein level for C-81 and C-33 (Fig. 4.3B). Additionally,
the basal and increased level of PSA mRNA following Her2 overexpression in C-
33 was also well described (Fig. 4.4). The PSA mRNA data was taken from a
separate LNCaP study [375]. The C-33 simulations captured the observed lower
PSA expression (∼ 4 fold) compared to C-81 in the absence of androgen (Fig.
4.3B, initial point). Following DHT stimulation (10nM at t = 1 hr) PSA expression
increased for both clones. However, the increase was more signiﬁcant for C-33 (Fig.
4.3B). The study of Meng et al. was used to constrain the relationship between
AR activation and PAcP expression [230]. The addition of DHT to C-33 cells
decreased PAcP expression and increased Her2 phosphorylation (Fig. 4.3A).
The model captured the positive feedback between Her2-induced MAPK ac-
tivation and androgen action. Several studies have demonstrated that MAPK
can activate AR in the absence of hormone stimulation. Activated AR transcrip-
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Figure 4.3: Simulation results for the addition of 10nm DHT at 1 hour to
C-33 and C-81 LNCaP clones. A: Her2 phosphoralation (cir-
cles) and cPAcP expression (squares) for C-33 cells following the
addition of DHT. Experimental data reproduced from Meng et
al. [230]. B: PSA expression following the addition of DHT to
C-81 (squares) and C-33 (circles) LNCaP clones. Experimental
data reproduced from Lee et al. [203]. The shaded region in each
plot denotes one standard deviation centered about the ensemble
mean (line).
tionally down-regulates cPAcP expression which in turn increases Her2 activation.
Both Her2 dimerization along with the traditional EGFR-growth factor pathway
can activate MAPK, leading to a positive feedback loop. However, typical growth
factor-induced MAPK activation is transient whereas deregulated Her2-induced
MAPK activation is persistent. The MAPK module in the model described both
activation pathways. Growth factor dependent MAPK activation was constrained
690
0.5
1
1.5
2
2.5
3
m
R
N
A
 
P
S
A
 
(
A
.
U
.
)
Her2 (nominal)
Model (C-33)
Measured (C-33)
Her2 (overexpression)
Figure 4.4: Simulated PSA mRNA levels in C-33 cells with and without Her2
overexpression. Her2 overexpression was modeled as a 50% in-
crease in the expression rate of Her2. Bars denote the mean PSA
mRNA level over the parameter ensemble while error bars denote
one ensemble standard deviation. The experimental PSA mRNA
data was adapted (replotted) from [375].
by dynamic measurements of phosphorylated ERK (ERKpp) levels following stim-
ulation of EGFR with 8nM EGF (Fig. 4.5D). The EGF-induced ERKpp data was
taken from HeLa cells [295]. However, we expect transient EGF-induced MAPK
activation in LNCaP cells will be qualitatively similar to HeLa given the conserved
nature of mitogenic signaling. We constrained Her2-induced MAPK activation
using cyclin D protein expression data in C-33 and C-81 cells without androgen
following PAcP expression (Fig. 4.5C). Cyclin D expression was coupled to ERK
through the ETS and AP1 transcription factors, both of which activate cyclin D
expression [363]. Her2-induced MAPK activation led to a persistent ETSp sig-
nal compared to ETS activation following EGFR-induced MAPK activation (Fig.
4.5D, inset). Nominally, C-33 cells have lower cyclin D expression compared to
C-81 (Fig. 4.5C, lane 1 and 4). The diﬀerence in cyclin D expression between
C-33 and C-81 cells was qualitatively consistent with increased C-81 proliferation
[161]. While the expression of cPAcP in C-81 reduced cyclin D levels (Fig. 4.5C,
70lane 2), sPAcP expression resulted in no change (Fig. 4.5C, lane 3). Furthermore,
the model predicted a dose-dependent increase in C-33 cyclin D levels 24 hours
after addition of DHT (Fig. 4.6A). Although the cyclin D increase is only notable
in response to high levels of DHT (10 or 100nM) the prediction is qualitatively
consistent with experimental data not included in the ensemble calculations [18].
To further constrain the relationship between MAPK, Her2 and AR activa-
tion, we used the Her2 perturbation study of Lee et al. [203] in the ensemble
calculations. Because the perturbation magnitudes were not reported, we assumed
±50% for all changes. Where possible, this assumption was validated by analyzing
the corresponding Western blots using the GelEval software package (v1.22, Frog
Dance Software). The ±50% perturbation magnitude was approximately consis-
tent with the published blots. A 50% increase in Her2 led to an approximately
50% increase in PSA expression in C-33 without androgen (Fig. 4.5A, lanes 1
and 3). While a 50% decrease in Her2 in C-81 led to a similar decrease in PSA
secretion (Fig. 4.5B, lanes 1 and 2). Further disruption of Her2 eﬀectively blocked
PSA expression in C-81 without androgen (Fig. 4.5B, lane 3). A 50% reduction
of MEK, one of the three primary protein kinases in MAPK, resulted in reduced
PSA expression in C-81 (Fig. 4.5B, lane 4). While a 50% increase of MEK in
C-33 increased PSA expression by 5-fold (Fig. 4.5A, lane 2). The combination of
MEK inhibition and Her2 activation (50% increase in Her2 and a 50% decrease
in MEK) decreased PSA expression in C-33 (Fig. 4.5A, lane 4). Furthermore,
the model predicted an increase in C-33 PSA levels 72 hours after a 2nM addition
of the androgen testosterone. Simulations performed with 10% of the AR initial
condition predicted an approximate 50% decrease in testosterone stimulated PSA
(Fig. 4.6B). The reduced PSA levels are consistent with reported experimental
data on AR antisense knock-downs in androgen dependent LNCaP cells [83]. This
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Figure 4.5: Simulation results for key species under androgen-free conditions.
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Figure 4.6: Independent model predictions versus experimental observations.
A Ensemble prediction of cyclin D expression following the addi-
tion of DHT at 1 hour to C-33 clones. The ensemble predicted a
dose dependent increase of cyclin D at 24 hours after DHT addi-
tion. Experimental data were adapted from Barnes-Ellerbe et al.
[18]. B Predicted eﬀect of an AR knockdown on PSA expression
following the addition of androgen at 1 hour to C-33 wild-type
and C-33 AR knock-down clones. The ensemble predicted an ap-
proximate 50% decrease in androgen-stimulated PSA expression
due to AR knock-down 72 hours after treatment. Experimental
data were reported by Eder et al. [83]. The error bar denotes
one standard deviation centered about the ensemble mean.
data was not included in the ensemble calculations. Taken together, the model
replicated qualitative features of the relationship between MAPK, AR activation
and androgen action. In addition, the qualitative agreement between model and
experiments for PSA and cyclin D expression suggested that the transcription and
translation subsystem models were operating correctly.
734.3.3 Sensitivity and robustness analysis revealed key sub-
systems in AI and AD cells.
Sensitivity analysis identiﬁed interactions important in C-33, C-51 and C-81 cells
(Fig. 4.7 and Table A.3). We calculated Overall State Sensitivity Coeﬃcients
(OSSCs) for the three LNCaP clones over the parameter ensemble (materials and
methods). The OSSC values were ranked-ordered based on their absolute mag-
nitude. The dissociation of AR from Heat Shock Proteins (HSP), components of
the Akt signaling axis and MAPK activation were important (top 2% of sensi-
tive interactions) irrespective of androgen status. Sequestered AR was unable to
become activated by androgens or MAPK. Thus, increased AR-HSP dissociation
promoted increased AR activation and AR-driven gene expression. Several com-
ponents of the MAPK cascade were also important including Ras binding to GAP
and Raf, and the dephosphorylation of ERK. The sensitivity of MAPK was not
unexpected. ERK was critical to outlaw activation of AR. Moreover, ERK activa-
tion was modeled as being Ras-dependent. We also found the Akt signaling axis
to have components in the top 2% of sensitive interactions irrespective of andro-
gen status. For example, the formation of PIP3, an early step in the PI3K/Akt
signaling axis regulated by PTEN, was found to be highly sensitive in all clones.
Looking beyond the upper 2% of sensitive interactions, additional common mech-
anisms were identiﬁed. These included AR interactions with DHT, recruitment of
adapter molecules by Her2, activation of ERK by MEKpp and additional regula-
tion of PIP3 formation by PTEN.
Translation interactions became more fragile while transcription became more
robust with increasing androgen independence. Her2 auto-activation and Her2
cPAcP interactions were also increasingly important with increasing androgen in-
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Figure 4.7: Sensitivity analysis of the model parameters. A: Comparison of
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models. Large ranks indicate fragility. Points left of the 45o line
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function. B: Comparison of the mean OSSC parameter ranks for
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translation initiation) in C-33 versus C-81 LNCaP clones. The
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tion becomes increasingly more robust w.r.t. cancer aggressive-
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D: The ﬁnal mechanism in PSA translation (translation termi-
nation) was increasingly fragile w.r.t. cancer aggressiveness, as
indicated by a signiﬁcant increase in mean OSSC rank. The re-
sults indicate a shift in the bottle neck for generation of PSA from
transcription to translation as prostate cancer cells lose their an-
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75dependence. The diﬀerence in the importance of interactions in AI versus AD
LNCaP clones was estimated by computing shifts in the sensitivity rankings (Ta-
ble A.2). In addition to considering C-33 and C-81, we analyzed a third clone,
C-51, which was moderately androgen dependent. There were 117 statistically
signiﬁcant shifts (52 more and 65 less sensitive) between the C-81 and C-33 clones.
However, only 14 shifts were larger than one standard above the mean shift. Of
the 14 large shifts, 50% involved PSA and PAcP translation while the remainder
were associated with Her2 and cPAcP. Conversely, PSA transcription became more
robust with increasing androgen independence. Similarly, when comparing C-33
to C-51, PSA translation and Her2 activity became more sensitive with increasing
androgen independence. Inspection of the importance of the ﬁnal step in PSA
transcription and translation among the individual models in the ensemble showed
a shift away from transcription (Fig. 4.7C) toward translation (Fig. 4.7D) across
the population of models. The increasing importance of translation was not lim-
ited to PSA, although PSA was the most signiﬁcant example. Globally, 16 of the
52 interactions that were more sensitive in C-81 involved translation while only 4
of 52 involved transcription. No translation mechanisms became more robust in
C-81 compared to C-33. Similar to PSA, translation of other key proteins such as
cPAcP became more sensitive in C-81 versus C-33. Of the statistically signiﬁcant
shifts, 7/9 of the cPAcP translation interactions were more sensitive in C-81. Ad-
ditionally, both mechanisms for the phosphorylation of 4E-BP1 by TOR kinase, a
key step in translation initiation that liberates eIF4E, were also more importance
in C-81. Taken together, the sensitivity analysis suggested that the fragility of the
translational subsystem directly correlated to androgen independence.
To quantify the eﬀects of perturbing key species in C-81 clones we performed
robustness analysis on four functional protein markers. The initial conditions of
76seven key protein species were altered by a factor of 10, 0.1 or 0 for knock-in, knock-
down or knock-out perturbations, respectively. We then calculated the eﬀect of
these perturbation on cyclin D and PSA expression levels along with ERK and
AR activation levels. Perturbation of Raf, MEK or ERK had similar eﬀects on
the functional markers with ERK being the most notable (Fig. 4.8 lanes 1, 2 and
3). Trivially, ERK perturbations directly aﬀected ERK activation levels. However,
more importantly, ERK perturbations greatly aﬀected cyclin D expression levels.
ERK knock-ins approximately doubled cyclin D while ERK knock-outs reduced
cyclin D to less then one third of wild-type levels. The functional markers were
robust to perturbations in AKT and TOR with diﬀering eﬀects on ERK activity
and slight decreases in expression levels upon AKT or TOR knock-out (Fig. 4.8
lanes 4 and 5). Furthermore, the translation initiation factor eIF4E demonstrated
a limiting reagent behavior in the expression of both cyclin D and PSA while
perturbations in 4E-BP1 had little eﬀect (Fig. 4.8 lanes 6 and 7). However, the
4E-BP1 results could be an artifact of artiﬁcially high background levels of eIF4E
as no direct eIF4E measurements were included in the training data. Knock-in
simulations of eIF4E demonstrated an 8.7 and 5.2 fold increase in cyclin D and
PSA expression. Reduction of eIF4E resulted in a 89% loss of expression and full
knock-out simulations predicted a complete loss of cyclin D and PSA.
4.3.4 The MAPK and Akt pathways synergistically acti-
vated cyclin D expression.
Complex systems composed of interacting subsystems can display emergent prop-
erties that are not explained by the individual subsystems alone [1]. In cancer
biology, it is common to speak of signal transduction pathways as if they were
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Figure 4.8: Robustness analysis of functional protein markers. The expres-
sion level of seven key proteins was altered by a factor of 10, 0.1
or 0 (knock-in, knock-down or knock-out) and robustness coeﬃ-
cients (area under the curve for the perturbed versus wild-type
simulation) were calculated for cyclin D and PSA expression lev-
els along with ERK and AR activation levels. Simulations were
run for C-81, with the indicated perturbation, to approximate
steady-state and 10nM of DHT was added for 72 hours. Ensem-
ble mean values are reported.
isolated. In reality, these components are highly interconnected and can interact
in a variety of ways sometimes leading to unpredictable behavior. In this study, we
explored whether the MAPK and Akt signaling axes synergistically activated the
expression of cyclin D. We compared the steady-state cyclin D expression in Akt
and ERK knock-outs with wild-type C-81 cells in the absence of androgens. At
steady-state, the MAPK and Akt pathways synergistically (∆cycD > 0) activated
cyclin D expression in C-81 cells without androgen (Fig. 4.9A). Thus, steady-
state cyclin D expression was greater in wild-type cells (Akt+-ERK+) than the
linear combination of cyclin D expression in Akt−-EKT+ and Akt+-ERK− cells.
The above-additive (superlinear) cyclin D expression was statistically signiﬁcant
within a 95% conﬁdence interval. However, the relatively large standard deviation
78suggested that cyclin D expression varied widely across the ensemble. To address
this, we inspected every model in the ensemble and found that each predicted an
above-additive increase in cyclin D expression (data not shown). Superlinear cyclin
D expression may be the result of positive synergy between the MAPK and transla-
tion subsystems. To elucidate the underlying mechanisms responsible for synergy
we expanded the analysis to include all modeled species (both proteins and protein
complexes) and rates. Many functional network subunits demonstrated no statis-
tically signiﬁcant deviations from additive behavior (Fig. 4.9C, grey). However, 22
species (79 interactions) were negatively coupled to Akt/ERK (∆j < 0; Fig. 4.9B,
red) while 14 species (37 interactions) had a positive synergy (∆j > 0; Fig. 4.9B,
green). Synergy between the MAPK and Akt signaling subsystems negatively af-
fected transcription factor activation. Phosphorylated ERK (ERKpp) activated
AR (pAR), and the transcription factors AP1 and ETS all showed a below ad-
ditive response (Fig. 4.9B). Conversely, positive synergy was almost exclusively
limited to translation interactions. The binding of eIF4E, 40S and 60S ribosomes
to form the mRNA initiation complex, elongation and termination steps all had
positive synergy with ERK/Akt knockdowns (Fig. 4.9B).
4.4 Discussion
A critical milestone in prostate cancer progression is the onset of androgen inde-
pendence. In this study, we formulated and analyzed an ensemble of mathematical
models of the androgen response of AI and AD LNCaP prostate cancer epithelial
cells. The model ensemble was identiﬁed using 14 diﬀerent steady-state and dy-
namic data sets taken from literature. With the exception of one study, all the
training data were generated in LNCaP cell lines. We estimated which molecular
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Figure 4.9: Synergy analysis between the ERK and Akt signaling axes in
LNCaP C-81 cells. The double ERK and Akt knock-out was
used as the control. A: The diﬀerence in steady-state cyclin D
expression (compared to the control) with the knock-in of Akt
(left), ERK (center) and both (right). The predicted cyclin D
levels were normalized by the basal C-81 steady-state cyclin D
level in each case. The error bars denote one standard deviation
centered about the ensemble mean. The region denoted by the as-
terisks represents above-additive cyclin D expression. B: Species
and interactions that demonstrated a positive (negative) synergy
are shown as green (red) in the connectivity diagram. Species or
interactions not aﬀected are shown in grey. C: The full connectiv-
ity diagram qualitatively clustered in functional groups. Positive
(negative) synergy are shown in green (red) in the connectivity
diagram. Species or interactions not eﬀected are shown in grey.
80subsystems were important in AI versus AD cells using sensitivity analysis. For ex-
ample, the assembly and regulation of Her2 adapter complexes and the regulation
of ERK were sensitive, irrespective of androgen status. The dissociation of AR
from HSP was also in the top 2% of sensitive interactions for both C-33 and C-81.
On the surface, the importance of AR in C-81 was surprising as the proliferation
of C-81 is androgen-independent. However, AR can be activated independently
of androgen, thus, the presence of androgen is not required for androgen action
[95, 142]. The diﬀerentiating factor between the AI and AD models described
here was the expression rate of PAcP conformers. We demonstrated the ability of
decreased PAcP expression to describe the PSA levels of increasingly androgen in-
dependent sub-lines. Moreover, interactions involving Her2 auto-phosphorylation,
cPAcP availability and cPAcP phosphatase activity were signiﬁcantly more fragile
in C-81 versus C-33. These results suggest that the regulation of the phosphory-
lation state of Her2 by cPAcP may be a critical interaction controlling androgen
action in the absence of hormone signals. Experimentally, this has been demon-
strated as forced expression of PAcP is suﬃcient to suppress C-81 xenograft tumor
growth [162].
Model analysis suggested that translation interactions were more fragile and
transcription more robust in AI versus AD cells. Globally, 16 of the 52 interac-
tions that were more sensitive in C-81 involved translation, while only 4 of 52
involved transcription. Moreover, no translation mechanisms became more robust
in AI versus AD cells. The importance of translation in more aggressive cancers
(increasing androgen independence) may be due, in part, to synergies between the
Akt and MAPK pathways. Simulations of ERK and/or Akt knockouts showed an
above-additive response almost exclusively limited to translation upon the simulta-
neous reinstitution of Akt and ERK. In-vivo studies of AIPC have demonstrated
81positive synergies between the MAPK and Akt pathways. Gao et al. observed
above-additive tumor growth rates in castrated and mock nude male mice upon
the forced expression of constitutively active Akt and B-RafV 600E [113]. These
experiments suggest that cell proliferation may be regulated by a complex integra-
tion of the MAPK and Akt signaling axes. Our robustness analysis suggested that
independent perturbations in TOR and AKT may have little or no eﬀect on AIPC.
However, we observed the possibility of an inverse relationship between TOR and
ERK activation. This suggests that if TOR or Akt were to be independently
targeted, AKT might be a more suitable therapeutic target. Additionally, we ob-
served that perturbations in Raf, MEK and ERK had a similar eﬀect on cyclin D
but not PSA expression, with ERK being more pronounced. Current therapeutics
such as trastuzumab or geﬁtinib, which target either Her2 or EGFR respectively,
have had little eﬃcacy against hormone-refractory prostate cancers [396, 39]. Our
results suggest that a possible factor in their lack of eﬀectiveness is that they fail
to address synergy between growth factor signaling, MAPK activation and the Akt
signaling axes. Our analysis also demonstrated that translation mechanisms were
generally more sensitive in increasingly androgen-independent models. The trans-
lation results suggest that the direct targeting of the translation machinery may
be useful for the treatment of AIPC. Our robustness analysis identiﬁed eIF4E as a
limiting reagent in the expression of both cyclin D and PSA in C-81 clones. Soni
et al. demonstrated the eﬀectiveness of directly targeting eIF4E in breast cancer.
Down-regulation of eIF4E resulted in decreased cyclin D expression and decreased
growth rate without the deleterious eﬀect of inhibitors such as rapamycin which
act further upstream [317]. Previous modeling studies from our laboratory have
also demonstrated the importance of translation beyond cyclin D [244]. However,
the current model has only a basic description of translation initiation. Moreover,
82translation parameters were only indirectly trained from the PSA mRNA and pro-
tein data. Thus, while the initial robustness and sensitivity results are encouraging
more studies are needed.
Analysis of the ensemble of AI models suggested the Akt and MAPK pathways
synergistically enhanced cyclin D expression by up-regulating translation. Cyclin
D is expressed early in the cell cycle and a point of convergence in the proliferative
action of multiple receptors [219]. Many studies have identiﬁed a direct correlation
between cyclin D regulation and prostate cancer, as well as breast and non-small
cell lung cancer [32, 391, 190]. Balk et al. demonstrated that increased cyclin D
expression in PTEN−/− LNCaP cells following DHT addition was largely because
of increased translation [368]. PTEN loss and presumably the activation of Akt has
been implicated with increased translation and the resistance to therapeutics which
target Her2 and EGFR [25, 241]. However, the underlying mechanism responsible
for the increased translation in the Balk et al. study was not solely Akt-dependent.
Early translation activation was due to PI3K/Akt signaling but TOR activation at
later time points was Akt-independent. One key diﬀerence between the modeling
and the Balk et al. study was the binding of activated AR with the regulatory
subunit of PI3K. This interaction, which was not included in the model, was at
least partially responsible for TOR activation and the eventual liberation of eIF4E.
In addition to direct AR binding, PI3K (and subsequently TOR) can be activated
through receptor adaptor complexes such as those associated with Her2. In the
model, PI3K was activated by androgen (in the absence of growth factor) because
of the down-regulation of cPAcP expression by activated AR. Up-regulated PI3K
then drove Akt-dependent activation of TOR which led to enhanced liberation of
eIF4E from 4E-BP1. Thus, while the initiating events driving TOR activation
were diﬀerent, the subsequent up-regulation of cyclin D translation was similar.
83This suggests that the model prediction of a complex synergy between interacting
signaling axes may be valid. It also suggests a falsiﬁable hypothesis that cPAcP
could be critical to enhanced translation following androgen stimulation.
The role of mechanistic mathematical modeling in drug design remains unclear.
A common criticism of such techniques has been the poorly characterized eﬀect
of model uncertainty. Model uncertainty has two forms. Structural uncertainty is
deﬁned as uncertainty in the biology, while parametric uncertainty is deﬁned as
incomplete knowledge of parameter values. In this study, parametric uncertainty
was minimized by considering a family of consistent models instead of a single
best-ﬁt, but uncertain, model. While model ensembles often poorly constrain in-
dividual parameter values, they may robustly constrain model predictions [128].
Structural uncertainty was addressed by considering only molecular interactions
supported by experimental evidence. However, the current model contained some
abstracted pathways and should be expanded to include additional biology. For
example, the analysis highlighted the importance of translation. However, the
current model contains a limited description of initiation factor activation and the
assembly of the 80S initiation complex. A more detailed translation interaction
network could further reﬁne which translation components were important in AI
versus AD cells. Another example is the mechanism by which AR transcription-
ally regulates the expression of target genes. In the current model, we ignored the
role of transcriptional co-regulators and assumed activated AR functioned alone.
While this is a reasonable ﬁrst approximation, well known co-repressors and acti-
vators [283], such as ARA70 [154], should be included. The regulation and activity
of these co-regulators may be diﬀerent in AI versus AD cells and could enhance
the list of diﬀerentially important targets. Additionally, a nuclear compartment
and enhanced cell cycle and cell death subnetworks should be added to the model.
84These additional networks could be critical to understanding cell proliferation and
survival eﬀects in AI versus AD cells. For example, androgen and AR are known
to regulate several components of the G1-phase of the cell cycle in prostate cells,
not just cyclin D [15]. Moreover, the model describes the activation of Akt in the
context of translation initiation, but not its well know survival functions [69, 217].
Lastly, given the importance of EGFR- and Her2-induced MAPK activation in
the current study and the therapeutic emphasis on receptor inhibition we plan to
include a more complete receptor signaling network. Other receptors, IGFR and
IL-6R have also been implicated in prostate cancer [192, 41, 327]. Understanding
the signaling associated with these receptors and their downstream targets should
be considered and will provide a better representation of how intra- extra-cellular
communication drives cell fate decisions. Furthermore, the application of advanced
sampling techniques may allow for a more exhaustive investigation of parameter
space. For example, multi-objective optimization ensemble techniques could be
used to balance conﬂicts in the training data [316]. Additionally, understanding
the topological details of the cost function in an extended parameter space could
provide statistical information on kinetic rates and initial conditions. Other tech-
niques, for example, the calculation of the mutual information matrix, could also
provide insight into correlations between model interactions. Also, computation
of second-order sensitivity coeﬃcients would allow the identiﬁcation of possible
synergies in the model. Thus, we expect that deeper insight could be generated by
extending the network structure and through the application of advanced model
analysis tools.
854.5 Materials and Methods
4.5.1 Formulation and solution of the model equations.
The prostate model was formulated as a set of coupled Ordinary Diﬀerential Equa-
tions (ODEs):
dx
dt
= N · v(x,k) x(to) = xo (4.1)
The symbol N denotes the stoichiometric matrix (212 × 384). The quantity x
denotes the species concentration (212 × 1). The term v(x,p) denotes the vector
of reaction rates (384 × 1). Each row in N described a species while each column
described the stoichiometry of network interactions. Thus, the (i,j) element of N,
denoted by ηij, described how protein i was involved in rate j. If ηij < 0, then
protein i was consumed in vj. Conversely, if ηij > 0, protein i was produced by vj.
Lastly, if ηij = 0, protein i was not involved in rate j.
We assumed mass-action kinetics for each interaction in the network. The rate
expression for protein-protein interaction or catalytic reaction q:
X
j∈{Rq}
ηjqxj →
X
p∈{Pq}
ηpqxp (4.2)
was given by:
vq (x,kq) = kq
Y
j∈{Rq}
x
−ηjq
j (4.3)
The set {Rq} denotes reactants for reaction q. The quantity {Pq} denotes the
set of products for reaction q. The kq term denotes the rate constant governing
the qth interaction. Lastly, ηjq,ηpq denote stoichiometric coeﬃcients (elements of
the matrix N). We treated every interaction in the model as non-negative. All
reversible interactions were split into two irreversible steps. The mass-action for-
mulation, while expanding the dimension of the prostate model, regularized the
86mathematical structure. The regular structure allowed automatic generation of the
model equations. In addition, an analytical Jacobian (A) and matrix of partial
derivatives of the mass balances with respect to the model parameters (B) were
also generated. Mass-action kinetics also regularized the model parameters. Un-
known model parameters were one of only three types, association, dissociation or
catalytic rate constants. Thus, although mass-action kinetics increased the number
of parameters and species, they reduced the complexity of model analysis. In this
study, we did not consider intracellular concentration gradients. However, we ac-
counted for membrane and cytosolic proteins by explicitly incorporating separate
membrane and cytosolic protein species. We did not consider a separate nuclear
compartment.
4.5.2 Simulation protocol.
An approximate steady-state was used as the starting point (t = 0 hr) for all
simulations presented in this study. For example, when calculating the response
of LNCaP to the addition of DHT, we ﬁrst ran the model to steady-state and
then simulated the addition of DHT. Although no individual cell is likely to be at
steady-state we assumed that steady-state was a reasonable approximation of the
population average behavior of LNCaP cells growing in the exponential phase. The
steady-state was estimated numerically by repeatedly solving the model equations
and estimating the diﬀerence between two subsequent time points:
kx(t + ∆t) − x(t)k2 ≤ ² (4.4)
The quantities x(t) and x(t + ∆t) denote the simulated concentration vector at
time t and t+∆t, respectively. The quantity k·k2 denotes the L2 vector norm. In
this study, we used ∆t = 50 hrs of simulated time and ² = 0.01 for all simulations.
874.5.3 Estimation of the prostate model parameter ensem-
ble.
An initial set of model parameters, denoted by p0, was chosen by hand to replicate
the training data. The training data consisted of 14 time-series and steady-state
data sets taken from literature sources (Table A.1). The initial parameter guess p0
was used to generate an ensemble of parameters that maximized the likelihood of
describing the training data. The diﬀerence between the measured and simulated
value of species j at time or condition i, denoted by ˆ xi,j and x(pk)i,j respectively,
was quantiﬁed by the normalized mean squared error, ψ:
ψ (pk) =
1
n
X
i,j
(ˆ xi,j − βjx(pk)i,j)2
ˆ σ2
i,j
, (4.5)
where the sum was carried out over all species j and observations i. The quantities
n and ˆ σi,j denote the total number of observations and the measurement standard
deviation of species j at time or condition i, respectively. If no experimental
error was reported, we assumed a standard deviation equal to 10% of the reported
observation. In cases where the quantiﬁcation of the stimulus or observation was
unclear, an augmented error of 20%-100% was applied to compensate for the added
uncertainty. βj is a scaling factor which is required when considering experimental
data that is accurate only to a multiplicative constant (assumed here to be the
case form immunobloting analysis). The scaling factor was chosen to minimize the
normalized squared error between a given experiment and species j [31]:
βj =
P
i(ˆ xi,jxi,j/ˆ σ2
i,j)
P
i(xi,j/ˆ σi,j)2 . (4.6)
Because of the scaling factor, the concentration units on simulation results were
arbitrary (consistent with the arbitrary units on the majority of the training data).
All simulation outputs reported in this study were scaled by the corresponding βj.
88There was insuﬃcient training data to properly constrain the 420 model param-
eters. To account for parametric uncertainty, a Monte-Carlo approach similar to
Battogtokh et al. [21] was used to generate an ensemble of parameters. Consider
a set of model parameters pi. Let the likelihood that model simulations with
parameters pi describe the training data be deﬁned as:
φ(pi) ≡ exp{
−ψ(pi)
α
}, (4.7)
where ψ(pi) denotes the simulation error associated with parameter set pi. The
quantity α is a parameter used to tune the rate of acceptance. Further let the
acceptance probability, P(p0
i+1|pi), of a new parameter set, p0
i+1, be
φ(p0
i+1)
φ(pi) if
φ(p0
i+1) < φ(pi) and 1 otherwise. P denotes the probability that p0
i+1 will be
accepted as pi for consecutive Monte-Carlo steps. Parameter sets were generated
by applying a small additive random perturbation in log space:
logp
0
i+1 = logpi + N (0,ν) (4.8)
where N (0,ν) is a normally distributed random number with zero mean and vari-
ance ν. The perturbation was applied in log space to account for the large vari-
ation in parameter scales and to ensure positivity. Monte-Carlo trajectories were
generated starting from p0 where ν =0.05 or 0.1 and α =1 or 0.5. The autocor-
relation function of each trajectory was calculated. The number of Monte-Carlo
steps between parameter sets which were added to the ensemble was taken to be
the number of steps after which the autocorrelation function dropped to 5% of its
initial value. This was done to ensure independence between sets in the ensem-
ble. To compensate for noise in the autocorrelation function an exponential ﬁt
was applied. The ﬁnal ensemble contained 107 parameter sets, which produced an
ensemble ψ of 5.25.
894.5.4 Sensitivity analysis of the prostate network.
Overall State Sensitivity Coeﬃcients (OSSC) were used to estimate which struc-
tural elements of the prostate network were sensitive [323]. OSSC values were
determined by ﬁrst calculating the ﬁrst-order sensitivity coeﬃcients at time tk:
sij (tk) =
∂xi
∂pj
¯
¯
¯
¯
¯
tk
(4.9)
First-order sensitivity coeﬃcients were computed by solving the matrix diﬀerential
equation:
dsj
dt
= A(t)sj + bj (t) j = 1,2,...,P (4.10)
subject to the initial condition sj(t0) = 0. In Eqn. 4.10, j denotes the parameter
index, P denotes the number of parameters in the model, A denotes the Jacobian
matrix, and bj denotes the jth column of the matrix of ﬁrst-derivatives of the
mass balances with respect to the parameter values (denoted by B). An analytical
Jacobian and matrix of ﬁrst-derivatives of the mass balances w.r.t the parameters:
A =
∂fx
∂x
¯
¯
¯
¯
¯
(x∗,p∗)
B =
∂fx
∂p
¯
¯
¯
¯
¯
(x∗,p∗)
(4.11)
were generated from the model equations. The quantity fx = N · v(x,p) and
(x∗,p∗) denotes a point along the unperturbed model solution. The sensitivity
equations required that we solve the model equations to evaluate the A and B
matrices. Thus, we formulated the sensitivity problem as an extended kinetic-
sensitivity system of equations [75]:
0
B
@
˙ x
˙ sj
1
C
A =
2
6
4
N · v(x,p)
A(t)sj + bj (t)
3
7
5 j = 1,2,...,P (4.12)
where ˙ x = dx/dt and ˙ sj = dsj/dt. We solved the kinetic-sensitivity system for
multiple parameters in a single calculation using the LSODE routine of OCTAVE
90(www.octave.org). The ﬁrst-order sensitivity coeﬃcients were then used to calcu-
late the OSSC value for parameter j:
Oj (t) =
pj
Ns
Ã
NT X
k=1
Ns X
i=1
"
1
xi
∂xi
∂pj
¯
¯
¯
¯
¯
tk
#2!1/2
(4.13)
The terms NT, Ns denote the number of time points considered and the state
dimension of the model, respectively. To account for parametric uncertainty, OSSC
values were calculated over the parameter ensemble. Parameters were rank-ordered
(1 ≤ θj ≤ 384) based upon the magnitude of the OSSC value. Large values of θj
indicated fragile or important interactions in the prostate network architecture.
Conversely, small values of θj indicated robustness.
Each model in the ensemble was run to approximately steady-state. At steady-
state, 10nM DHT was added and the ﬁrst-order sensitivity coeﬃcients were calcu-
lated for 100 seconds of simulated time. OSSC values were then calculated and the
rank-ordering determined. We collected interactions whose rank was at least one
standard deviation above the mean rank calculated over all parameters. Highly
ranked interactions were statistically signiﬁcantly diﬀerent between LNCaP clones
if the null hypothesis could be rejected with 95% conﬁdence via a t-test. To esti-
mate signiﬁcance, we performed a two variable unequal variance double tail t-test
using the MATLAB (R) statistical toolbox (2007a, The Mathworks, Natick, MA).
4.5.5 Robustness analysis of functional protein markers.
Robustness coeﬃcients of the form:
α(i,j,to,tf) =
µZ tf
to
xi (t)dt
¶−1 µZ tf
to
x
(j)
i (t)dt
¶
(4.14)
91were calculated to understand the regulatory connectedness of functional protein
markers in the LNCaP network. The robustness coeﬃcient α(i,j,to,tf) is the
ratio of the integrated concentration of a network output in the presence (numera-
tor) and absence (denominator) of structural or operational perturbation. Here t0
and tf denote the initial and ﬁnal simulation time respectively. Simulations were
taken of C-81 from approximate steady-state at t0, 10nM of DHT was added at
1 hour and tf was taken to be 72 hours after DHT addition. The network out-
put was taken to be the network states. The quantity i denotes the index for a
marker or reference species while j denotes the perturbation index, respectively.
If α(i,j,to,tf) > 1, then the perturbation increases the output concentration.
Conversely, if α(i,j,to,tf) ¿ 1 the perturbation decreases the output concentra-
tion. Lastly, if α(i,j,to,tf) ∼ 1 the perturbation does not inﬂuence the output
concentration.
4.5.6 Calculation of steady-state synergy coeﬃcients.
To understand the connectedness of subsystems in the prostate network following
ERK and/or Akt knockdowns we computed synergy coeﬃcients of the form:
∆j =
δxj,Erk+Akt − (δxj,Erk + δxj,Akt)
xj,total
(4.15)
The quantity xj,total denotes the steady-state concentration (ﬂux) of species (inter-
action) j in wild-type C-81. The quantity δxj,Erk (δxj,Akt) denotes the steady-state
concentration (ﬂux) of species (interaction) j in the presence of an Akt (ERK)
knock-out minus the basal value of quantity j. The term δxj,Erk+Akt denotes the
steady-state concentration (ﬂux) of species (interaction) j in wild-type C-81. If
∆j > 0, the quantity j has a positive synergy with Akt and ERK. In other words,
92the steady-state concentration (ﬂux) of species (interaction) j in the wild-type was
greater than the sum of the individual contributions in single Akt or ERK knock-
downouts. Conversely, if ∆j < 0, the quantity j has a negative synergy with Akt
and ERK. Lastly, if ∆j ∼ 0 then there is no connection between quantity j and
the Akt/ERK signaling axes.
93CHAPTER 5
MODELING AND ANALYSIS OF RETINOIC ACID-INDUCED
DIFFERENTIATION OF UNCOMMITTED PRECURSOR CELLS†
5.1 Summary
Manipulation of diﬀerentiation programs has therapeutic potential in a spectrum
of human cancers and neurodegenerative disorders. In this study, we integrated
computational and experimental methods to unravel the response of a lineage un-
committed precursor cell line, HL-60, to Retinoic Acid (RA). HL-60 is a human
myeloblastic leukemia cell line used extensively to study human diﬀerentiation pro-
grams. Initially, we focused on the role of the BLR1 receptor in RA-induced diﬀer-
entiation and G1/0-arrest in HL-60. BLR1, a putative G protein-coupled receptor
expressed following RA exposure, is required for RA-induced cell-cycle arrest and
diﬀerentiation and causes persistent MAPK signaling. A mathematical model of
RA-induced cell-cycle arrest and diﬀerentiation was formulated and tested against
BLR1 wild-type (wt) knock-out and knock-in HL-60 cell lines with and without
RA. The current model described the dynamics of 729 proteins and protein com-
plexes interconnected by 1356 interactions. An ensemble strategy was used to
compensate for uncertain model parameters. The ensemble of HL-60 models reca-
pitulated the positive feedback between BLR1 and MAPK signaling. The ensemble
of models also correctly predicted Rb and p47phox regulation and the correlation
between p21-CDK4-cyclin D formation and G1/0-arrest following exposure to RA.
Finally, we investigated the robustness of the HL-60 network architecture to struc-
tural perturbations and generated experimentally testable hypotheses for future
0† Reproduced by permission of The Royal Society of Chemistry,
http://pubs.rsc.org/en/Content/ArticleLanding/2011/IB/c0ib00141d [332]
94study. Taken together, the model presented here was a ﬁrst step toward a sys-
tematic framework for analysis of programmed diﬀerentiation. These studies also
demonstrated that mechanistic network modeling can help prioritize experimental
directions by generating falsiﬁable hypotheses despite uncertainty.
5.2 Introduction
Understanding the molecular basis of diﬀerentiation, the process by which a cell be-
comes a more specialized cell, is one of the grand unmet challenges facing molecular
cell biology. If diﬀerentiation programs could be rationally manipulated, advanced
therapies could be developed to treat a spectrum of human cancers, spinal cord
injuries and neurodegenerative disorders. However, the molecular basis of these
fundamental programs is still emerging in both adult and embryonic models [49].
To rationally reprogram these networks we must ﬁrst understand their connectivity
and regulation. Lessons learned in simple systems could perhaps inform analysis
of more complex programs. One such model system for the study of diﬀerentia-
tion is the lineage uncommitted human myloblastic cell line HL-60. HL-60 is an
archetypal in vitro diﬀerentiation model studied since the late 1970’s [58, 28, 376].
Depending upon the stimulus, HL-60 undergoes G1/0-arrest followed by either
myeloid or monocytic diﬀerentiation. Retinoic Acid (RA) or Dimethyl Sulfox-
ide (DMSO) causes G1/0-arrest and myeloid diﬀerentiation. On the other hand,
1,25-dihydroxy vitamin D3 (D3) or sodium butyrate causes arrest with monocytic
diﬀerentiation. Stimuli such as RA or D3 drive MEK-dependent activation of the
ERK1/2-MAPK pathway [383, 384, 151, 356]. Elevated MAPK signaling persists
until cells G1/0-arrest and terminally diﬀerentiate. The onset of G1/0 arrest and
terminal diﬀerentiation requires approximately 48 hr. During this period, HL-60
95cells undergo approximately two division cycles [382, 379, 377, 380]. Interestingly,
during the ﬁrst 24 hours of treatment, called a precommitment period, cells are
primed to diﬀerentiate without lineage speciﬁcity. Lineage speciﬁcity is deter-
mined in the second 24 hr period. Disruption of MEK signaling leads to failure
of ERK1/2 activation and HL-60 diﬀerentiation. Activation of both Retinoic Acid
Receptor (RAR) and Retinoid X Receptor (RXR) is necessary for RA-induced
G1/0-arrest, MAPK signal activation [378, 19, 381] and myeloid diﬀerentiation
[384, 151, 356, 20].
RA-induced diﬀerentiation is contingent on the early transcriptional up-
regulation of BLR1 (Burkitt’s Lymphoma Receptor-1). BLR1, also known as
CXCR5, is a putative serpentine heterotrimeric Gq protein-coupled receptor, with
a sequence similar to IL-8 receptors [76]. It was ﬁrst discovered in a screen for
diﬀerentially expressed genes that conferred metastatic capability to human B-cell
lymphomas [76, 91]. BLR1 was identiﬁed as an early RA (or D3)-inducible gene
in HL-60 cells using diﬀerential display [376, 225], suggesting it had a broader
function than lymphocyte regulation. Studies of the BLR1 promoter identiﬁed a
5’ 17bp GT box approximately 1 kb upstream of the transcriptional start that
conferred RA responsiveness [354]. Over-expression of BLR1 in HL-60 cells en-
hanced ERK2 activation in both RA-untreated and treated cells and accelerated
RA- and D3-induced diﬀerentiation and G1/0-arrest. Alternatively, BLR1 ho-
mologous knockout cells failed to produce a sustained MAPK response, arrest or
diﬀerentiate. However, activation of MAPK signaling via constitutively active c-
Raf over-expression was able to rescue the diﬀerentiation response. Furthermore,
inhibiting MAPK activation via a c-Raf inhibitor or siRNA knockdown resulted
in decreased BLR1 expression, and loss of diﬀerentiation and arrest [355]. Thus,
RA-induced BLR1 expression appears to contribute to sustained ERK2 activation
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Figure 5.1: Overview of BLR1-MAPK positive feedback loop driving RA-
induced HL-60 arrest and diﬀerentiation. RA signals are inter-
cepted by a family of RAR/RXR nuclear receptors which in turn
drive the expression of genes with RARE promoter elements. One
key RA-regulated protein is BLR1. BLR1, a putative G protein-
coupled transmembrane surface receptor, drives an atypical sus-
tained MAPK signal which, in turn, activates the expression of
genes required for the execution of the cell-cycle arrest and dif-
ferentiation programs. MAPK also activates factors in the BLR1
transcriptional activator complex resulting in positive feedback.
97and propulsion of-induced diﬀerentiation and G0 arrest.
To analyze RA-induced arrest and diﬀerentiation in HL-60 we integrated exper-
imental and computational methods. Many have suggested that the integration of
experimental and computational research is required to unravel critical questions
facing modern cell biology [9, 8]. Toward this end, mathematical modeling has
become an important tool to understand biological complexity [188]. A common
method of modeling biological pathways is to formulate coupled Ordinary Diﬀer-
ential Equations (ODEs) [155, 111, 295, 323, 268, 209, 324, 218, 316, 48, 189, 331].
However, to formulate and solve ODE models both the network structure and
parameter estimates are required. Yeast Two-Hybrid (Y2H) [97, 38, 342, 163],
Fluorescence Resonance Energy Transfer (FRET) [388] or Chromatin Immuno-
precipitation (ChIP)-DNA microarray techniques [93, 114, 148, 204] have all been
used to identify network interactions. Although error-prone [96, 353], these tech-
niques along with traditional low-throughput immunoprecipitation have been the
basis for most experimental network discovery. Computational motif discovery
[233, 373, 175], high-throughput network reconstruction [387, 333, 126, 215] or text
processing [5], have also contributed signiﬁcantly to network identiﬁcation. The
integration of these studies has led to comprehensive on-line network databases
such as STRING [167], NetworKIN [213, 214] or KEGG [6, 173, 249]. However,
while network structural knowledge continues to evolve, the identiﬁcation of model
parameters remains a fundamental challenge.
Many forms of experimental data can be used to estimate the parameters and
challenge physiochemical models. The direct simulation of metabolite, mRNA and
protein concentrations provides a direct means of incorporating absolute or relative
experimental measurements into the model identiﬁcation process. In this study,
98we made use of protein and mRNA data from Western and Northern blot analysis.
Blotting techniques are common low throughput strategies to measure relative
protein or mRNA levels. Relative levels of multiple proteins and post-translational
modiﬁcations can also be measured by micro or multiplex Westerns [55, 26, 107],
multi-parameter ﬂuorescence techniques [238, 326], and absolute values by HPLC-
mass spectrometry [258, 196]. Data from high throughput RNA technologies,
e.g., oligonucleotide arrays [156, 159, 186], are also valuable for constraining model
parameters. Future data sets can be used to challenge the current model structure.
Paradoxically, the best result of this type of challenge is catastrophic model failure;
qualitative model failure often suggests new biology and helps focus experimental
investigation. Thus, the real value of physiochemical modeling is not constructing
a model that is consistent with current data. Rather, it is generating an integrated
platform that can be used to systematically check consistency and help focus our
understand of complex biology.
5.3 Results
In this study, we tested the suﬃciency of the BLR1-MAPK architecture to re-
capitulate persistent MAPK activation and to predict qualitative molecular fea-
tures of RA-induced arrest and diﬀerentiation in HL-60. The model was orga-
nized around the regulation of seven transcription factors by ERK1/2 and PKCα
and the subsequent RA-induced transcriptional program (Table A.4). The sig-
naling and transcription factor network architecture was assembled by aggregat-
ing information from online databases such as NetworKIN [213] and TRANSFAC
[51] along with experimental literature. Model parameters and structure were re-
identiﬁed to make the model HL-60 speciﬁc. The composite network included
99steroid/hormone activated nuclear transcription factor receptors [226, 225]. Yen
and coworkers established that RA treatment induces BLR1 expression through
a non-canonical retinoic acid-responsive element (RARE) in the BLR1 promoter
[354]. However, the mechanism by which BLR1 drives c-Raf activation in HL-60
remains uncertain. There is evidence suggesting that BLR1 acts as a Gq protein-
coupled receptor [172, 104]. Moreover, Kolch et al. showed that protein kinase C
activator (PKCα) phosphorylates c-Raf, at several sites, in NIH 3T3 ﬁbroblasts
[191]. Here we hypothesized that RA-induced BLR1 activated PKCα through its
Gq protein-coupled receptor activity and PKCα, in turn, phosphorylates c-Raf.
The c-Raf driven MAPK signal then activates factors in the BLR1 transcriptional
activator complex resulting in positive feedback. We encoded this connectivity
by re-identifying the Gq protein-coupled receptor model of Song and Varner [316]
in HL-60. To complete the loop MAPK family members must be connected in
some way with BLR1 expression. Components of the BLR1 transcriptional acti-
vator complex, e.g., NFATc3 and CREB, can be phosphorylated by ERK, JNK
or p38 MAPK family members [371]. In the model, we encoded the simplest
route, namely the phosphorylation of NFATc3 by ppERK1/2. The in vivo phos-
phorylation of NFATc3 by ppERK1/2 has been shown in a variety of blood cell
types [371]. PI3K/AKT/TOR-mediated translation initiation [352, 275, 243] and
G1/0 mammalian cell-cycle regulation [244] were also included. All molecular in-
teractions, including transcription and translation, were modeled as elementary
reactions using mass-action kinetics. Mass balance equations describing the dy-
namics of network components were formulated as a system of non-linear Ordinary
Diﬀerential Equations (ODEs). The deterministic system of ODEs modeled the
average behavior of a cell culture population. Thus, we ignored stochastic eﬀects
in this study; both experimental and computational evidence suggest that cell pop-
100ulations act deterministically [338, 122]. While we assumed spatial homogeneity,
we diﬀerentiated between cytosolic, membrane and nuclear localized processes us-
ing segregated compartments. In total, the model described 729 species and 1356
interactions (Fig. 5.1 and Table S1). The model had 1462 unknown parameters
(1356 kinetic constants and 106 initial conditions). The kinetic constants were of
three types: association, dissociation or catalytic rate constants. Identiﬁcation of
these unknown model parameters posed a signiﬁcant challenge. We addressed this
challenge by identifying an ensemble of parameter sets consistent with the training
data instead of a single best ﬁt but uncertain parameter set. The ensemble of HL-
60 models recapitulated the positive feedback between BLR1 and MAPK signaling.
The ensemble of models was also capable of making important predictions. For
example, the model ensemble correctly predicted Rb and p47phox regulation and
the correlation between p21-CDK4-cyclin D formation and G0 arrest. Finally, we
investigated the robustness of the HL-60 network subjected to structural pertur-
bations and generated experimentally testable hypothesis for future study. Model
parameters and all model code are available in the supplemental materials.
5.3.1 Estimating an ensemble of HL-60 models.
Signal transduction models often exhibit complex behavior [10, 30, 228, 152]. It
is often not possible to identify model parameters, even with extensive training
data and perfect models [112]. Thus, despite identiﬁcation standards [116] and
the integration of model identiﬁcation with experimental design [16], parameter
estimation remains challenging. In this study, an ensemble of plausible model
parameters was estimated from the study of Wang and Yen [355]. The data sets
used for model training and validation along with the model error are summarized
101in Table A.5. We used the time-course of MAPK activation and BLR1 expression
following RA treatment to generate the HL-60 ensemble (Fig. 5.3). In addition,
measurements of the MAPK-BLR1 signaling axis in genetically engineered HL-60
cell lines were also used (Fig. 5.4). We employed a maximum likelihood random-
walk strategy similar to Battogtokh et al. [21] to identify the ensemble (Fig.
5.2A). We generated 2377 possible parameter sets and selected the most likely
sets for inclusion in the ensemble (lowest mean squared error; N = 100). The
use of multiple parameter sets allowed for quantitative estimation of the eﬀect of
parametric uncertainty.
The median binding aﬃnity for interactions in the model (calculated over the
ensemble) was approximately 100 nM, while the median kcat ' 0.5 s−1. Thus,
although no speciﬁc constraint was applied, the parameters were physiologically
reasonable. Additionally, the correlation between ensemble parameter sets showed
that we sampled from at least two local minima (Fig. A.2). This suggested that
the ensemble was diverse and explored multiple possible local solutions. Seventy-
two percent of parameters in the ensemble had a Coeﬃcient of Variation (CV)
of less than 100% (Fig. 5.2B). Thus, the order of magnitude of approximately
three-quarters of the model parameters was identiﬁed from the training data. Un-
constrained parameters typically involved processes not activated by RA or not
associated with BLR1 signaling.
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Figure 5.2: Parameter identiﬁcation strategy. (A) Multiple Monte-Carlo tra-
jectories were used to randomly explore parameter space. The
simulation likelihood was used to generate a family of parame-
ter sets used in the simulation study. We generated N = 2377
possible parameter sets and selected the 100 sets with the high-
est likelihood for inclusion in the ensemble. (B) Coeﬃcient of
Variation (CV; standard deviation of a parameter relative to its
mean value) for the parameter ensemble used in this study. A
small CV suggested a parameter was tightly constrained by the
training data used for model identiﬁcation. Black circles repre-
sent the CV values for the full N = 100 sets used in the ensemble.
The gray circles indicate the CV values for a sub-ensemble (N =
47) selected from the main ensemble and used in the robustness
analysis study. CV values were sorted from lowest to highest
relative to the full ensemble.
5.3.2 The ensemble of HL-60 models recapitulated RA-
induced BLR1 expression and MAPK activation.
Wang and Yen demonstrated that RA-induced BLR1 expression was necessary for
sustained MAPK activation [355]. In this study, we explored whether a BLR1
control element was suﬃcient for sustained MAPK activation. We incorporated
a putative BLR1-MAPK feedback architecture supported by literature. BLR1
acted as a Gq protein-coupled receptor [172, 104] which activated c-Raf via PKCα.
The MAPK signaling axis was connected back to BLR1 expression through the
103regulation of the BLR1 transcriptional activator complex.
The HL-60 connectivity recapitulated RA-induced sustained MAPK activation
and feedback between BLR1 and MAPK (Fig. 5.3 and Fig. 5.4). The ensemble of
HL-60 models, following the addition of RA, captured the transient expression of
BLR1 (Fig. 5.3A). BLR1 then drove c-Raf phosphorylation through its hypoth-
esized Gq protein-coupled activity (Fig. 5.3B). Activated c-Raf was then free to
activate downstream MAPK kinases (Fig. 5.3C and 5.3D). The median training
error for RA-induced BLR1/MAPK signaling was ∼ 2, where ppERK1/2 was the
least constrained species (Table A.5). An error of 1.0 indicated the model accu-
racy was equal to experimental error (assumed to be ± 20% for the training blots).
Thus, the model recapitulated three of the four species to within a neighborhood
around the experimental error. The ensemble of models also recapitulated aspects
of BLR1/MAPK signaling following c-Raf and BLR1 perturbations (Fig. 5.4).
Because the perturbation magnitudes were not reported, we assumed ±50% for
all changes, excluding the BLR1 homologous knockout. A 50% decrease in c-Raf
expression resulted in a signiﬁcant reduction in BLR1 message after 48 hr of RA
exposure (Fig. 5.4A). Conversely, a 50% increase in c-Raf activation increased
BLR1 transcription (Fig. 5.4A). Removal of BLR1 blocked RA-induced c-Raf ac-
tivation, while increased BLR1 expression increased c-Raf phosphorylation (Fig.
5.4B). The BLR1-MAPK perturbation simulations were qualitatively consistent
with experimental measurements (Fig. 5.4 bottom panel).
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Figure 5.3: Model simulations over the parameter ensemble captured the sus-
tained activation of MAPK following RA exposure (1µM) at time
= 1 hour. Dashed lines denote the simulation mean. Shaded re-
gions denote one ensemble standard deviation. (A) Experimental
and simulated levels of BLR1 mRNA following RA exposure. (B)
Time proﬁle of phosphorylated RAF1 activation following RA
exposure. (C) Simulated versus measured phosphorylated MEK
activation following RA exposure. (D) Simulated versus mea-
sured phosphorylated ERK following RA exposure. Data were
adapted from Wang and Yen [355].
5.3.3 The HL-60 ensemble predicted RA-induced expres-
sion shifts and qualitative features of G1/0 cell-cycle
arrest.
We tested the ability of the model to predict qualitative features of RA-induced
diﬀerentiation not included in the training data (Table A.5). The model ensemble
predicted that Rb, a known cell-cycle regulator, protein levels decreased following
RA treatment (Fig. 5.5B). Down-regulation of the Rb protein level was consistent
105with Western blot measurements, performed in this study, 24 hrs after RA treat-
ment (Fig. 5.5B, lower inset). Interestingly, Rb protein levels decreased despite a
stable mRNA signal, as demonstrated by Northern blot measurements taken from
RA-induced HL-60 cells under similar conditions [385] (Fig. 5.5B, top inset). Ulti-
mately, the model suggested that competition for translational machinery resulted
in the decreased Rb protein levels. One might consider measuring either mRNA
or protein levels to determine regulatory changes in a cell population. However,
mRNA and protein levels are not always directly related. Our approach includes
both transcription of genes into mRNA and translation of mRNA into protein by
directly modeling the mechanisms involved in these processes. This detailed mech-
anistic approach allowed us to directly simulate both mRNA and protein levels and
to identify possible kinetic diﬀerences between the transcription and translation
rates for proteins in the model. Thus, the model correctly predicted an unan-
ticipated experimental observation. Other factors not present in the model, for
example, RA-induced degradation mechanisms could also play a role. In addition
to shifts in Rb expression, the model ensemble also predicted other RA-induced
cell-cycle responses. For example, the model ensemble predicted increased associa-
tion of p21 with the CDK4-cyclin D complex following RA-treatment (Fig. 5.5A).
Because p21 is a known cell-cycle inhibitor, increased p21-CDK4-cyclin D levels
may be representative of previous data on the kinetics of RA-induced G1/0-arrest
(Fig. 5.5A, inset). However, there was some discrepancy between the previous
arrest studies and the cyclin D expression data, as cyclin D expression levels were
not consistently predicted (Table 5.1).
Finally, we were interested in identifying the extent to which the current net-
work captured the global RA-induced diﬀerentiation program. We predicted the
expression of seven key proteins, identiﬁed as being commonly regulated in HL-60
106Table 5.1: Predicted and measured RA-induced protein expression shifts at
3, 12 and 24 hrs after the addition of 1µM RA to exponentially
growing HL-60 cells. Plus (+) indicates the model and experiment
agreed on the statistically signiﬁcant direction of the shift (up,
down or no change). Minus (-) indicates no match. The data
were reproduced from Yen and co-workers [386].
Protein 3hr 12hr 24hr
p47Phox + + +
SPRK2 + + +
PRK + + -
RhoGDI + - -
Cyclin D - + -
CD45 + - -
IRF - - -
diﬀerentiation by Western blot analysis [386]. These protein level measurements
were not used in the model training. Unlike the cell-cycle, the model was not
tailored to speciﬁcally account for the detailed mechanisms involved in regulating
each of these proteins. Rather, regulatory information was limited to the identiﬁca-
tion of putative transcription factors (TRANSFAC; [51]) and their phosphorylation
dependent activation (NetworKIN; [213]). The expression shift (up, down or un-
changed) at three time points (3, 12 and 24 hrs) post RA-treatment was compared
with model simulations. In total, the BLR1-MAPK control element was responsi-
ble for approximately half of the signiﬁcant RA-induced protein shifts (Table 5.1).
A completely random assignment of expression shift would be correct only one
out of three times, indicating the model prediction was above random. For some
key proteins the given network structure and kinetics, although relatively limited,
was suﬃcient to describe the expression proﬁle. For example, the model ensem-
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Figure 5.4: The model recapitulated RA-induced feedback between BLR1
expression and MAPK activation. (A) Simulated BLR1 expres-
sion normalized to wildtype (WT) with Raf inhibition (-, 50%
decrease in Raf initial condition) and overexpression (+, 50% in-
crease in Raf initial condition) 48 hr after the addition of RA.
(B) Simulated phosphorylated Raf levels normalized to wildtype
(WT) with BLR1 knockout (KO, BLR1 gene initial condition
set to zero) and overexpression (+, 50% increase in BLR1 gene
initial condition) 12 hr after the addition of RA. (bottom panel)
Corresponding model training data adapted from Wang and Yen
[355]. First row: eﬀect of Raf siRNA (left) and overexpression
(right) on the expression of BLR1 (Northern). Second row: eﬀect
of BLR1 knockout and overexpression of the level of phosphory-
lated Raf (S621).
ble consistently predicted the experimentally observed up-regulation of p47Phox,
a component of oxidative metabolism important in the functional diﬀerentiation
of mature myeloid cells [59]. Consistently missed predications, like IRF, indicated
the involvement of important regulatory components beyond RA-activated nuclear
transcription factors and the MAPK cascade.
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was performed in our lab as described in the Methods section.
Dashed lines denote the simulation mean. Shaded regions denote
one ensemble standard deviation.
1095.3.4 Robustness analysis identiﬁed essential nodes in RA-
induced diﬀerentiation of HL-60.
Signal transduction architectures often contain redundancy, feedback and
crosstalk. These and other features make signaling networks robust to perturba-
tion. However, robust networks which are highly optimized for speciﬁc tasks may
also contain hidden fragility [42]. Here, we generated falsiﬁable predictions about
the fragility or robustness of structural features of the HL-60 network using ro-
bustness analysis. We calculated the direction of RA-induced concentration shifts
for 729 markers following the deletion of 106 network components. The structural
perturbations included the deletion of 80 constitutively expressed proteins, the
genes for 20 regulated proteins or the removal of calcium, ATP, etc. Robustness
coeﬃcients were calculated to quantify the eﬀect of perturbations where values >
1 indicated a marker increased compared to wild-type and values < 1 indicated a
marker decreased. We identiﬁed markers that were statistically signiﬁcantly shifted
up (red) or down (blue) over the ensemble (Fig. 5.6A). We then rank-ordered the
results from least (rank = 1) to most (rank = 106) eﬀective knock-down (x-axis)
and least (rank = 1) to most (rank = 729) aﬀected marker (y-axis). Eﬀectiveness
was deﬁned as the number of expression shifts caused or the number of perturba-
tions aﬀecting a marker.
The majority of deletions resulted in only small changes in the network output
following the addition of RA. Approximately 80% of the entries in the robustness
matrix were equal to zero indicating no signiﬁcant shift (Fig. 5.6A, green). For
those species that did inﬂuence the network state, there was an approximately
30% correlation between connectivity and inﬂuence. For example, deletion of
RNA polymerase (RNAp) resulted in the largest number of statistically signiﬁ-
110cant shifts, 468 or 64% of the network components. RNAp was also the most
connected component with 191 connections (connected to approximately 26% of
the network species). However, the Spearman rank correlation between connec-
tivity and knock-down eﬀectiveness was only 0.32. Globally, the largest impact
was made by removing RNAp as well as components of translation initiation. In-
terestingly, while deletion of translation components aﬀected many markers, there
were only a limited number of perturbations that impacted translation. Deletion
of other structural elements with much lower connectivity also produced global
variation. For example, removal of BLR1 or the BLR1 transcription factor com-
plex aﬀected on average 280 markers, or 38% of the network. BLR1 or components
of its transcriptional activator complex had an average connectivity of 11, or just
1.5% of the network. Small molecules such as calcium ions, ATP and GDP were
also structurally critical, on average aﬀecting 185 markers. Interestingly, MAPK
species appeared nearly midway through the ordered list with ERK at rank 43/106
and MEK at rank 46/106. The most inﬂuential MAPK component was c-Raf at
rank 59/106.
No single structural deletion led to enhanced diﬀerentiation of HL-60 following
RA exposure. We considered three markers to represent a signiﬁcant tendency
towards HL-60 diﬀerentiation: ppERK1/2 represented sustained MAPK signal-
ing; the p21-CDK4-cyclin D complex represented initial aspects of cell-cycle ar-
rest; p47phox expression represented early aspects of the inducible reactive oxygen
species machinery. Of the 106 deletions, none consistently up-regulated all three
markers. Twenty-two network components (or 21% of those tested) were essential
for diﬀerentiation (Fig. 5.6B). Sixteen of these involved translation and RNAp.
The remaining six targets were members of the BLR1 transcription factor complex
including RAR/RXR. Analysis of the shifts for the individual markers following
111the structural perturbations suggested functional relationships in the network. For
example, deletion of 32 components (or 30% of those explored) reduced ppERK1/2
formation (Fig. 5.6B, top panel). These included BLR1, RXR/RAR, proteins in
the Gq protein-coupled cascade connecting BLR1 with c-Raf, upstream kinases
and MAPK phosphatases. Thirty-six perturbations (or 34% of those explored)
inﬂuenced p21-CDK4-cyclin D formation (Fig. 5.6B, center panel). In addition to
those perturbations associated with ppERK1/2, deletion of components involved
with cyclin D expression also inﬂuenced p21-CDK4-cyclin D levels. For example,
deletion of the phosphatase responsible for dephosphorylating AP1 (transcription
factor for cyclin D) increased p21-CDK4-cyclin D levels. Twenty-seven perturba-
tions (or 25% of those explored) shifted p47Phox expression (Fig. 5.6B, bottom
panel). These structural perturbations were largely associated with the regulation
of the transcription factors driving p47Phox expression.
5.3.5 Robustness coeﬃcients identiﬁed distinguishable
species and functional subnetworks.
Direct observation of robustness coeﬃcients for functional markers provided very
speciﬁc information about model behavior. Global analysis of the robustness co-
eﬃcients provide systems-level insight into the RA-induced HL-60 diﬀerentiation
program. For our global analysis, we considered the log of the robustness coeﬃ-
cients (LRC) as the primary metric for measuring response to species knockouts.
An LRC of +1 represents an order of magnitude increase from wild-type while
a value of -1 represents a ten-fold decrease. The vectors in LRC space provide
information on both the direction and the magnitude of a given knockout over all
729 markers. We constructed a dendrogram by separating the species knockouts
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Figure 5.6: Calculation of robustness coeﬃcients. Each non-zero initial con-
dition (conserved species) was removed, the model was run to
approximate steady-state and RA was added at time = 1 hour.
The area under the curve was calculated for each model species.
(A) Qualitative coupling results. Removed species are along the
x-axis from lowest to largest impact and observed model species
are along the y-axis from least to most aﬀected. Blue or red mark-
ers depict a statistical decrease or increase, respectively, in area
under the curve within a 90% conﬁdence interval. Gray regions
contain a large number of infrastructure proteins (i.e., transcrip-
tional/translational). (B) Coupling coeﬃcients (area under the
curve from the simulation with species removed over wild-type
simulation) for three markers of diﬀerentiation: phosphorylated
ERK, p47phox expression and p21-CDK4-cyclin D complex. Red
circles indicate knock-downs which demonstrated a statistical de-
crease in all three markers: (left to right) RAR, RXR, BLR1,
NFATc3, RNAp, eIF4E, Oct1, CREB, 40s and 60s ribosomes,
met tRNA, EIF2, PABP, eIF4A,B,G,H, and eIF1,1A,3,5,5B.
113into clusters which minimized the variance in LRC (Fig. 5.7A).
The most distinct separation was between infrastructure species, e.g., RNAp
and components of the translation initiation complex, and the remaining signal-
ing species. The segregation of infrastructure from signaling species reduced the
initial variance by approximately two thirds (Fig. 5.7A colored groups). Clusters
beyond the initial segregation represented distinct functional groups; cell-cycle,
the MAPK-BLR1 control element, and transcriptionally regulated markers. Inter-
estingly, although functional relationships emerged in each cluster, the correlation
between elements in a cluster was minimal; of the 11,130 possible knockout pairs
only 32 returned correlation coeﬃcients above 0.95.
Approximately 50% of the responses following structural perturbation to the
HL-60 network were redundant and shared by two or more structural perturba-
tions. We computed the magnitude of the orthogonal component of these changes
in LRC space for each knockout over the ensemble (Fig. 5.7B). The orthogonal
component was used to establish a unique marker that could be associated with
the diﬀerent structural perturbations. Interestingly, all knockouts were found to
have orthogonal components with magnitudes greater than one with a 95% con-
ﬁdence. This suggested that each of the 106 knockouts produced a unique order
of magnitude, or more, shift from wild-type. Furthermore, half were found to be
statistically signiﬁcantly above ﬁve (Fig. 5.7B red).
5.4 Discussion
A grand challenge in tumor biology continues to be an understanding of the regu-
lation of cell division and diﬀerentiation. The primary obstacle to understanding
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Figure 5.7: Global robustness analysis. (A) Dendrogram of knockout species.
The distance metric was the Euclidean norm and the linkage
function was the inner square product (variance minimization
algorithm). Each additional cluster is chosen to reduce the vari-
ance (y-axis). The color threshold was chosen to be 200 which
is 50% of the remaining variance after the initial division. Gen-
eral species and/or functions are indicated below each colored
group. (B) Distinguishability as the magnitude of the orthogo-
nal components for all knockout species considered. Species are
ordered from largest to smallest magnitudes. Red markers indi-
cate species which are statistically signiﬁcantly above 5. Speciﬁc
species are identiﬁed as shown. Error bars show one standard
deviation over the parameter ensemble.
these programs has been their complexity and scale. Interrogating these systems
species by species is simply intractable. A computational approach that allows in
silico analysis versus experimental surveying would be a tool of widespread utility
to push past this hurdle. Our ultimate objective is to develop a cell-type-agnostic
mathematical model of hormone/growth factor regulated cell division and diﬀeren-
tiation. However, as an initial step towards this goal, we focused on the archetypal
in vitro cell line HL-60. Upon RA treatment HL-60 undergoes growth arrest and
myeloid diﬀerentiation. Our basic hypothesis has been that RA-induced cell diﬀer-
entiation is regulated by BLR1 which signals through a RAF/MEK/ERK axis. In
turn, the MAPK cascade activates a limited number of transcription factors which
then drive the expression of proteins mediating the phenotypic shift [354]. The
current network incorporates these basic signaling features. We established that
115a literature-based positive feedback loop between BLR1 and MAPK signaling was
suﬃcient to generate the BLR1 expression and MAPK activation proﬁles observed
experimentally (Fig. 5.3 and Fig. 5.4). Furthermore, we demonstrated that the
current model was capable of making important predictions including the regula-
tion of Rb and p47phox along with the correlation between the p21-CDK4-cyclin
D complex and G0 arrest.
Robust networks or systems maintain performance despite structural or opera-
tional perturbations. In this study, we performed a robustness analysis to estimate
which architectural features of the HL-60 network promoted or destroyed diﬀerenti-
ation. This analysis also generated falsiﬁable predictions on the role of individual
model species and global insight into the network itself. For example, the core
translation machinery was a robust yet fragile subsystem. Deletion of translation
components aﬀected roughly 60% of the entire network (Fig. 5.6A). However,
translation was robust in that removal of other network species had little impact
on its function. The majority of translation, except for met-tRNA and eIF5, were
in the lower third of eﬀected markers. However, while necessary, the translation
subnetwork may not be experimentally interesting.
To focus on phenotypic conversion we considered three markers of programmed
diﬀerentiation and G1/0-arrest: ppERK1/2, p21-CDK4-cyclin D and p47phox.
These markers were representative of sustained MAPK activity, cell-cycle arrest
and early ROS machinery, respectively. Simulations of RA-induced phenotypic
change in the wild-type model showed these markers were reliable compared to
experimental data. None of the structural perturbations considered consistently
up-regulated all three markers. This suggested that no single structural pertur-
bation enhanced the eﬀect of RA and that, given the current network, no com-
116ponents were blocking diﬀerentiation. Structural perturbations that consistently
down-regulated all three markers were considered targets that would prevent dif-
ferentiation. Again the translational core machinery along with RNAp proved to
be necessary for diﬀerentiation. Beyond these global components, we also found
that deletion of RAR, RXR, BLR1, NFATc3, Oct1 and CREB (Fig. 5.6B) also
down-regulated diﬀerentiation. RAR and RXR were obvious candidates for mit-
igating the RA diﬀerentiation response [370]. Removal of BLR1 has previously
been shown to prevent diﬀerentiation [355] and was indeed a motivating factor in
the original model design. NFATc3, Oct1, and CREB were all required for tran-
scriptional activation of the BLR1 gene and were therefore of similar importance
[354]. While this study identiﬁed key diﬀerentiation regulators, the list was not
complete. For example, Yen et al. showed that Raf and MEK activation was also
required for diﬀerentiation [355, 383]. In the current network, ERK deletion re-
pressed only two (ppERK1/2 and p21-CDK4-cyclin D) of the three diﬀerentiation
markers, not eﬀecting p47phox. While ERK may regulate p47phox expression, it
may also impact inducible ROS response at other points in the network. A more
detailed model, including other diﬀerentiation markers, is required to fully unravel
the key species in the diﬀerentiation program.
We demonstrated that there was a limited relationship between the direct con-
nectivity of a node and the functional consequences of its removal. It has been
suggested that many biological networks, including protein-protein interaction net-
works, have a non-random scale-free or hub and spoke topology [17]. Scale-free
networks contain many nodes with very few connections and a small number of
highly connected nodes producing a power law connectivity distribution. In scale-
free networks connectivity has been experimentally related to biological functions,
such as mutation lethality in the S. cerevisiae protein protein interaction network
117[168]. However, increasingly persuasive evidence suggests a divergence between
topological metrics like connectivity and importance [130, 343, 135]. While the
HL-60 model architecture was approximately scale-free (Fig. A.1), we observed a
poor relationship (Spearman rank = 0.32) between the connectivity and inﬂuence
of network nodes. Furthermore, the unique response to structural perturbation is
linear unlike the degree distribution (Fig. 5.7B); one would expect an exponen-
tial decrease in response if connectivity alone dominated. Thus, both interaction
topology and dynamics must be considered in complex biological programs such
as diﬀerentiation.
The initial model presented here was a step toward a systematic framework
for the organization and prediction of hormone-induced programmed diﬀerentia-
tion. However, there are several issues that should be addressed in subsequent
studies. For example, a common criticism of large complex mathematical models
is the poorly characterized eﬀect of model uncertainty. Model uncertainty has two
forms. Structural uncertainty is uncertainty in the biology, while parametric un-
certainty is incomplete knowledge of model parameters. As discussed previously,
we used an ensemble approach to overcome parametric uncertainty. The HL-60
ensemble predicted the expression of a panel of markers found previously to be
important [386]. These predictions were successful despite the large uncertainty
in the model parameters. However, the prediction error rate was signiﬁcant. This
suggested that structural uncertainty was also important. It is likely that struc-
tural uncertainty was present both in terms of missing interactions (false negatives)
and incorrect interactions (false positives). We partially mitigated structural un-
certainty by associating each interaction with experimental studies or previously
validated network models. However, in some cases, connectivity had to be hypoth-
esized from literature. For example, the connectivity between BLR1 signaling and
118c-Raf activation was hypothesized from studies in ﬁbroblasts. G coupled-protein
receptor (GCPR) signaling and the subsequent activation of PKCα was modeled
as a sequential series of activating events. This basic architecture was suﬃcient to
generate an RA-induced sustained MAPK signal. Furthermore, we demonstrated
that all of the 106 conserved model species played a unique functional role. Re-
moval of any these resulted in an order of magnitude, or more, shift from wild-type
that was orthogonal to all other knockout species (Fig. 5.7B). Despite the apparent
importance of all modeled species, the exact connectivity remains to be validated
in HL-60. To validate the proposed architecture, we are employing biochemical
strategies to characterize intermediate complexes in the BLR1 signaling axis. False
negative structural defects also represent a signiﬁcant challenge. Current compu-
tational and biological limitations render a full cell model intractable. Thus, the
choice of scope is an important aspect to modeling protein interaction networks.
In this study, we focused on MAPK-BLR1 positive feedback. Inclusion of other
signaling pathways or a more advanced transcriptional regulation network will be
required to capture the RA-induced expression shifts missed here as well as other
HL-60 diﬀerentiation data. The framework provided in this study is amenable to
expansion. The inclusion of more experimental data and a more detailed network
architecture could improve the predictive power of the model and provide an in
silico tool for understanding hormone-induced programmed diﬀerentiation.
5.5 Conclusions
In this study, we presented a mechanistic mathematical model of RA-induced
diﬀerentiation of the hematopoietic cell line HL-60. We demonstrated that a
BLR1-MAPK positive feedback mechanism was suﬃcient for sustained RA-induced
119MAPK activation. Furthermore, we demonstrated that, while limited in biological
scope, this control element was suﬃcient to describe the transcriptional regulation
of several proteins found to be important in HL-60 diﬀerentiation. Through in sil-
ico knockouts we also showed the model’s ability to generate falsiﬁable predictions.
For example, we predicted that no knockout, of the species considered, resulted
in an increased diﬀerentiation. Structurally, the HL-60 diﬀerentiation network
demonstrated the divergence between simple topological metrics like connectivity
and biological function. Interestingly, we found that conserved species, the major-
ity which have low connectivity, contributed a unique and distinguishable response
to RA treatment. Finally, a systematic clustering analysis identiﬁed distinct sub-
networks important to the diﬀerentiation response. One of these subnetworks, the
protein synthesis/translation subnetwork, exhibited robust yet fragile behavior.
While perturbations to translation resulted in general program failure, translation
itself was robust to outside perturbation. This is a prime example of how biological
networks are structured to protect against catastrophic failure. We believe that
this study is a signiﬁcant ﬁrst step in providing a computational tool for under-
standing the pathways involved in hormone-induced programmed diﬀerentiation.
5.6 Experimental
5.6.1 Cell culture, RA treatment and Western blot analy-
sis.
Human myeloblastic leukemia cells (HL-60) were grown in a humidiﬁed atmo-
sphere of 5% CO2 at 37 C and maintained in RPMI 1640 supplemented with 5%
120fetal bovine serum (Invitrogen). The cells were cultured in constant exponential
growth as previously described [29]. The experimental cultures were initiated at
a cell density of 0.2 × 106 cells/ml. RA (Sigma) was dissolved in 100% ethanol
with a stock concentration of 5 mM, and used at a ﬁnal concentration of 1µM as
previously described [29]. For Western blot analyses, 1.2 × 107 cells were lysed
using 400µl of M-Per lysis buﬀer (Pierce) and lysates were cleared by centrifu-
gation at 16,950 × g in a microcentrifuge for 20 min at 4oC. Equal amounts of
protein lysates (20µg) were resolved by 8% SDS-PAGE at 90 volts, transferred to
nitrocellulose membranes, and probed with a primary and secondary antibodies for
visualization. Antibody solutions contained 10µL of the appropriate antibody and
1g bovine serum albumin dissolved in 20mL 1X TBS, 0.1% Tween. The primary
Retinoblastoma (Rb) antibody was purchased from Zymed. A GAPDH antibody
(Cell Signaling, Beverly, MA) was used to check uniform loading. Anti-rabbit
and anti-mouse horseradish peroxidase-linked secondary antibodies (Cell Signal-
ing, Beverly, MA) were used for visualization.
5.6.2 Formulation and solution of the model equations.
The HL-60 model was formulated as a set of coupled Ordinary Diﬀerential Equa-
tions (ODEs):
dx
dt
= N · v(x,p) x(to) = xo (5.1)
The symbol N denotes the stoichiometric matrix (729 × 1356). The quantity
x denotes the concentration vector of proteins or protein complexes (729 × 1).
The term v(x,p) denotes the vector of reaction rates (1356 × 1). Each row in
N described a protein while each column described the stoichiometry of network
interactions. Thus, the (i,j) element of N, denoted by ηij, described how protein
121i was involved in rate j. If ηij < 0, then protein i was consumed in vj. Conversely,
if ηij > 0, protein i was produced by vj. Lastly, if ηij = 0, there was no protein i
in rate j.
We assumed mass-action kinetics for each interaction in the network. The rate
expression for protein-protein interaction or catalytic reaction q was given by:
vq (x,kq) = kq
Y
j∈{Rq}
x
−ηjq
j (5.2)
The set {Rq} denotes reactants for reaction q. The kq term denotes the rate
constant governing the qth interaction. Lastly, ηjq denotes stoichiometric coef-
ﬁcients (elements of the matrix N). We treated every interaction in the model
as non-negative. All reversible interactions were split into two irreversible steps.
The mass-action formulation, while expanding the dimension of the model, reg-
ularized the mathematical structure. The regular structure allowed automatic
generation of the model equations using the UNIVERSAL code generation tool
(http://code.google.com/p/universal-code-generator/). Mass-action kinetics also
regularized the model parameters. Unknown model parameters were one of only
three types: association, dissociation or catalytic rate constants. Thus, although
mass-action kinetics increased the number of parameters and species, they reduced
the complexity of model analysis. In this study, we did not consider intracellu-
lar concentration gradients. However, we accounted for membrane, cytosolic and
nuclear species by explicitly incorporating separate well mixed compartments.
5.6.3 Simulation protocol.
A pseudo steady-state was used as the starting point (t = 0 hr) for all simulations
presented in this study. For example, when calculating the response of HL-60 to
122the addition of RA, we ﬁrst ran the model to steady-state and then simulated
the addition of RA. We assumed that a pseudo steady-state was a reasonable
approximation of the population average behavior of HL-60 growing in the expo-
nential phase. The steady-state was estimated numerically by repeatedly solving
the model equations and estimating the diﬀerence between two subsequent time
points:
kx(t + ∆t) − x(t)k2 ≤ ² (5.3)
The quantities x(t) and x(t + ∆t) denote the simulated concentration vector at
time t and t+∆t, respectively. The quantity k·k2 denotes the L2 vector norm. In
this study, we used ∆t = 50 hrs of simulated time and ² = 0.01 for all simulations.
5.6.4 Estimating an ensemble of model parameters.
The 1462 unknown model parameters (1356 kinetic constants and 106 non-zero ini-
tial conditions) were estimated using the experimental studies performed by Wang
and Yen [355]. The experimental work focused on the existence of a BLR1-MAPK
positive feedback loop and included time course data and genetically engineered
cell lines to capture perturbations in both the BLR1 and MAPK signaling axis.
The initial parameter guess p0 was used to generate an ensemble of parameters
that maximized the likelihood of describing the training data. The diﬀerence be-
tween the measured and simulated value of species j at time or condition i, denoted
by ˆ xi,j and x(pk)i,j respectively, was quantiﬁed by the normalized mean squared
error, ψ:
ψ (pk) =
1
n
X
i,j
(ˆ xi,j − βjx(pk)i,j)2
ˆ σ2
i,j
, (5.4)
where sum was carried out over all species j and observations i. The quantities
n and ˆ σi,j denote the total number of observations and the measurement error of
123species j at time or condition i, respectively. If no experimental error was reported,
we assumed a standard deviation equal to 10% of the reported observation. In cases
where the quantiﬁcation of the stimulus or observation was unclear an augmented
error of 20%-100% was applied to compensate for the added uncertainty. The
scaling factor βj was chosen to minimize the normalized squared error for a given
experiment and species j [31]:
βj =
P
i(ˆ xi,jxi,j/ˆ σ2
i,j)
P
i(xi,j/ˆ σi,j)2 . (5.5)
Because of the scaling factor, the concentration units on simulation results were
arbitrary (consistent with the arbitrary units associated with the majority of the
training data). There was insuﬃcient training data to properly constrain the
model parameters. To account for parametric uncertainty, a Monte-Carlo approach
similar to Battogtokh et al. [21] was used to generate an ensemble of parameters.
Consider a set of model parameters pi. Let the likelihood that model simulations
with parameters pi describing the training data be deﬁned as:
φ(pi) ≡ exp{
−ψ(pi)
T
}, (5.6)
where σ(pi) denotes the simulation error associated with parameter set pi. The
quantity T is a parameter used to tune the rate of acceptance. Further, let the
acceptance probability, P(p0
i+1|pi), of a new parameter set, p0
i+1, be
φ(p0
i+1)
φ(pi) if
φ(p0
i+1) < φ(pi) and 1 otherwise. P denotes the probability that p0
i+1 will be
accepted as the starting point for consecutive Monte-Carlo steps. Parameter sets
were generated by applying a small additive random perturbation in log space:
logp
0
i+1 = logpi + N (0,ν) (5.7)
where N (0,ν) is a normally distributed random number with zero mean and vari-
ance ν. The perturbation was applied in log space to account for the large vari-
ation in parameter scales and to ensure positivity. Monte-Carlo trajectories were
124generated starting from p0 where ν =0.05 or 0.1 and T =1 or 0.5. The autocor-
relation function of each trajectory was calculated. The number of Monte-Carlo
steps between parameter sets which were added to the ensemble was taken to be
the number of steps after which the autocorrelation function dropped to 5% of its
initial value. This was done to ensure independence between sets in the ensemble.
To compensate for noise in the autocorrelation function an exponential ﬁt was ap-
plied. We generated 2377 possible parameter sets from which we selected the 100
sets with the highest likely-hood for inclusion in the ﬁnal ensemble.
5.6.5 Robustness analysis of the HL-60 architecture.
Robustness coeﬃcients of the form:
α(i,j,to,tf) =
µZ tf
to
xi (t)dt
¶−1 µZ tf
to
x
(j)
i (t)dt
¶
(5.8)
were calculated to understand the regulatory connectedness of the HL-60 network.
The robustness coeﬃcient α(i,j,to,tf) is the ratio of the integrated concentration
of a network output in the presence (numerator) and absence (denominator) of
structural or operational perturbation. Here t0 and tf denote the initial and ﬁnal
simulation time, respectively. The network output was taken to be the network
states. The quantity i denotes the index for a marker or reference species while
j denotes the perturbation index, respectively. If α(i,j,to,tf) > 1, then the per-
turbation increases the output concentration. Conversely, if α(i,j,to,tf) ¿ 1 the
perturbation decreases the output concentration. Lastly, if α(i,j,to,tf) ∼ 1 the
perturbation does not inﬂuence the output concentration. Because of computa-
tional constraints, we calculated the robustness coeﬃcients using a sub-ensemble
(N = 47) selected from the full ensemble (N = 100). The sub-ensemble had a CV
125distribution similar to the full ensemble (Fig. 4.2B, circles). While we sampled a
sub-ensemble, this subset had a diversity similar to the full ensemble. Thus, we
expect results calculated using the sub-ensemble will be similar to the full ensem-
ble.
5.6.6 Species clustering and dendrogram.
A dendrogram was derived by considering each of the 106 knockouts as variables
and the average log of robustness coeﬃcient (LRC) for each of the remaining 728
species as observations. We used the Euclidean norm in LRC space as the distance
metric. The linkage function (objective function for identifying variable clusters)
was the inner squared distance (minimum variance algorithm). The Statistical
Toolbox of Matlab (The Mathworks, Natick, MA) was used to generate the dis-
tances, linkages and the ﬁnal dendrogram.
5.6.7 Identiﬁcation of distinguishable species.
Robustness coeﬃcients were used to rank-order knockout experiments in terms
of the greatest unique responses and to identify species (network nodes) which
were linearly distinguishable. As described above, 106 in silico knockouts were
performed. The response of these knockouts was measured in terms of robustness
coeﬃcients. Here we considered the log of the robustness coeﬃcients (LRC) as the
primary metric for measuring response. The LRC has desirable linear properties,
such that no response (no change in trajectories from wildtype) returns a value
of zero and similar negative and positive responses have diﬀerent directions but
similar magnitudes:
126F(0) = 0
|F(X)| = |F(−X)|.
We considered the unique component of the response to be the orthogonal compo-
nent in LRC space and the magnitude of the response to be the Euclidean norm.
The orthogonal components and there magnitude were identiﬁed for each parame-
ter set in the ensemble by ﬁrst choosing the knockout with the greatest magnitude,
x1, and placing it in the empty set V . The knockout x1 deﬁnes the orthogonal
directions in LRC space. We then calculated the orthogonal components for all
remaining knockouts relative to x1, and added the knockout species with the great-
est orthogonal magnitude to set V . In general the components of all remaining xi
orthogonal to set V were calculated and the largest was moved into set V . This
process was continued until all knockout species,xi were added to set V . Math-
ematically two species were considered distinguishable if and only if they were
linearly independent (the orthogonal components were non-zero). We considered
a threshold value of one or ﬁve and performed a student t-test (Matlab Statistical
Toolbox, The Mathworks, Natick, MA) to identify which species had orthogonal
components above the threshold with a 95% conﬁdence over the ensemble.
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INVESTIGATION OF THE CRAF INTERACTOME AND
STEADY-STATE MULTIPLICITY IN RETINOIC ACID-INDUCED
DIFFERENTIATION OF HL-60 CELLS
6.1 Summary
The complexity of human diﬀerentiation networks complicates analysis of their
architecture and function. Lessons learned in model systems could perhaps inform
the analysis of more complex programs. One such model system is the lineage-
uncommitted human myeloblastic cell line HL-60. HL-60 undergoes myeloid diﬀer-
entiation along with G1/0-arrest when exposed to Retinoic Acid (RA). One of the
deﬁning features of this program is slow and persistent MAPK activation. At the
protein level, the mechanism of RA-induced commitment, arrest and functional
diﬀerentiation is only partially understood. In this study, we explored the RA-
inducible cRaf interactome to determine the functional and regulatory architecture
responsible for persistent MAPK activation in HL-60 cells. We surveyed a panel of
19 possible cRaf interaction partners with and without RA and the cRaf inhibitor
GW5074. We found ﬁve proteins (AKT, CK2, 14-3-3, Src and VAV) that inter-
acted with cRaf under diﬀerent conditions. Of these ﬁve, the interaction between
cRaf and VAV demonstrated a constant correlation with RA-inducible MAPK ac-
tivation and aspects of functional diﬀerentiation. To better understand the role of
cRaf in the RA-induced diﬀerentiation program, we constructed a family of mech-
anistic mathematical models of the transcriptional and post-translational events
driving persistent RA-induced MAPK activation. The proposed mechanistic ar-
chitecture was shown to be consistent with experimental observation. Bifurcation
128analysis of this model family predicted bistability in ppERK levels as a function
of RA forcing. A functional consequence of this non-linear behavior was the abil-
ity to lock the MAPK cascade into a self-sustaining activated state, even in the
absence of RA. These simulations were qualitatively validated with RA washout
experiments. The results provide further details on sustained MAPK activation,
mechanistic insight for aspects of cellular memory, and proof-of-concept that a
combination of experimental and computational methods is an eﬀective strategy
for dissecting complex intracellular programs.
6.2 Introduction
Understanding the molecular basis of diﬀerentiation, the process by which a cell
becomes a more specialized cell, is a grand challenge facing biology. If diﬀeren-
tiation programs could be rationally manipulated, advanced therapies could be
developed to treat a spectrum of cancers, spinal cord injuries and neurodegener-
ative disorders. However, the molecular basis of these programs is still emerging
[389, 131]. To rationally reprogram diﬀerentiation networks, we must ﬁrst under-
stand their connectivity and regulation. Lessons learned in model systems, such
as the lineage-uncommitted human myeloblastic cell line HL-60, could perhaps in-
form our analysis of more complex programs. HL-60 has been studied extensively
since the 1970’s and remains a durable experimental model [58, 28, 376]. Depend-
ing upon the stimulus, HL-60 undergoes G1/0-arrest followed by either myeloid or
monocytic diﬀerentiation. For example, Retinoic Acid (RA) induces G1/0-arrest
and myeloid diﬀerentiation in HL-60, whereas 1,25-dihydroxy vitamin D3 induces
arrest with monocytic diﬀerentiation. Commitment to cell cycle arrest and termi-
nal diﬀerentiation requires approximately 48 hr of treatment during which HL-60
129cells undergo approximately two division cycles. Interestingly, cells treated with
RA for time periods shorter than the commitment phase, retain a limited inherita-
ble memory which reduces the time required to reach commitment during repeated
RA exposure [382, 379].
Sustained MAPK activation is a deﬁning feature of RA-induced diﬀerentia-
tion in HL-60. RA drives slow yet sustained MEK-dependent activation of the
ERK2/MAPK pathway, leading to arrest and diﬀerentiation [383]. MEK inhibi-
tion results in the loss of both ERK and Raf phosphorylation, as well as the failure
to arrest and terminally diﬀerentiate [383, 151]. At the transcriptional level, RA
(and its degradation products) are ligands for the hormone activated nuclear tran-
scription factor families Retinoic Acid Receptor (RAR) and Retinoid X Receptor
(RXR) [226, 224]. Activation of both RAR and RXR is necessary for RA-induced
Raf phosphorylation and MAPK signal activation, suggesting that the initiation
of MAPK signaling is partially transcriptionally regulated [151]. RA, through ac-
tivation of a transcription factor complex including RAR and RXR, also induces
the expression of BLR1. BLR1, also known as CXCR5, is a putative serpentine
heterotrimeric Gq protein-coupled receptor that is necessary for MAPK activa-
tion, growth arrest and functional diﬀerentiation [376, 225, 354, 91]. BLR1 was
identiﬁed as an early RA (or D3)-inducible gene in HL-60 cells using diﬀerential
display [376, 225], suggesting it had a broader function than lymphocyte regulation.
Studies of the BLR1 promoter identiﬁed a 5’ 17bp GT box approximately 1 kb
upstream of the transcriptional start that conferred RA responsiveness [354]. Ad-
ditionally, members of the BLR1 transcriptional activator complex, e.g. NFATc3
and CREB, can be phosphorylated by ERK, JNK or p38 MAPK family mem-
bers [371]. This suggested positive feedback between BLR1 expression and MAPK
activation. BLR1 overexpression accelerated cRaf phosphorylation and terminal
130diﬀerentiation, while BLR1 knock-out HL-60 cells failed to activate cRaf or diﬀer-
entiate in the presence of RA [355]. Interestingly, both the knockdown or inhibition
of cRaf, also reduced BLR1 expression and functional diﬀerentiation [355]. A re-
cent computational study of RA-induced diﬀerentiation in HL-60 cells suggested
that the BLR1-MAPK positive feedback circuit was suﬃcient to explain sustained
MAPK activation and the expression of diﬀerentiation markers [332]. Not surpris-
ingly, model analysis also suggested that cRaf was the most distinguishable of the
MAPK proteins.
A critical question is whether the BLR1-MAPK positive feedback circuit is both
necessary and suﬃcient to drive RA-induced functional diﬀerentiation of HL-60.
Wang and Yen showed that ectopic expression of the CR3 domain of Raf1 restored
RA-induced G0 arrest and diﬀerentiation in BLR1 knock-out cells [355]. However,
ectopic expression of Raf1 CR3 alone, in the absence of RA, failed to induce arrest
or diﬀerentiation. Thus, a second RA-inducible cRaf circuit, which independently
drives arrest and diﬀerentiation in the absence of BLR1, may exist. In this study,
we explored this hypothesis using a combination of experimental and computa-
tional tools. First, we considered how MAPK activation and diﬀerentiation were
eﬀected by the inhibition of cRaf kinase activity in the presence and absence of RA
and the Raf inhibitor GW5074 (GW). We showed that cRaf activity was directly
proportional to ERK phosphorylation and to functional diﬀerentiation processes
such as the generation of reactive oxygen species (ROS). Surprisingly, the combina-
tion of RA and GW enhanced arrest and the expression of diﬀerentiation markers
such as cluster of diﬀerentiation molecule 11B (CD11b). Next, we explored the
RA-inducible cRaf interactome by surveying a panel of 19 possible binding part-
ners using immunoprecipitation (IP), in the presence and absence of RA and GW.
Initially, we expected to see increased RA-dependent association between cRaf and
131kinases linked to the Gq coupled receptor activity of BLR1; however, this was not
supported by data. Instead, we found that the interaction between the Guanine
nucleotide exchange factor Vav and cRaf was both RA-inducible and simultane-
ously sensitive to GW. Lastly, we proposed a mechanistic mathematical model of
the cRaf-Vav circuit that was based on the IP and Western blot data presented
in this study, and from from previous literature. The proposed model architec-
ture was consistent with the RA-induced sustained MAPK activation observed
experimentally. Additionally, we found the cRaf-Vav circuit possessed interesting
dynamic features such as bistability, that could explain RA-induction memory ef-
fects. Taken together, this study established the working hypothesis that Vav is
a member of an RA-inducible trigger complex that could propel sustained MAPK
activation, arrest and diﬀerentiation even in the absence of BLR1.
6.3 Results
6.3.1 Inhibition of cRaf kinase activity modulated MAPK
activation and diﬀerentiation markers.
We ﬁrst considered the eﬀect of the cRaf kinase inhibitor GW5074 (GW) on RA-
induced growth arrest and diﬀerentiation. HL-60 cells were treated with 2µM GW
with or without RA (1µM) at 0hr. This GW dosage had a negligible eﬀect on the
cell-cycle distribution, compared to RA treatment alone (Fig. 6.1). A negative
control with no treatment (neither GW or RA) was also included. RA treatment
alone increased both cRaf phosphorylation at S621/S259 and cRaf expression 24hr
post treatment (Fig. 6.2A). The phosphorylation of cRaf at S338 (canonical active
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Figure 6.1: The cell cycle distribution at 72 hours for diﬀerent concentrations
of Raf inhibitor GW5074. G1 and S phase percentages are shown
as determined by ﬂow cytometry.
site) was also detected. However, there was no diﬀerential eﬀect on S338 phospho-
rylation following RA treatment (Fig. 6.2B). Lastly,RA-induced phosphorylation
of ERK was blocked by GW, consistent with the loss of cRaf kinase activity (Fig.
6.2A). Surprisingly, both the phosphorylation and expression of cRaf was inhib-
ited by GW. This suggested a positive feedback between cRaf kinase activity, cRaf
phosphorylation and ERK action on cRaf transcription factors.
RA treatment alone statistically signiﬁcantly increased the G1 percentage over
the untreated control, while GW alone had a negligible eﬀect on the cell cycle
distribution (Fig. 6.3A). Interestingly, the combination of GW and RA statistically
signiﬁcantly increased the G1 population (82 ± 1%) compared with RA alone (61
± 0.5%). Increased G1/0 arrest following the combined treatment with GW and
RA was unexpected, as the combination of RA and the MEK inhibitor (PD98059)
has been shown previously to decrease RA-induced growth arrest [383]. However,
growth arrest is not the sole indication of functional diﬀerentiation. Expression of
the cell surface marker CD11b has also been shown to coincide with HL-60 myeloid
diﬀerentiation [147]. We measured CD11b expression, for the various treatment
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Figure 6.2: MAPK activation at 24hr in response to RA and/or the Raf
inhibitor GW5074. Relative levels of cRaf total expression, phos-
phorylation at S621 and S259 and phosphorylated ERK as deter-
mined by Western blots analysis, GapDH was used as a loading
control.
groups, using immuno-ﬂuorescence ﬂow cytometry 48hr post-treatment. As with
G1/0 arrest, RA alone increased CD11b expression over the untreated control,
while GW further enhanced RA-induced CD11b expression (Fig. 6.3B). GW alone
had no statistically signiﬁcant eﬀect on CD11b expression, compared with the
untreated control.
Neutrophils release reactive oxygen species (ROS) in response to chemical
markers left by foreign invaders, such as bacteria. Thus, the inducible ROS re-
sponse can be used as a functional marker of diﬀerentiated neutrophils. We mea-
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Figure 6.3: Diﬀerentiation phenotypic markers for RA at 24 hours with and
without the Raf inhibitor GW5074. A) Cell Cycle distribution as
determined by ﬂow cytometry indicated arrest-induced by RA,
which was increased by the addition of GW5074. B) Expression
of the cell surface marker CD11b as determined by ﬂow cytom-
etry indicated increased expression-induced by RA, which was
enhanced by the addition of GW5074. C) Ineducable Reactive
Oxygen Species as determined by DCF ﬂow cytometry indicated
a functional diﬀerentiation response in RA treated cells, which
was mitigated by the addition of GW5074.
135sured the ROS response-induced by the phorbol ester 12-O-tetradecanoylphorbol-
13-acetate (TPA) using ﬂow cytometry. TPA induces an ROS response in mature
neutrophils and has been used in several studies to identify diﬀerentiated HL-60
cells [205, 383, 60]. Untreated cells showed no discernible TPA response, with
only 7.0 ± 3.0% ROS induction (Fig. 6.3C). Cells treated with RA had a signiﬁ-
cant increase in the TPA response, 53 ± 7% ROS induction 48hr post-treatment.
Treatment with both RA and GW statistically signiﬁcantly reduced ROS induc-
tion (22 ± 0.6%) compared to RA alone. Interestingly, Western blot analysis did
not detect a GW eﬀect on RA-induced expression of p47phox, a required upstream
component of the ROS response (Fig. 6.3C, bottom). Thus, the inhibitory eﬀect
of GW on inducible ROS must occur downstream of p47phox expression.
6.3.2 Interrogation of the cRaf interactome suggested Vav
was involved with RA-induced initiation of MAPK
activity.
Inhibition of cRaf kinase activity in combination with RA treatment signiﬁcantly
changed cRaf phosphorylation, the cell-cycle distribution and expression of diﬀer-
entiation markers such as CD11b. However, it was not clear how RA-induced cRaf
activation. To explore this question, we conducted immunoprecipitation and subse-
quent Western blotting to identify physical interactions between cRaf/cRaf(S621)
and 19 putative interaction partners. A panel of 19 possible cRaf interaction
partners (kinases, GTPases, scaﬀolding proteins etc) was constructed based upon
known signaling pathways. However, the most likely binding partner, the small
GTPase RAS was not considered, as previous studies have ruled it out in HL-60
136cells [355, 176]. Total cRaf and cRaf(S621) were used as bait proteins for the im-
munoprecipitation. A negative control with no bait protein was used to exclude
the direct interaction of proteins with the A/G beads. Western blot analysis us-
ing total cRaf and cRaf(S621) speciﬁc antibodies conﬁrmed the presence of the
bait proteins in the immunoprecipitate (Fig. 6.4A). Of the 19 proteins sampled,
Vav, Src, CK2, AKT, and 14-3-3 precipitated out with cRaf, suggesting a direct
physical interaction. However, only the associations between cRaf and Vav and
cRaf and Src were RA-inducible (Fig. 6.4, lane 1). Furthermore, the Vav and
Src associations were correlated with cRaf(S621) levels in the precipitate. Others
proteins e.g., CK2, Akt and 14-3-3, bound cRaf regardless of phosphorylation sta-
tus or RA treatment. The remaining 14 proteins were expressed, but were either
not detectable in the precipitate or detectable at levels comparable to the negative
control (Fig. 6.4B). GW treatment following RA exposure reduced the association
of Vav with cRaf (Fig. 6.5). GW did not inﬂuence the association of CK2 or
14-3-3 with cRaf, further demonstrating their independence from cRaf phospho-
rylation. The cRaf AKT interaction was qualitatively increased upon treatment
with GW (with or without RA). Taken together, the immunoprecipitation and
GW results implicated Vav association to be correlated with cRaf activation fol-
lowing RA-treatment. Previous studies have demonstrated a Vav-Slp76-Cbl-CD38
complex to play an important role in RA-induced MAPK activation and diﬀer-
entiation of HL-60 [303]. Here we did not observe direct interaction of cRaf with
Cbl or Slp76; however, this complex could be involved upstream. We do note
that the RA-induced interaction of Src and cRaf warrants further investigation.
Although we saw no evidence of Src-dependent phosphorylation of cRaf at Y342,
Src family kinases are known to play an important role in myeloid diﬀerentiation
[234]. The role of Src family kinases in RA-induced diﬀerentiation was investigated
137independently (A. Yen and J. Congleton Leukemia; submitted).
6.3.3 Formulation of a mechanistic model of RA-induced
MAPK activation in HL-60
The immunoprecipitation and GW studies suggested that the guanine exchange
factor Vav acted as an RA-inducible initiator of sustained MAPK activation. To
test this hypothesis, we constructed a mechanistic mathematical model of a puta-
tive cRaf-Vav activation circuit (Fig. 6.6). The immunoprecipitation and kinase
inhibitor studies suggested that cRaf kinase activity was required for RA-induced
ERK phosphorylation and ROS response. Furthermore, the phosphorylation and
expression of cRaf itself decreased in response to Raf inhibition. These results
suggested a possible positive feedback loop between cRaf kinase activity and in-
creased cRaf expression, possible through ppERK-dependent transcription factors
such as Sp1 and STAT1 [183, 232, 394, 210]. Both Sp1 and STAT1 have puta-
tive binding domains in the cRaf promoter (TRANSFAC). However, this loop is
not RA-responsive, without an RA-inducible trigger, which we hypothesize is Vav.
The Vav gene contains an upstream canonical Retinoic Acid Response Element
(RARE) sequence motif (TRANSFAC) which could allow Vav expression to be at
least partially regulated by RA.
A family of cRaf-Vav models was estimated using the eight datasets taken from
this study (38 total data points), and the previous study of Wang and Yen [355].
We used the random walk ensemble approach described previously [331] with a
Levenberg-Marquardt local reﬁnement step to minimize the diﬀerence between
model simulations and experimental measurements. Cross validation (data split
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Figure 6.4: Investigation of a panel of possible cRaf interaction partners. A)
Species identiﬁed to precipitate out with cRaf: ﬁrst column shows
Western blot analysis on total cRaf immunoprecipitation with
and without 24hr RA treatment, the second on pS621 speciﬁc
cRaf immunoprecipitation, and the third on total lysate. B) The
expression of species considered that did not precipitate out with
cRaf at levels detectable detectable by Western blot analysis.
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Figure 6.5: Eﬀect of the Raf inhibitor GW on cRaf interactions as determined
by Western blot analysis of total cRaf immunoprecipitations.
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Figure 6.6: Schematic of the mechanistic formulation for a simpliﬁed MAPK
feedback loop, controlled by an RA-induced limiting reagent.
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Figure 6.7: Optimization of model parameters. Graph shows the training
error as determined by relative mean squared error for training
on the complete data set, the red dot indicates the nominal (or
best-ﬁt) set and the green dots indicate sets within 20%. The
inset table shows the mean results of (20/80) cross validation for
the initial set, the set after one optimization, and the set with
the nominal training error after the full optimization.
into 80% training and 20% validation) demonstrated that, on average, the model
identiﬁcation scheme decreased both training and prediction error (Fig. 6.7). The
cross validation results were also suggestive of the predictive ability of the model
and demonstrated that the nominal parameter set did not result in over-ﬁtting. In
the subsequent analysis, we considered a family (N = 99) of likely parameter sets
with relative mean squared errors within 20% of the best-ﬁt set. The model family
recapitulated both time-series data (including sustained MAPK activation) and
the GW results (Fig. 6.8). These simulations suggested that the cRaf-Vav circuit
was consistent with RA-induced cRaf activation and sustained MAPK activation.
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Figure 6.8: Training results for a subset of the data, error bars denote stan-
dard deviation over the ensemble, data is shown above. Time
course data from Wang and Yen [355], and others from this study.
6.3.4 Bistability in the MAPK feedback loop
One of the most interesting properties of HL-60 is the RA-induction memory ef-
fect. HL-60 cells treated with RA for time periods shorter than the commitment
phase, retain a limited inheritable memory which reduces the time required to
reach commitment during repeated RA exposure [382, 379]. We analyzed the
family of cRaf-Vav models to determine if this circuit architecture could explain
these memory eﬀects. Surprisingly, bifurcation analysis of the cRaf model pre-
dicted a bistability in ppERK concentrations between two stable ﬁxed points for
low values of RA (RA<0.15µM) and a single stable solution for high RA values
(RA>0.15µM). We identiﬁed a stable ppERK ﬁxed point (S1) at RA = 0 (Fig.
6.9A, top) using a continuation algorithm with an analytical Jacobian (materials
142and methods). Increasing RA in increments of 0.01µM, monotonically increased
one of the system’s eigenvalues towards zero (Fig. 6.9A, middle) as RA approached
0.15µM (point S4). Running the same algorithm in decreasing increments start-
ing from RA = 1.0 to 0.0µM identiﬁed a second branch of ppERK ﬁxed points
(Fig. 6.9A top, bold line). Interestingly, the eigenvalues of this second branch
were always negative over the full range of RA values. A saddle node bifurca-
tion near RA = 0.15µM destabilized the lower branch of ﬁxed points causing the
steady-state ppERK solution to jump discontinuously to the higher stable solution
branch. cRaf possessed the largest coeﬃcient in the corresponding eigenvector;
demonstrating that increased cRaf expression levels were the dominating initial
factor in destabilization of the inactive state. A semi-constrained bifurcation anal-
ysis conﬁrmed the continuation algorithm predictions. We denote the total rate
of pERK phosphorylation or production of ppERK as v+, and the total rate of
ppERK dephosphorylation or consumption of ppERK as v−. We explored v+ and
v− as a function of ppERK concentration, with all other MAPK species constrained
to their respective steady-state values. When v+ and v− intersect, the full MAPK
loop will be at steady-state or a ﬁxed point for the system. At RA = 0, three
intersections existed (Fig. 6.9B, top): the two stable points (S1 and S3) identiﬁed
previously, and one unstable point (S2). As RA was increased, the lower end of
the curves pulled away forcing the ﬁxed points to collide (S4) near RA = 0.15µM
(Fig. 6.9B, middle). Although both bifurcation approaches gave similar results,
the semi-constrained strategy demonstrated better numeric convergence near the
bifurcation point (Fig. 6.9A, bottom). Taken together, the bifurcation results sug-
gested two possible MAPK activation branches were possible for experimentally
testable RA values. Second, the analysis suggested the RA-induced cRaf/MAPK
architecture could be locked into a sustained signaling mode (high ppERK) even
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Figure 6.9: The bistability and hysteresis of the MAPK feedback loop. A
top) Phase diagram of ERK double phosphorylation as a function
of total RA, the two solid lines indicate stable steady-state values,
the blue arrows indicate the path taken for increasing RA from
0.0 and the red errors indicate the path for decreasing RA. A
middle) corresponding eigenvalues for the vector that becomes
unstable in the lower steady-state. A bottom) residuals of solving
for steady-state are suﬃciently near zero save the bifurcation
point. B top) Rates of ppERK consumption and production as
a function of ppERK in the semi constrained loop, calculated
at RA = 0. Intersections identify steady-states of the complete
system and are labeled with grey dots (dot correspond to the
states in A). B bottom) magniﬁed lower portion of the curve
calculated for diﬀerent RA values to demonstrate the separation
of the curves and loss of the steady-state.
in the absence of a RA signal. This latter property could give rise to a treatment
memory, e.g. HL-60 cells initially treated with high RA might continue to signal,
even after the RA stimulus is removed.
We computationally and experimentally tested the RA memory eﬀect in HL-
60 cells. Bifurcation analysis suggested that once beyond a critical RA value,
the MAPK loop was locked into a persistent signaling state, even without RA
144stimulus (point S3). To illustrate the memory eﬀect, ﬁrst we ran simulations
of RA removal after 24 hours of exposure (Fig. 6.10 top left). All parameter
sets in the ensemble predicted sustained MAPK activation even after removal
of the RA stimulus. Upon breaking the feedback between ppERK activity and
cRaf expression, degradation and dephosphorylation mechanisms quickly drove
the system to an inactive state (Fig. 6.10 top right). We experimentally tested
the self-sustaining active state in HL-60 cells treated with 1µM RA for 24 hours,
followed by resuspension in RA free media. Cells were reseeded in RA-free media
every 24 hours to prevent overgrowth. The RA-induced ERK phosphorylation
signal persisted over control for 96hr (corresponding to multiple division cycles;
Fig. 6.10 bottom left). However, at 144 hours, the ppERK signal returned to levels
comparable to control. This eventual decrease in ppERK suggested components
were missing from the simple control circuit presented here. Finally, we tested
whether RA was required to initiate the loop by simulating diﬀerent initial cRaf
levels starting with an inactive loop (Fig. 6.11). The cRaf-Vav circuit was robust to
the initial level of cRaf. Interestingly, 10x cRaf overexpression did produce diﬀering
behavior over the ensemble; however, to reliably initiate the loop in the absence of
RA required more than a 50x overexpression of cRaf and auto-phosphorylation at
S621.
6.4 Discussion
A critical question is whether the BLR1-MAPK positive feedback circuit is solely
responsible for driving RA-induced diﬀerentiation in HL-60. We know from pre-
vious studies in BLR1- HL-60 cells, that diﬀerentiation could be rescued by over-
expression of the CR3 domain of Raf1 in the presence of RA [355]. Interestingly,
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expression of the CR3 domain alone without RA failed to induce arrest or dif-
ferentiation. Thus, there must be a secondary RA-inducible trigger that propels
the arrest and diﬀerentiation program in the absence of BLR1. In this study, we
explored this question by surveying the cRaf interactome to determine the func-
tional and regulatory architecture responsible for RA-induced MAPK activation
in HL-60 cells. We conducted immunoprecipitation studies and identiﬁed a limited
number of RA-dependent and -independent cRaf interaction partners. While we
were unable to detect the association of cRaf with common kinases and GTPases
such as PKC, PKA, p38, Rac and Rho (Fig. 6.4 B), we did establish potential
interactions between cRaf and key partners such as Src, AKT, CK2, 14-3-3 and
Vav (Fig. 6.4 A). All of these partners are known to be associated with cRaf
activation or function. For example, the interaction between Src and cRaf was
RA-inducible; however, it did not result in cRaf phosphorylation at Y241. Src
is known to bind cRaf through an SH2 domain, this association has been shown
147to be dependent of the serine phosphorylation of cRaf [56]. Thus, the inducible
Src/cRaf association may be a result of increased cRaf phosphorylation and not
the cause of the phosphorylation. We also identiﬁed an interaction between cRaf
and the Ser/Thr kinases AKT and CK2. AKT can phosphorylate cRaf at S259,
as demonstrated by studies in a human breast cancer line [397]. CK2 can also
phosphorylate cRaf, although the literature has traditionally focused on S238 and
not S621 [277]. However, neither of these kinase interactions were RA-inducible,
suggesting their association with cRaf alone was not responsible for RA-induced
cRaf phosphorylation. The adapter protein 14-3-3 was also constitutively associ-
ated with cRaf. The interaction between cRaf and 14-3-3 has been associated with
both S621 and S259 phosphorylation and activity [369, 335, 341, 143] Addition-
ally, the association of cRaf with 14-3-3 not only stabilized S621 phosphorylation,
but also reversed the S621 phosphorylation from inhibitory to activating [73]. Fi-
nally, we found that the Vav/cRaf association correlated with cRaf activity, was
RA-inducible and was decreased by treatment with GW. The presence of Vav in
cRaf/Grb2 complexes has been shown to correlate with increased cRaf activity in
mast cells [314]. Furthermore, studies on Vav knockout mice demonstrated that
the loss of Vav resulted in deﬁciencies of ERK signaling for both T-cells as well as
neutrophils [62, 123]. Interestingly, while an integrin ligand-induced ROS response
was blocked in Vav knockout neutrophils, TPA was able to bypass the Vav require-
ment and stimulate both ERK phosphorylation and ROS [123]. In this study, the
TPA response was dependent upon cRaf kinase activity, and was mitigated by the
addition of GW. It is possible that Vav is downstream of various integrin recep-
tors but upstream of cRaf in terms of inducible ROS responses Vav has also been
shown to associate with a Cbl-Slp76-CD38 complex in an RA-dependent manner;
furthermore, transfection of HL-60 with Cbl mutants that fail to bind CD38, yet
148still bind Slp76 and Vav, prevents RA-induced MAPK activation [303]. The liter-
ature suggest a variety of possible receptor-signaling pathways, which involve Vav,
for MAPK activation; moreover, given the RA-inducible association Vav may play
a direct role in cRaf activation.
We hypothesized that Vav is a member of an RA-inducible trigger which pro-
pels the initiation of a sustained MAPK signal, arrest and diﬀerentiation. Our
working hypothesis is that RA-induced Vav expression drives increased association
between Vav and cRaf. This increased interaction then facilitates phosphorylation
and activation of cRaf by pre-bound AKT and/or CK2 at S621. Constitutively
bound 14-3-3 may also act to stabilize the S621 phosphorylation, modulate the
activity and/or up-regulate autophosphorylation. Activated cRaf can then drive
ERK activation, which in turn closes the positive feedback loop by activating cRaf
transcription factors, e.g. Sp1 and/or STAT1 [183, 232, 394, 210]. We tested
this working hypothesis using mathematical modeling. The model recapitulated
both RA time-course data as well as the GW inhibitor eﬀects. This suggested
the proposed cRaf-Vav architecture was at least consistent with the experimental
studies. Further, analysis of the cRaf-Vav model identiﬁed bistability in ppERK
levels. Thus, two possible MAPK activation branches were possible for experimen-
tally testable RA values. The analysis also suggested the RA-induced cRaf-Vav
architecture could be locked into a sustained signaling mode (high ppERK) even
in the absence of a RA signal. This locked-in property could give rise to an RA-
induction memory. We validated the treatment memory property predicted by
the cRaf-Vav circuit experimentally using RA-washout experiments. ERK phos-
phorylation levels remained high for more then 96 hours after RA was removed.
Previous studies demonstrated that HL-60 cells possessed an inheritable memory of
RA stimulus [382, 379]. Although the active state was self-sustaining, the inactive
149state did demonstrated considerable robustness to perturbation. For example, we
found that 50x overexpression of cRaf was required to reliably lock MAPK into the
activated state, while small perturbations had almost no eﬀect on ppERK levels
over the entire ensemble. Our computational and experimental results showed that
positive feedback, through ERK-dependent cRaf expression, could sustain MAPK
signaling through many division cycles. Thus, providing a starting point to un-
derstand how HL-60 cells remember previous RA treatments. Although several
issues remain to be explored, we believe the current study demonstrates that the
integration of experimental and computational methods is an eﬀective strategy for
dissecting complex intracellular programs.
6.4.1 Future Studies
The experimental results presented identiﬁed plausible aspects of RA-induced cRaf
activation. However, the results were correlative and not a proof of causality, it
is likely and there are other details to the mechanism of cRaf activation left to
be discovered. We suggested the existence of a cRaf complex with constitutively
bound kinases and an adapter protein and RA-induced binding of Vav, but the
immunoprecipitation studies do not prove the existence of a single complex. It may
be informative to crosslink the cells, with a chemical such as paraformaldehyde,
prior to the immunoprecipitation. The entire complex could then be resolved by
SDS-PAGE and could be probed by Western blotting to determine the presence
of each binding partner in a single complex. To provide some evidence that asso-
ciation with Vav increases cRaf activity, one could extract the cRaf complex from
wild type HL-60 and preform in vitro kinase assays, with and without puriﬁed Vav
protein. Considering the network architecture presented here, RA-induced Vav
150expression acts as an initiating event for MAPK activation. Vav overexpression in
HL-60 should be investigated to determine if increased levels of Vav are suﬃcient
for sustained MAPK activation, or at least if it augments the RA response. The
Vav-cRaf architecture presented was, however, a simpliﬁcation, and we know that
other species play a critical role in cRaf activation. We know, for example, that
BLR1 is necessary to achieve RA-induced MAPK activation in otherwise wild type
cells, but we also know that this response can be rescued, suggesting that there
exists an BLR1-independent mechanism. If Vav is involved in this alternate mech-
anism, then overexpression of Vav in a BLR1 knockout, or knockdown, cell line
should rescue the cells in the same manner as cRaf overexpression. To determine
if Vav is necessary for cRaf activation, an HL-60 Vav knockout line (Vav-/-) would
be valuable. If RA fails to induce cRaf activation in a Vav-/-, then we would know
that Vav is required for cRaf activation, and may lie along the same signaling axis
as BLR1. If we were to observe a decrease in, but not loss of, RA-induced cRaf
activity we may surmise that Vav is involved in a redundant mechanism for cRaf
activation. Of course, generation of knockout cell lines is technically challenging,
and the diverse function of Vav may cause unwanted or unforeseen eﬀect eﬀects
in a Vav-/-. However, the literature already demonstrates the viability of mouse
Vav-/- cells [123]. If performed, these experimental studies together could more
deﬁnitively identify Vav as a key component of RA-induced MAPK activation.
Of course, Vav is not likely to be the only cRaf binding partner of interest.
Our study was limited a small subset of possible cRaf partners, and a more ex-
haustive search is warranted. Implementation of a high-throughput method for
interaction identiﬁcation would allow an unbiased investigation for cRaf partners
on a much larger scale. Methods like tandem aﬃnity puriﬁcation followed by mass
spectrometry is one such method. However, tandem aﬃnity puriﬁcation relies on
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that do not occur given typical expression levels in wild type cells. Furthermore,
mass spectrometry for protein analysis is cost-prohibitive in most cases. If the cur-
rent strategy of immunoprecipitation is to be continued, it might be worthwhile
to focus on identifying associated GTPases. If, in fact, Vav is involved in cRaf
activation, it most likely acts as a guanine exchange factor on some GTPase. The
results of such an investigation could provide details on other species, other than
Vav, that may play a role in cRaf activation.
Finally, while the current cRaf-Vav model did provide valuable insight, many
modiﬁcations are possible. In the current control architecture, we assumed ERK
mediated transcriptional regulation of cRaf; however, other mechanisms are known.
Studies have identiﬁed ERK to directly bind and phosphorylate sites upstream of
the cRaf CR3 kinase domain. There are examples of this mechanism resulting in
positive [14] as well as negative [81] feedback. It would be interesting, and would
require a minimal increase in dimension, to include ERK phosphorylation of Raf
in the current cRaf-Vav control element. The study could indicate if a phosphory-
lation driven positive or negative feedback is involved in the RA-induced MAPK
activation of HL-60. Furthermore, it might be possible to distinguish the relative
importance between cRaf expression versus phosphorylation feedback. An inter-
esting aspect of cRaf activation is that it correlates with cRaf accumulation in
the nucleus [312]. The current model could be altered to represent two MAPK
loops acting in tandem, connected perhaps by nuclear import/export mechanisms.
Experimental data could be gathered by considering the cytosolic and nuclear
fractions independently. The results could indicate the preference of sustained ac-
tivation and the relative stabilities, which could provide insight on the eﬀects of
signal localization. Ultimately, we must consider the control element as a single
152sub-system of a much larger network. For example, the model predicted that the
MAPK loop would sustain ERK activation indeﬁnitely. However, experimentally,
we know that ERK phosphorylation returned to normal 96 hours after RA removal.
We expect events outside of the current model inﬂuenced the long-time behavior
of the MAPK loop. To overcome this issue, we could incorporate the Vav-Raf con-
trol element, along with the corresponding experimental data, into our previously
published large-scale model [332]. It would be wise to consider two connectivity
schemes; one could consider the Vav mechanism to fall along the BLR1 signal axis
(Vav AND BLR1), while the other could consider Vav as part of an alternative
pathway (Vav OR BLR1). Computational analysis might provide falsiﬁable obser-
vations that distinguish the two connectivities. Experimentally investigating such
observations might be a more cost and time-eﬀective means of elucidating the role
of Vav compared to the studies suggested above. We expect that continued ad-
vancement of model architecture and analysis will provide increased information
on the mechanism of RA-induced MAPK activation and diﬀerentiation.
6.5 Materials and Methods
6.5.1 Cell Culture and Treatment
Human myeloblastic leukemia cells (HL-60) were grown in a humidiﬁed atmosphere
of 5% CO2 at 37oC and maintained in RPMI 1640 from Gibco (Carlsbad, CA)
supplemented with 5% fetal bovine serum from Hyclone (Logan, UT). Cells were
cultured in constant exponential growth as described previously [29]. Experimental
cultures were initiated at 0.1×106 cells/mL 24 hours prior to 1µM RA treatment;
153if indicated, cells were also treated with GW5074 18 hours before and also with
RA treatment at 2µM.
6.5.2 Chemicals
All-Trans Retinoic Acid from Sigm-Aldrich (St. Louis, MO) was dissolved in 100%
ethanol with a stock concentration of 5mM, and used at a ﬁnal concentration of
1µM. The Raf inhibitor GW5074 from Sigm-Aldrich (St. Louis, MO) was dissolved
in DMSO with a stock concentration of 10mM, and used at a ﬁnal concentration
of 2µM.
6.5.3 CD11b expression studies by ﬂow cytometry
Approximately 1.0 × 106 HL-60 cells were harvested by centrifugation. Cells were
resuspended in 200µL PBS containing 5µL of allophycocyanin (APC)conjugated
anti-CD11b antibody from BD Biosciences (San Jose, CA). Following incubation
for 1hr at 37oC, cells were analyzed by ﬂow cytometry (LSRII ﬂow cytometer,
BD Biosciences; San Jose, CA) using 633nm red laser excitation. The threshold
to determine percent increase of expression was set at the highest 5% of control
(untreated) cells.
6.5.4 Measurement of inducible oxidative metabolism
Approximately 0.5 × 106 Cells were harvested by centrifugation. Cells were re-
suspended in 200µL 37oC PBS containing 10µmol/L 5-(and-6)-chloromethyl-2,7-
154dichlorodihydro-ﬂuorescein diacetate acetyl ester (DCF from Invitrogen; Carls-
bad, CA) and 0.4µg/mL 12-O-tetradecanoylphorbol-13-acetate (TPA from Sigma-
Aldrich; St. Louis, MO) with incubation for 20 min in a humidiﬁed atmosphere of
5% CO2 at 37oC. Flow cytometric analysis was done as described previously [274].
6.5.5 Cell cycle analysis
Approximately 1.0 × 106 cells were collected by centrifugation. Cells were re-
suspended in 500µL hypotonic staining solution containing 50µg/mL propidium
iodine, 1µL/mL Triton X-100, and 1 mg/mL sodium citrate. Cells were incubated
at room temperature for 1 h and analyzed by ﬂow cytometry (BD LSRII) using
488-nm excitation.
6.5.6 Immunoprecipitation and Western blot
Approximately 1.2 × 107 cells were lysed using 400µL of M-Per lysis buﬀer from
Thermo Scientiﬁc (Waltham, MA). Lysates were cleared by centrifugation at
16,950 × g in a micro-centrifuge for 20 min at 4oC. Lysates were pre-cleared using
100µL protein A/G Plus agarose beads from Santa Cruz Biotechnology (Santa
Cruz, CA) by inverting overnight at 4oC. Beads were cleared by centrifugation
and total protein concentration was determined by BCA from Thermo Scientiﬁc
(Waltham, MA) assay. Immunoprecipitations were set up by bringing lysate to
a concentration of 1.0g/L in a total volume of 300µL (M-Per buﬀer was used for
dilution). cRaf, pS621 cRaf antibody was added at 3 6µL respectively. After 1.0hr
of inversion at 4oC 20µL of agarose beads was added and samples were left to invert
overnight at 4oC. Samples were then washed 3 times with M-Per buﬀer by centrifu-
155gation. Finally, proteins were eluted from agarose beads using a laemmli loading
buﬀer. Eluted proteins were resolved by SDS-PAGE and Western blotting. Total
lysate samples were normalized by total protein concentration (20µg per sample)
and resolved by SDS-PAGE and Western blotting. Secondary HRP bound anti-
body was used for visualization. All antibodies were purchased from Cell Signaling
(Boston, MA) with the exception of cRaf pS621 from Biosource/Invetrogen (Carls-
bad, CA), cRaf pS338, cRaf pY341 and pTyr all from Santa Cruze Biotecnology
(Santa Cruze, CA); Retinoblastoma from Zymed (South San Fransisco, CA); and
CK2 from BD Biosciences (San Jose, CA).
6.5.7 Formulation, identiﬁcation and solution of the model
equations
cRaf activation was modeled using a set of coupled ordinary diﬀerential equations
(ODEs):
dx
dt
= N · v(x,p) x(to) = xo (6.1)
The symbol N denotes the stoichiometric matrix (15×22). The quantity x denotes
the concentration vector of model species (15 × 1). The term v(x,p) denotes the
vector of reaction rates (22×1) and p denotes the kinetic parameter vector (28×1).
Each row in N described a species while each column described the stoichiometry
of network interactions. Thus, the (i,j) element of N, denoted by ηij, described
how species i was involved in rate j. If ηij < 0, then species i was consumed in vj.
Conversely, if ηij > 0, species i was produced by vj. All model code is available in
the supplemental materials.
The unknown model parameters (28 kinetic constants and two non-zero initial
156conditions) were estimated using the experimental data presented in this study in
addition to the previous report by Wang and Yen [355]. In total, eight data sets,
with 38 total data points, were considered from four diﬀerent simulation protocols
(no perturbation, RA, GW, GW plus RA). The diﬀerence between the measured
and simulated value of a species in set j at time or condition i, denoted by ˆ xi,j and
x(pk)i,j respectively, was quantiﬁed by normalized residuals, ψ (pk)i,j:
ψ (pk)i,j =
ˆ xi,j − βjx(pk)i,j
ˆ xi,j
, (6.2)
The scaling factor βj was chosen to minimize the normalized squared error for a
given set j [31]:
βj =
P
i(xi,j/ˆ xi,j)
P
i(xi,j/ˆ xi,j)2. (6.3)
Because of the scaling factor, simulated concentrations had arbitrary units (con-
sistent with the arbitrary units associated with the training data). Simulation
performance was quantiﬁed using the normalized mean squared error, φ:
φ(pk) =
1
n
X
i,j
²(pk)
2
i,j , (6.4)
where the sum was carried out over all sets j and observations i. The quantity
n denotes the total number of observations. An approximate steady-state was
used as the starting point for all simulations. The steady-state was approximated
numerically by repeated solution of the model equations until the concentration
rate of change fell below 1% per hour for Raf, pRaf, ppMEK and ppERK.
Parameter ﬁtting and ensemble generation was performed using the metropo-
lis random walk algorithm described previously [331] with one alteration. The
random walk trajectories were supplemented with a Levenberg-Marquardt local
reﬁnement step to minimize ψ. The local reﬁnement step was implemented using
the FMINUNC routine of the Optimization toolbox of MATLAB (The Mathworks;
Natick, MA). Special options included
157’LargeScale’ = off, ’MaxFunEvals’ = 10000, ’MaxIter’ = 1000.
An arbitrary initial value of one was used for all parameters. A single iteration
of the complete algorithm consisted of a FMINUNC call, followed by 100 steps of
the standard random walk. Cross-validation was used to simultaneously calculate
the prediction and training error, and to protect against over-ﬁtting. For cross-
validation, 20% of the data was randomly removed from the training data set. After
ten complete iterations, the best-ﬁt parameter set was used to compute φ for the
20% of the data not used for training (validation data). The mean validation φ was
computed from ten diﬀerent training subsets. The nominal parameter ensemble
was generated by using the full data set for training. After 10 iterations the best-
ﬁt, φ∗, was identiﬁed. To estimate errors, all parameter sets within 20% of φ∗ were
included in the nominal parameter ensemble.
A general continuation algorithm was used for nonlinear dynamic analysis and
the identiﬁcation the ﬁxed point bifurcation. Initially a steady-state was identiﬁed,
this state was used as the initial conditions to identify a new steady-state after a
small parameter step change. The process was iterated to cover a desired parameter
range. To identify the steady-state, i.e. states where Eq. 6.1 equals zero, an
approximation was ﬁrst made by running the simulation for 10000 time units. To
improve accuracy, we then used the approximation as an initial guess in the Matlab
root-ﬁnding function ”fsolve”. We employed the following options:
’MaxFunEvals’= 20000,’Algorithm’ = ’levenberg-marquardt’,
’Jacobian’ = ’on’, ’MaxIter’ = 4000.
The analytical Jacobian (found using the Matlab Symbolic Toolbox) was used to
compute the eigenvalues of steady-state solutions. The same steady-state ﬁnding
158process was used in the semi constrained system. Total RA was conserved and
treated as a parameter; the continuation trajectories went from 0 to 0.15 by steps
of 0.01 or from 1 to 0 by steps of -0.01. The default tolerance on the residual
was 1E-6 (although 1E-7 or lower was typical) this tolerance was met in all cases
except for when the continuation algorithm approached the bifurcation at RA =
0.14 and 0.15.
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SUMMARY AND CONCLUDING REMARKS
Cellular function hinges on the ability to process information from the outside
environment into speciﬁc decisions. Ultimately these processes decide cell fate,
whether it be to undergo proliferation, apoptosis, diﬀerentiation, migration and
other cellular functions. These processes can be thought of as ﬁnely tuned pro-
grams evolved to maintain robust function in spite of environmental perturbations
[322, 187, 240]. Malfunctions in these programs can lead to improper cellular func-
tion and various disease states [70, 282]. To develop more eﬀective, personalized
and even preventative therapeutics we must attain a better, more detailed, under-
standing of the programs involved. Cancer causes one out of every four deaths
in the United States[166], and is a prime example of malfunctions in the cellu-
lar programing. The primary obstacle in overcoming this disease has been the
unanticipated complexity of the biological systems involved. Thus, a grand chal-
lenge in cancer biology continues to be the understanding of failures in complex
biological programs such as proliferation and diﬀerentiation. Like most cellular
behaviors, these programs arise from the interactions between several functional
modules which are, in turn, composed of the interactions between many diﬀerent
types of molecules [134]. The overall behavior of such systems emerge not only from
speciﬁc molecular function, but also from component positioning within a complex
interaction network [188]. Identiﬁcation of the protein-protein and protein-DNA
interactions that make up speciﬁc systems has been facilitated by a variety of
impressively successful experimental strategies [350, 299, 148, 353, 36]. However,
the experimental results have provided a tremendous amount of information, so
much so that the dream of a complete understanding of cellular function is quickly
becoming buried.
160To this end, mechanistic mathematical modeling and other computational tools
have been applied to extract hidden information from the experimental data, and
elucidate other emergent properties[188, 2, 35, 218, 244]. Although the success of
computational techniques has been documented in the literature, few experimental
biologists have taken full advantage of these tools. The barrier between computa-
tional and experimental biology is a result of inaccessibility and poor motivation.
Inaccessibility arises from issues concerning mathematical and computational tech-
niques, diﬀerences in terminology and other technical issues, while over-simpliﬁed
biological networks and applications to non-physical or irrelevant biological issues
is the cause of poor motivation. We believe improved integration of both exper-
imental and computational forms of knowledge discovery will provide a strategy
for advancing our understanding of relevant biochemical systems. The complex
networks associated with cancer are a perfect target for such strategies. Failures
in programed diﬀerentiation, the ability of a cell to become functional, and reg-
ulation of proliferation, the control mechanisms of cell growth, are the hallmark
of many cancers. Although the speciﬁc mechanisms involved diﬀer between these
two programs, between various cancers and even between cell lines, there are key
pathways that have repeatedly demonstrated importance. The mitogen-activated
kinase (MAPK) cascade, a signaling cascade involved in extracellular communica-
tion, is one such pathway. MAPK is known to produce a necessary, sustained ac-
tivation in the-induced diﬀerentiation of leukemia cell lines[383]. Hyper-activation
of MAPK is also associated with the unchecked proliferation of hormone refractory
cancer cell lines[203]. Understanding the mechanisms of this subnetwork and the
interplay with other well conserved protein signaling networks may provide insight
in disease progression and potential therapies. It has been our long-term objective
to extend the relevance of mechanistic mathematical modeling. We have demon-
161strated the ability of computational strategies to assist in experimental investi-
gations of relevant human health problems and we have encouraged an iterative
problem solving approach.
A variety of computational modeling strategies have been implemented in the
literature. Stoichiometric models and Flux balance analysis (FBA) are among
the most pervasive tools for modeling metabolic interaction networks [270, 250].
FBA has been successful in many studies; however, it lacks predictive ability. To
overcome this obstacle methods have been developed to model gene regulatory
networks [174]. The deepest level of network analysis requires the prediction of
dynamics by considering both the stoichiometry and the corresponding reaction
rates. One such modeling strategy is the implementation of continuous dynamics
to model the time-evolution of modeled species due to reaction rates. Continuous
deterministic models rely on continuum mathematics and ignore discrete events.
In some systems, it may be necessary to consider this level of detail [88]. In these
instances, stochastic simulation algorithms are required [119]). Dimensionality,
nonlinearity and uncertain biology can make the construction and implementation
of the above models diﬃcult. One strategy to overcome this is fuzzy logic which
incorporates qualitative or semiquantitative rules into biochemical models through
the use of logical statements like IF THEN. Our lab primarily focuses on the use
of continuous models. This particular strategy allows us to capture the dynamics
of cell populations and the results can be directly related to experimental observa-
tions. To facilitate our modeling eﬀorts, we have designed the software platform
UNIVERSAL. UNIVERSAL is an extensible code generation framework which
produces editable, fully commented platform-independent physiochemical model
code in several common programming languages from a variety of inputs. In par-
ticular, UNIVERSAL generates mass-action ODE models of intracellular signal
162transduction processes and model analysis code, such as adjoint sensitivity bal-
ances. We have applied this strategy to a variety of cellular programs responsible
for deciding cellular fate.
We have constructed several biochemical interaction networks which repre-
sent cellular decision-making programs for proliferation and diﬀerentiation. In
the context of prostate cancer, we studied a mechanism for conferring androgen-
independence in which MAPK could directly activate Androgen Receptor (AR)
in the absence of androgen (Fig. 4.1). We employed the same network archi-
tecture to model both androgen dependent as well as independent sub-lines of
the prostate cancer cell line LNCaP. We observed that translational mechanisms
increased in sensitive with increasing androgen independence (Fig. 4.7). Further-
more, we demonstrated that MAPK and AKT acted synergistically to promote
translation and the expression of Cyclin D (Fig. 4.9). Perhaps the poor eﬃcacy
of therapeutics such as trastuzumab or geﬁtinib in treating hormone-refractory
prostate cancers arises from their inability to address synergy between growth fac-
tor signaling, MAPK activation and the Akt signaling axis. Our analysis suggested
that the direct targeting of the translation machinery may be more eﬀective in the
treatment of androgen independent prostate cancer. We have also studied pro-
grams that control growth arrest and eventual diﬀerentiation. Using the human
leukemia cell line HL-60, we investigated Retinoic Acid (RA)-induced granulocytic
diﬀerentiation. Initially, we constructed a large interaction network for RA-induced
BLR1 expression and sustained MAPK activation. The network essentially en-
coded waves of transcriptional regulation that resulted in positive feedback (Fig.
5.1). We identiﬁed functional sub-systems such as a large group of infrastructure
proteins that possessed a fragile yet robust characteristic (Fig. 5.7A). Furthermore,
we identiﬁed the species that had the most signiﬁcant yet unique impact on RA
163response (Fig. 5.7B). This analysis suggested that cRaf would be the most distin-
guishable member of the MAPK proteins. Next, we experimentally investigated
the eﬀect of inhibiting cRaf kinase activity on RA-induced HL-60 diﬀerentiation.
We found that that cRaf inhibition not only prevented ERK activation, but also
prevented its own RA-induced phosphorylation and expression (Fig. 6.2A). We
also conducted an investigation to identify RA-inducible cRaf binding partners.
Of the 19 proteins we considered the guanine exchange factor Vav was found to
associate with cRaf in an RA-dependent fashion (Fig. 6.4); an association that
was diminished upon cRaf inhibition (Fig. 6.5). Finally, based on experimental
results, we proposed a simpliﬁed positive control element to describe RA-induced,
sustained MAPK activation (Fig. 6.6). We predicted that MAPK could be locked
into a self-sustaining active state that would be unaﬀected by the removal of RA
(Fig. 6.10top). A prediction that was qualitatively validated by experiment and
could provide mechanistic insight on previously observed cellular memory eﬀects.
Taken together our results demonstrated that computational modeling can identify
therapeutically relevant targets for human disease such as cancer. Furthermore we
demonstrated the ability of an iterative strategy between computational and ex-
perimental analysis to provide insight on key regulator circuits for complex cellular
programs such as diﬀerentiation.
We believe that both the strategies and various network architectures inves-
tigated here could be used successfully in modeling other cellular systems. One
example is Estrogen Receptor negative (ER-) breast cancer. Typically, breast can-
cer cells require androgens, like estrogen, to rapidly proliferate. However, just as
in prostate cancer, breast cancer can present as androgen-independent. In these
cases, which are commonly ER-, ErbB signaling can play a critical role. It has
been observed that increased expression of Her2, a member of the ErbB family,
164correlates with poor prognosis [294]. A detailed model of ErbB signaling and its
eﬀect on cell cycle may prove useful in the study of ER- breast cancer. A prelim-
inary model of ErbB signaling was developed in our lab. We compiled pathways
on EGFR and Her2, MAPK, AKT, translation initiation, transcription and cell
cycle from previous studies (Fig. A.3). Receptor signaling was augmented with
detailed mechanisms on ligand binding, dimerization and adaptor recruitment as
described in the literature [48, 372, 129, 125, 311, 272, 298, 227]. Ultimately the
network included four receptors (EGFR, Her2, Erbb3 and 4) and ten diﬀerent lig-
ands (Table A.6). To make a connection to cell cycle, we used the online database
TRANSFAC (www.gene-regulation.com) to identify a set of transcription factors
that were regulated by pathways in the current network (Table A.7). Finally, we
employed TRANSFAC to include mechanisms for the transcriptional regulation
of all 72 proteins in the network (Fig. A.4). The ﬁnal network consisted of 8178
reactions and 3435 species. We found that a network of this dimension is computa-
tionally intractable given our current tools and strategies. By taking advantage of
network sparsity and by implementing the eﬃcient ODE solver SUNDIALS (com-
putation.llnl.gov/casc/sundials/main.html) it was possible to run various simula-
tions. However, due to excessive processing time, it is currently not feasible to
properly investigate parameter space and therefore it is currently not possible to
employ our standard computational analysis.
As our understanding of cellular function increases and -omics technologies
continue to provide tremendous quantities of data, our need to model and analyze
systems of considerable dimensionality becomes obvious. The preliminary model
of ErbB signaling considers only on family of receptors, two signaling pathways
and only a handful of transcription factors. Given the existence of 20K+ protein
encoding genes, along with splice variants, possible variations in tertiary structure
165and localization, multiple post-translational modiﬁcations, and the vast number
of important small molecules, the number of possible complexes and interactions
is intractable. Furthermore, it is unlikely that any ’pathway’ or ’sub-system’ truly
operates in isolation. Even to attempt to mechanistically model a fraction of this
interaction space, we simply must advance our computing ability. While improve-
ments in processing speed, for example, the use of graphical processing units, would
prove useful we must also consider alternate strategies for model implementation
and scope deﬁnition. Many computational ﬁelds have greatly beneﬁted from the
use of parallelization techniques. The ability to divide a problem up into multiple
independent processes, and to solve them simultaneously is quite eﬀective. How-
ever, as we have alluded to, the systems involved in cellular function are highly
coupled. It would be of tremendous beneﬁt to devise a method to partition systems
into smaller groups with minimal overlap, or minimal loss of accuracy. These par-
titions could be solved in parallel, and communication between partitions at pre-
speciﬁed, regular intervals could further reduce information loss. Another strategy
is to simply reduce the size of the system being investigated. In fact, the scope for
each system considered here was chosen to describe a particular function of interest.
Our networks were formulated based on literature and expert opinion regarding
what was ‘important’ for a particular function. While we attempted to include as
much detail as possible, we were ultimately biased by existing preconceptions. To
identify truly novel regulatory aspects of cellular function we must overcome this
bias. While systematic means of model reduction do exist, they typically require
the solution of model equations or the calculation of costly metric like sensitivity
coeﬃcients, and are, therefore, only useful for subsequent simulations. Structural
methods that could identify paths between stimuli and desired targets would be of
great use to systematically identify relevant sub-systems. Two simple implemen-
166tations would be path ﬁnding algorithms used on graphs and FBA methods used
to identify paths of mass-ﬂow. However, both have limitations. We have already
demonstrated in section 3.3.7 that graphical methods have a poor correlation to
biological function. On the other hand, path-ﬁnding methods using FBA, which
properly considers network structure, have been quite successfully for metabolic
networks. However, signaling networks directly model the regulation of enzymes,
and this regulation is typically crucial for network function. Since enzymes are
catalysts that are either consumed or created in the corresponding enzymatic re-
action, their regulation is often missed by FBA. Development of algorithms to
identify biologically relevant One last consideration is data driven relational mod-
els. These models do not include any mechanistic or physical detail, instead they
simply identify correlations between diﬀerent species or between species and re-
sponses. It is often diﬃcult to interpret the physical meaning of such models and
to generate falsiﬁable predictions. However, relational modeling could be used to
systematically identify a subset of key species for a particular cellular function.
This subset could then be used to reduce the scope of more detailed mechanistic
models. With more improved and more eﬃcient computational methods, coupled
with a more systematic identiﬁcation of model scope, the strategies presented in
this work could be expanded to increasingly complex systems and, perhaps one
day, to a whole cell level analysis.
167APPENDIX A
SUPPLEMENTARY INFORMATION
A.1 Additional Information for Chapter 4 on Prostate
Cancer
Table A.1: Experimental training data used to estimate the ensemble of prostate
model parameters.
Experimental Setup Observation citation use
C-81 transfection with WT PAcP cyclin D 0.7 of C-81 WT † training
C-81 transfection with cPAcP cyclin D 0.3 of C-81 WT † training
C-81 transfection with sPAcP cyclin D 1.1 fold of WT C-81 † training
Addition of 10nm DHT to C-81 PSA increased over time [203] training
Addition of 10nM DHT to C-33 PSA & Her2 activation increased and PAcP de-
creased
[203] training
Overexpression of Her2 in C-33 PSA mRNA 2.2 fold of C-33 WT [375] training
Overexpression of Her2 in C-33 PSA 2 fold of C-33 WT [203] training
Transfection of constitutively active MEK in
C-33
PSA 3 fold of C-33 WT [203] training
1µM MEK inhibitor PD98059 in C-81 PSA 0.6 of C-81 WT [203] training
MEK inhibitor PD98059 in C-33 with Her2
overexpression
PSA 1.86 of C-33 WT (compared to 2 with
Her2 overexpression alone)
[203] training
0.5µM Her2 inhibitor AG879 in C-81 PSA 0.58 of C-81 WT [203] training
10µM Her2 inhibitor AG879 in C-81 PSA 0.17 of C-81 WT [203] training
EGFR inhibitor AG1478 in C-81 no PSA eﬀect [203] training
50ng/ml EGF to HeLa cell culture transient increase in Erk activity [295] training
0.1nM DHT added to AD LNCaP increased cyclin D expression [18] validation
2nM milbolerone added to AD LNCaP Increased PSA secretion [83] validation
2nM milbolerone added to AD LNCaP with an-
tisense AR
Increased PSA secretion to lower extent then
WT
[83] validation
168Table A.2: Statistically signiﬁcant sensitivity diﬀerences between AI and AD
LNCaP clones. Negative changes in the mean rank denote interactions that were
more sensitive in AI versus AD cells.
Reaction p-value ∆ mean rank
rank(C-33) - rank(C-81)
Her2-2→Her2-2-p 2.41E-14 -87.2565701
cPAcP→[] 2.97E-11 -60.05830583
Her2-2-p-cPAcP→Her2-2+cPAcP 1.11E-16 -46.32587703
Ar-PSA→PSA+40S+60S+mRNA-PSA 9.08E-14 -45.08495294
mRNA-cPAcP-eIF4E-40S-60S→mRNA-cPAcP-eIF4E-40S+60S 2.10E-05 -43.08984232
Ar-cPAcP→cPAcP+40S+60S+mRNA-cPAcP 8.00E-12 -40.0840973
MEK-pp-Pase2→MEK-p+Pase2 0.005304844 29.80992544
2*Her2-2-p+cPAcP-2→2Her2-2-p-cPAcP-2 2.34E-11 34.46632441
ERK-p+Pase3→ERK-p-Pase3 2.30E-14 35.77753331
cPAcP-4→2*cPAcP-2 1.74E-08 44.76995477
AR-p-DHT-2+g-sPAcP→AR-p-DHT-2-g-sPAcP 1.14E-14 44.86273072
2*cPAcP-2→cPAcP-4 9.22E-09 45.43002078
AR-p-DHT-AR-p+g-sPAcP→AR-p-DHT-AR-p-g-sPAcP 8.30E-10 46.80723628
g-PSA-AR-p-DHT-2-RNAp→g-PSA-AR-p-DHT-2+RNAp+mRNA-PSA 0 66.02713605
rank(C-33) - rank(C-51)
Her2-2-p-cPAcP→Her2-2+cPAcP 0.000173573 -11.53809276
2Her2-2-p-cPAcP-2→2*Her2-2+cPAcP-2 0.005962433 -10.58394997
Her2-2-p+cPAcP→Her2-2-p-cPAcP 0.039330397 -8.560083377
4Her2-2-p-cPAcP-4→4*Her2-2+cPAcP-4 0.030899498 -7.999478895
Ar-PSA→PSA+40S+60S+mRNA-PSA 0.0163948 -7.574361647
g-CycD-RNAp→g-CycD+RNAp+mRNA-CycD 0.008798024 6.428035435
Her2-2-p-Grb2-Sos→Her2-2-p-Grb2+Sos 0.03404035 10.82219906
4*Her2-2-p+cPAcP-4→4Her2-2-p-cPAcP-4 7.57E-05 14.0875456
g-PSA-AR-p-DHT-2-RNAp→g-PSA-AR-p-DHT-2+RNAp+mRNA-PSA 0.006362828 14.14799375
rank(C-51) - rank(C-81)
Her2-2→Her2-2-p 2.28E-10 -73.21936322
cPAcP→[] 7.80E-07 -45.71812865
mRNA-cPAcP-eIF4E-40S-60S→mRNA-cPAcP-eIF4E-40S+60S 1.06E-05 -44.09317739
Ar-cPAcP→cPAcP+40S+60S+mRNA-cPAcP 1.22E-10 -37.77205978
Ar-PSA→PSA+40S+60S+mRNA-PSA 3.96E-10 -37.51059129
Her2-2-p-cPAcP→Her2-2+cPAcP 1.73E-10 -34.78778428
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Her2-2-p-Shc-p-Grb2-Sos-ERK-pp→Her2-2-p-Shc-p-Grb2+Sos+ERK-pp 2.51E-09 -24.51604938
AR-p-DHT-AR-p-g-sPAcP→AR-p-DHT-AR-p+g-sPAcP 1.72E-05 25.18258609
4Her2-2-p-cPAcP-4→4*Her2-2+cPAcP-4 4.10E-05 29.57764782
ERK-p+Pase3→ERK-p-Pase3 1.68E-10 30.16075374
2*Her2-2-p+cPAcP-2→2Her2-2-p-cPAcP-2 3.71E-12 36.44704353
AR-p-DHT-2+g-sPAcP→AR-p-DHT-2-g-sPAcP 1.81E-13 42.27784276
cPAcP-4→2*cPAcP-2 4.06E-08 44.55932424
2*cPAcP-2→cPAcP-4 3.21E-08 44.70318389
AR-p-DHT-AR-p+g-sPAcP→AR-p-DHT-AR-p-g-sPAcP 2.05E-09 46.47654321
g-PSA-AR-p-DHT-2-RNAp→g-PSA-AR-p-DHT-2+RNAp+mRNA-PSA 5.55E-16 51.8791423
170Table A.3: Interactions determined to be signiﬁcantly fragile for the C-33, C-
51 and C-81 LNCaP clones. Overall State Sensitivity Coeﬃcients (OSSCs) were
calculated over the parameter ensemble. The OSSC values were ranked ordered.
The mean rank and standard deviation for interactions with rank greater than at
least one standard deviation above the overall mean rank are reported.
Reaction mean rank st. dev rank p-value
C-33
AR-p-DHT-2+g-sPAcP→AR-p-DHT-2-g-sPAcP 302.4059406 15.97843734 0.039916369
Ras-GTP-Raf→Ras-GTP+Raf-p 302.7821782 18.9159705 0.046713871
AP1-p-Pase6→AP1+Pase6 302.8118812 9.99773526 0.00082649
ETS-p+Pase5→ETS-p-Pase5 303.0693069 17.82547816 0.02648256
mRNA-sPAcP-eIF4E+40S→mRNA-sPAcP-eIF4E-40S 303.4851485 11.65648068 0.000567415
Pdk1-m+Akt-m→Pdk1-m-Akt-m 303.960396 8.723384746 1.11E-06
ETS-p-Pase5→ETS+Pase5 304.3465347 12.61418002 0.000133415
AP1-p+Pase6→AP1-p-Pase6 309.0891089 31.45076272 0.001584816
mRNA-sPAcP-eIF4E-40S-60S→Rm-sPAcP+eIF4E 309.8118812 21.69943781 3.90E-06
2*AR-p-DHT→AR-p-DHT-2 313.5643564 27.07211339 6.11E-07
mRNA-sPAcP→[] 315.7524752 63.3152424 0.006070198
2*Her2-2-p+cPAcP-2→2Her2-2-p-cPAcP-2 315.8613861 33.36003113 2.00E-06
ERK-pp-Pase3→ERK-p+Pase3 318.5148515 49.25034329 0.000106094
mRNA-CycD-eIF4E-40S+60S→mRNA-CycD-eIF4E-40S-60S 318.8019802 31.76024659 1.25E-08
mRNA-CycD-eIF4E+40S→mRNA-CycD-eIF4E-40S 318.9306931 33.70966822 5.07E-08
AR-p-DHT+Pase5→AR-p-DHT-Pase5 319.3663366 26.60556138 1.80E-11
Her2-2-sPAcP→Her2-2-p+sPAcP 321.8217822 25.22037368 1.90E-14
Raf-p-Pase1→Raf+Pase1 323.7821782 22.38130583 8.18E-19
Act-Akt-Pase7→Akt+Pase7 325.4158416 60.54411162 2.25E-05
Her2-2-p-Shc-p-Grb2-Sos+ERK-pp→Her2-2-p-Shc-p-Grb2-Sos-ERK-pp 326.8811881 33.90589397 8.76E-13
g-PSA-AR-p-DHT-2-RNAp→g-PSA-AR-p-DHT-2+RNAp+mRNA-PSA 327.990099 32.83064707 4.36E-14
g-PSA+AR-p-DHT-AR-p→g-PSA-AR-p-DHT-AR-p 328.1584158 15.42386775 2.07E-34
g-cPAcP-RNAp→g-cPAcP+RNAp 329.8217822 23.27042743 1.65E-23
AR-DHT→AR-p-DHT 330.039604 16.97809934 2.49E-33
ERK-pp-ETS→ERK-pp+ETS-p 330.4356436 22.63241163 7.61E-25
Her2-2-p-Shc-p-Grb2-Sos+Ras-GDP→Her2-2-p-Shc-p-Grb2-Sos-Ras-
GDP
330.7425743 29.10705861 1.40E-18
Shc-p→Shc 331.5346535 14.6216741 3.60E-40
Her2-2-p+cPAcP→Her2-2-p-cPAcP 331.5346535 28.40846491 9.25E-20
ERK-pp+Pase3→ERK-pp-Pase3 332.1980198 31.79669944 1.34E-17
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mRNA-cPAcP-eIF4E-40S+60S→mRNA-cPAcP-eIF4E-40S-60S 332.2871287 39.08921926 1.83E-13
AR+DHT→AR-DHT 335.4950495 28.38861289 8.88E-23
Ras-GTP-GAP→Ras-GTP+GAP 335.5049505 50.04604291 6.32E-11
ERK-pp-AP1→ERK-pp+AP1-p 336.960396 15.82823695 5.38E-43
mRNA-cPAcP-eIF4E+40S→mRNA-cPAcP-eIF4E-40S 336.980198 41.72896522 9.27E-15
Her2-2-p-Shc-p-Grb2+Sos→Her2-2-p-Shc-p-Grb2-Sos 338.0990099 35.12960585 3.83E-19
MEK-pp-Pase2→MEK-pp+Pase2 338.2871287 39.07173819 5.55E-17
ERK-pp-AP1→ERK-pp+AP1 338.7029703 18.00524926 5.81E-40
Her2-2+sPAcP→Her2-2-sPAcP 338.8415842 29.06930356 1.40E-24
ERK-pp-ETS→ERK-pp+ETS 339.5148515 23.01511078 3.15E-32
MEK-pp+Pase2→MEK-pp-Pase2 339.7227723 38.86613706 9.42E-18
mRNA-cPAcP+eIF4E→mRNA-cPAcP-eIF4E 339.8910891 35.54133028 5.79E-20
PtdIns3+PTEN→PtdIns3-PTEN 340.039604 27.87700028 1.17E-26
Grb2+Sos→Grb2-Sos 341.3564356 37.79192228 2.44E-19
Her2-2-p-Shc-p-Grb2→Her2-2-p-Shc-p+Grb2 341.3861386 30.78477517 9.83E-25
Her2-2-p-Grb2→Her2-2-p+Grb2 341.5742574 21.43160733 2.56E-36
ERK-MEK-pp→ERK-p+MEK-pp 342.2673267 31.13461386 5.26E-25
MEK-p+Raf-p→MEK-p-Raf-p 343.5643564 37.26023438 5.78E-21
g-sPAcP+RNAp→g-sPAcP-RNAp 343.960396 21.50013622 3.89E-38
ERK-pp+AP1→ERK-pp-AP1 344.7227723 12.55571253 2.64E-59
AR-p-DHT+AR-p→AR-p-DHT-AR-p 345.8217822 17.42957316 2.33E-47
mRNA-sPAcP+eIF4E→mRNA-sPAcP-eIF4E 346.6435644 34.26818637 4.71E-25
ERK-p+Pase3→ERK-p-Pase3 346.9009901 24.64179214 1.26E-35
ERK-p+MEK-pp→ERK-p-MEK-pp 347.3465347 27.47147419 2.69E-32
sPAcP→sPAcP-e 348.2673267 27.44351213 5.87E-33
Her2-2-p-Shc-p+Grb2→Her2-2-p-Shc-p-Grb2 348.5346535 21.65689443 2.17E-41
g-PSA+AR-p-DHT-2→g-PSA-AR-p-DHT-2 348.7623762 17.48331511 1.32E-49
ERK-pp+ETS→ERK-pp-ETS 349.5346535 11.96328075 2.12E-65
g-cPAcP+RNAp→g-cPAcP-RNAp 349.8316832 6.127473123 7.84E-94
PtdIns3-PTEN→PtdIns2+PTEN 350.0990099 29.71098572 1.44E-31
g-sPAcP-RNAp→g-sPAcP+RNAp+mRNA-sPAcP 352.4851485 40.24617659 8.00E-24
Ras-GTP-GAP→Ras-GDP+GAP 353.2376238 19.0482184 1.17E-49
Her2-2-p-Grb2-Sos+ERK-pp→Her2-2-p-Grb2-Sos-ERK-pp 354.019802 21.93102608 7.57E-45
Her2-2-p-Shc-p→Her2-2-p+Shc-p 355.3168317 18.11565195 4.27E-53
Her2-2-p-Grb2-Sos+Ras-GDP→Her2-2-p-Grb2-Sos-Ras-GDP 355.4356436 18.33754782 1.06E-52
Her2-2-p+Grb2-Sos→Her2-2-p-Grb2-Sos 361.0792079 35.52873141 3.78E-32
Raf-p+Pase1→Raf-p-Pase1 361.6237624 16.52651724 4.71E-61
Her2-2-p+Shc→Her2-2-p-Shc 363.1485149 16.06569812 3.41E-63
Ras-GTP+Raf→Ras-GTP-Raf 366.8712871 9.359342626 3.28E-88
PtdIns2-Act-PI3K→PtdIns3+Act-PI3K 367.6732673 19.44024045 2.98E-58
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Ras-GTP+GAP→Ras-GTP-GAP 368.3861386 6.688204923 1.46E-103
AR-HSP→AR+HSP 375.4950495 17.27851282 1.70E-67
ERK-p-Pase3→ERK+Pase3 377.1584158 15.50453953 6.74E-73
ERK+MEK-pp→ERK-MEK-pp 381.029703 4.115788113 7.95E-132
C-51
AP1-p-Pase6→AP1+Pase6 302.1578947 8.575750131 0.001745756
Ras-GTP-Raf→Ras-GTP+Raf-p 303 19.88599084 0.045952102
ETS-p+Pase5→ETS-p-Pase5 303.3157895 16.59502979 0.014236152
Pdk1-m+Akt-m→Pdk1-m-Akt-m 303.7368421 9.106632084 9.61E-06
ETS-p-Pase5→ETS+Pase5 303.9473684 11.5297039 0.000161664
mRNA-sPAcP-eIF4E+40S→mRNA-sPAcP-eIF4E-40S 304.9684211 15.17439161 0.000369539
Her2-2-p-cPAcP→Her2-2+cPAcP 308.5578947 24.48144981 0.000269085
AP1-p+Pase6→AP1-p-Pase6 310.2421053 25.34383172 4.28E-05
mRNA-sPAcP-eIF4E-40S-60S→Rm-sPAcP+eIF4E 313.2947368 22.27666879 1.83E-08
mRNA-CycD-eIF4E-40S+60S→mRNA-CycD-eIF4E-40S-60S 313.7052632 33.07913118 3.50E-05
g-PSA-AR-p-DHT-2-RNAp→g-PSA-AR-p-DHT-2+RNAp+mRNA-PSA 313.8421053 38.17282467 0.000222221
2*AR-p-DHT→AR-p-DHT-2 314.1263158 24.0220259 2.85E-08
ERK-pp-Pase3→ERK-p+Pase3 316.9157895 48.00365406 0.000338143
mRNA-sPAcP→[] 317.5684211 63.22635237 0.003381905
2*Her2-2-p+cPAcP-2→2Her2-2-p-cPAcP-2 317.8421053 33.02608723 2.69E-07
AR-p-DHT+Pase5→AR-p-DHT-Pase5 318.0736842 24.49156336 3.60E-11
mRNA-CycD-eIF4E+40S→mRNA-CycD-eIF4E-40S 318.5894737 34.67548648 3.28E-07
Raf-p-Pase1→Raf+Pase1 321.3578947 22.06922878 6.66E-16
Act-Akt-Pase7→Akt+Pase7 325.3684211 60.78799269 4.01E-05
Her2-2-sPAcP→Her2-2-p+sPAcP 326.5789474 27.72708307 1.28E-15
ERK-pp+Pase3→ERK-pp-Pase3 326.6526316 33.45374447 3.03E-12
Her2-2-p-Shc-p-Grb2-Sos+ERK-pp→Her2-2-p-Shc-p-Grb2-Sos-ERK-pp 327.9473684 37.42933508 3.32E-11
g-PSA+AR-p-DHT-AR-p→g-PSA-AR-p-DHT-AR-p 328.4842105 14.39799925 4.01E-35
AR-DHT→AR-p-DHT 329.1052632 16.30271123 8.22E-32
g-cPAcP-RNAp→g-cPAcP+RNAp 329.2736842 23.57449206 1.81E-21
Her2-2-p-Shc-p-Grb2-Sos+Ras-GDP→Her2-2-p-Shc-p-Grb2-Sos-Ras-
GDP
331.3368421 29.15859015 5.32E-18
mRNA-cPAcP-eIF4E-40S+60S→mRNA-cPAcP-eIF4E-40S-60S 331.4 39.66926425 4.29E-12
ERK-pp-ETS→ERK-pp+ETS-p 331.8 19.2636008 2.36E-29
Ras-GTP-GAP→Ras-GTP+GAP 333.0842105 51.16406287 3.58E-09
Shc-p→Shc 333.3684211 15.7600779 2.70E-37
ERK-pp-AP1→ERK-pp+AP1 336.7263158 20.51158446 8.55E-32
ERK-pp-AP1→ERK-pp+AP1-p 337.0736842 12.72150447 1.64E-48
MEK-pp-Pase2→MEK-pp+Pase2 337.2947368 37.76265872 3.96E-16
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mRNA-cPAcP-eIF4E+40S→mRNA-cPAcP-eIF4E-40S 337.3157895 42.40786004 7.00E-14
ERK-pp-ETS→ERK-pp+ETS 337.3473684 23.58267358 4.79E-28
AR+DHT→AR-DHT 338.2 24.96844324 5.00E-27
MEK-pp+Pase2→MEK-pp-Pase2 338.7157895 37.64590232 5.70E-17
Her2-2-p-Shc-p-Grb2+Sos→Her2-2-p-Shc-p-Grb2-Sos 338.8105263 34.82597178 9.32E-19
Grb2+Sos→Grb2-Sos 338.9052632 39.71532216 6.11E-16
PtdIns3+PTEN→PtdIns3-PTEN 339.5684211 29.20838114 1.27E-23
Her2-2-p+cPAcP→Her2-2-p-cPAcP 340.0947368 29.00637813 3.67E-24
ERK-p+Pase3→ERK-p-Pase3 341.2842105 26.78949643 3.28E-27
Her2-2+sPAcP→Her2-2-sPAcP 342.4421053 30.45193479 2.28E-24
ERK-pp+AP1→ERK-pp-AP1 342.5894737 16.21597311 1.12E-44
Her2-2-p-Shc-p-Grb2→Her2-2-p-Shc-p+Grb2 342.7684211 25.81287016 2.40E-29
Her2-2-p-Grb2→Her2-2-p+Grb2 342.7789474 21.45407774 3.41E-35
g-sPAcP+RNAp→g-sPAcP-RNAp 342.9894737 21.4478534 2.31E-35
MEK-p+Raf-p→MEK-p-Raf-p 343.1578947 38.42622892 6.58E-19
ERK-MEK-pp→ERK-p+MEK-pp 343.7473684 27.89075245 1.05E-27
ERK-p+MEK-pp→ERK-p-MEK-pp 344.2315789 27.88791575 4.97E-28
mRNA-cPAcP+eIF4E→mRNA-cPAcP-eIF4E 345.6842105 36.12296635 8.80E-22
Her2-2-p-Shc-p+Grb2→Her2-2-p-Shc-p-Grb2 346.4315789 23.27666671 3.54E-35
AR-p-DHT+AR-p→AR-p-DHT-AR-p 346.8315789 16.13929669 2.98E-48
g-PSA+AR-p-DHT-2→g-PSA-AR-p-DHT-2 347.2315789 16.73725918 3.13E-47
ERK-pp+ETS→ERK-pp-ETS 347.6736842 12.66611069 5.41E-58
mRNA-sPAcP+eIF4E→mRNA-sPAcP-eIF4E 347.7473684 35.32643812 1.66E-23
PtdIns3-PTEN→PtdIns2+PTEN 349.4105263 30.11608933 5.28E-29
g-cPAcP+RNAp→g-cPAcP-RNAp 349.7157895 6.308996347 4.17E-87
sPAcP→sPAcP-e 351.0105263 28.577317 1.40E-31
Ras-GTP-GAP→Ras-GDP+GAP 351.9473684 19.54340294 4.92E-45
g-sPAcP-RNAp→g-sPAcP+RNAp+mRNA-sPAcP 351.9578947 40.97365413 8.11E-22
Her2-2-p-Grb2-Sos+Ras-GDP→Her2-2-p-Grb2-Sos-Ras-GDP 352.1789474 20.4743634 1.57E-43
Her2-2-p-Shc-p→Her2-2-p+Shc-p 354.9894737 16.77372302 1.03E-52
Her2-2-p-Grb2-Sos+ERK-pp→Her2-2-p-Grb2-Sos-ERK-pp 355.8105263 19.06625276 1.64E-48
Her2-2-p+Grb2-Sos→Her2-2-p-Grb2-Sos 358.6631579 37.79657755 2.57E-27
Her2-2-p+Shc→Her2-2-p-Shc 361.2315789 19.83800321 1.95E-50
Raf-p+Pase1→Raf-p-Pase1 361.5157895 16.62646157 2.99E-57
Ras-GTP+Raf→Ras-GTP-Raf 366.5789474 9.591200954 6.39E-82
PtdIns2-Act-PI3K→PtdIns3+Act-PI3K 367.2210526 20.72790082 3.00E-52
Ras-GTP+GAP→Ras-GTP-GAP 367.8210526 7.643337584 8.85E-92
ERK-p-Pase3→ERK+Pase3 376.9894737 14.42986285 2.04E-71
AR-HSP→AR+HSP 377.8210526 5.201171826 6.56E-113
ERK+MEK-pp→ERK-MEK-pp 380.2315789 5.008314417 1.12E-115
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C-81
ETS-p-Pase5→ETS+Pase5 301.1604938 11.5297039 0.044372614
Pdk1-m+Akt-m→Pdk1-m-Akt-m 304.308642 9.106632084 6.31E-05
Her2-2-p-Shc-p-Grb2-Sos-ERK-pp→Her2-2-p-Shc-p-Grb2+Sos+ERK-pp 304.7160494 18.6392907 0.044183504
ETS-p+Pase5→ETS-p-Pase5 305.2222222 16.59502979 0.000259343
Rm-cPAcP→Ar-cPAcP 305.9259259 35.39776978 0.035058001
ERK-pp+Pase3→ERK-pp-Pase3 306.8765432 33.45374447 0.006750525
mRNA-sPAcP-eIF4E+40S→mRNA-sPAcP-eIF4E-40S 306.8888889 15.17439161 0.000275699
AP1-p+Pase6→AP1-p-Pase6 309.037037 25.34383172 8.85E-10
Her2-2-p-Shc→Her2-2-p-Shc-p 309.5925926 28.82266729 0.001615564
AR-p-DHT+Pase5→AR-p-DHT-Pase5 310.0246914 24.49156336 9.34E-05
ERK-p+Pase3→ERK-p-Pase3 311.1234568 26.78949643 0.000360203
Her2-2-p-Grb2-Sos-ERK-pp→Her2-2-p-Grb2+Sos+ERK-pp 313.0123457 25.30996979 0.000134248
mRNA-CycD-eIF4E+40S→mRNA-CycD-eIF4E-40S 314.0123457 34.67548648 3.02E-05
mRNA-sPAcP-eIF4E-40S-60S→Rm-sPAcP+eIF4E 314.1358025 22.27666879 2.25E-06
mRNA-sPAcP→[] 314.1604938 63.22635237 0.010774155
2*AR-p-DHT→AR-p-DHT-2 314.2469136 24.0220259 3.92E-07
mRNA-CycD-eIF4E-40S+60S→mRNA-CycD-eIF4E-40S-60S 315 33.07913118 6.12E-06
Her2-2-sPAcP→Her2-2-p+sPAcP 315.3580247 27.72708307 3.46E-08
Her2-2-p-Grb2+Sos→Her2-2-p-Grb2-Sos 317.6296296 59.31322182 0.000564659
Raf-p-Pase1→Raf+Pase1 320.1481481 22.06922878 4.43E-16
MEK-p+Raf-p→MEK-p-Raf-p 320.8518519 38.42622892 8.15E-06
ERK-pp-AP1→ERK-pp+AP1 324.1975309 20.51158446 9.84E-12
Act-Akt-Pase7→Akt+Pase7 324.9382716 60.78799269 0.000162736
Ras-GTP-GAP→Ras-GTP+GAP 325.4691358 51.16406287 2.46E-06
Ar-cPAcP→cPAcP+40S+60S+mRNA-cPAcP 326.0246914 23.44263701 1.16E-07
ERK-p+MEK-pp→ERK-p-MEK-pp 327.0493827 27.88791575 1.06E-17
Grb2+Sos→Grb2-Sos 327.1604938 39.71532216 3.42E-08
Her2-2+sPAcP→Her2-2-sPAcP 327.3580247 30.45193479 1.27E-09
MEK-pp-Pase2→MEK-pp+Pase2 328.1604938 37.76265872 3.48E-10
ERK-pp-ETS→ERK-pp+ETS 328.1728395 23.58267358 8.85E-16
AR-DHT→AR-p-DHT 328.5061728 16.30271123 3.19E-20
MEK-pp+Pase2→MEK-pp-Pase2 329.691358 37.64590232 6.26E-11
g-PSA+AR-p-DHT-AR-p→g-PSA-AR-p-DHT-AR-p 330.1975309 14.39799925 6.17E-34
ERK-pp+AP1→ERK-pp-AP1 330.8518519 16.21597311 2.17E-17
ERK-MEK-pp→ERK-p+MEK-pp 332.1975309 27.89075245 1.29E-22
ERK-pp-ETS→ERK-pp+ETS-p 332.7654321 19.2636008 5.16E-28
mRNA-cPAcP-eIF4E-40S+60S→mRNA-cPAcP-eIF4E-40S-60S 333.5802469 39.66926425 1.46E-11
g-cPAcP-RNAp→g-cPAcP+RNAp 334.0617284 23.57449206 2.04E-22
continued on next page
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Reaction mean rank st. dev rank p-value
g-sPAcP+RNAp→g-sPAcP-RNAp 335.2345679 21.4478534 1.11E-25
ERK-pp-AP1→ERK-pp+AP1-p 336.5679012 12.72150447 1.21E-42
AR+DHT→AR-DHT 336.6419753 24.96844324 2.66E-19
Her2-2-p-Shc-p-Grb2-Sos+Ras-GDP→Her2-2-p-Shc-p-Grb2-Sos-Ras-
GDP
338.382716 29.15859015 1.19E-20
ERK-pp+ETS→ERK-pp-ETS 339.3580247 12.66611069 3.29E-31
g-PSA+AR-p-DHT-2→g-PSA-AR-p-DHT-2 339.4567901 16.73725918 1.08E-33
PtdIns3+PTEN→PtdIns3-PTEN 339.5432099 29.20838114 4.00E-19
Shc-p→Shc 340.962963 15.7600779 2.34E-36
mRNA-cPAcP-eIF4E+40S→mRNA-cPAcP-eIF4E-40S 341.1234568 42.40786004 3.29E-14
Her2-2-p-Shc-p-Grb2-Sos+ERK-pp→Her2-2-p-Shc-p-Grb2-Sos-ERK-pp 341.345679 37.42933508 6.94E-17
Her2-2-p-cPAcP→Her2-2+cPAcP 343.345679 24.48144981 1.80E-16
sPAcP→sPAcP-e 343.4691358 28.577317 1.82E-18
Her2-2-p+Grb2-Sos→Her2-2-p-Grb2-Sos 344.4074074 37.79657755 5.91E-14
Her2-2-p-Grb2-Sos+Ras-GDP→Her2-2-p-Grb2-Sos-Ras-GDP 344.7654321 20.4743634 5.62E-29
mRNA-sPAcP+eIF4E→mRNA-sPAcP-eIF4E 345.8641975 35.32643812 2.14E-23
Her2-2-p-Shc-p-Grb2+Sos→Her2-2-p-Shc-p-Grb2-Sos 346.345679 34.82597178 2.39E-23
g-sPAcP-RNAp→g-sPAcP+RNAp+mRNA-sPAcP 346.7530864 40.97365413 1.22E-18
PtdIns3-PTEN→PtdIns2+PTEN 348.4814815 30.11608933 6.77E-23
AR-p-DHT+AR-p→AR-p-DHT-AR-p 348.7530864 16.13929669 2.31E-37
Ras-GTP-GAP→Ras-GDP+GAP 349.2222222 19.54340294 1.37E-41
Her2-2-p+cPAcP→Her2-2-p-cPAcP 351.1358025 29.00637813 1.58E-26
Her2-2-p-Grb2→Her2-2-p+Grb2 351.308642 21.45407774 8.46E-36
g-cPAcP+RNAp→g-cPAcP-RNAp 351.7037037 6.308996347 7.31E-52
mRNA-cPAcP+eIF4E→mRNA-cPAcP-eIF4E 353.0493827 36.12296635 8.29E-22
Her2-2-p-Shc-p-Grb2→Her2-2-p-Shc-p+Grb2 354.4567901 25.81287016 2.21E-40
Her2-2-p-Shc-p+Grb2→Her2-2-p-Shc-p-Grb2 355.7530864 23.27666671 3.34E-44
Raf-p+Pase1→Raf-p-Pase1 356.7037037 16.62646157 1.53E-46
Her2-2-p-Grb2-Sos+ERK-pp→Her2-2-p-Grb2-Sos-ERK-pp 357.3333333 19.06625276 1.92E-52
ERK+MEK-pp→ERK-MEK-pp 363.691358 5.008314417 2.09E-35
ERK-p-Pase3→ERK+Pase3 364 14.42986285 3.04E-33
Ras-GTP+Raf→Ras-GTP-Raf 364.6296296 9.591200954 1.32E-59
Her2-2-p-Shc-p→Her2-2-p+Shc-p 364.9382716 16.77372302 1.25E-61
PtdIns2-Act-PI3K→PtdIns3+Act-PI3K 365.8395062 20.72790082 1.52E-39
Ras-GTP+GAP→Ras-GTP-GAP 366.2592593 7.643337584 4.45E-60
Her2-2-p+Shc→Her2-2-p-Shc 366.5555556 19.83800321 6.79E-53
AR-HSP→AR+HSP 373.962963 5.201171826 5.92E-56
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177Table A.4: Transcription factors (TFs), corresponding kinases and transcrip-
tion factor target genes used in the transcription subnetwork.
∗TFs for BLR1 interact with each other to promote BLR1 tran-
scription (AND relationship). Alternatively, the other TFs in the
model were assumed to independently drive gene expression of
their target genes (OR relationship). † Interaction determined
via NetworKIN [213].
TF Kinase Targets Citation
IRF, SRPK2
ETS ERK p47Phox, SIIIp15 [386, 363]
CD45, EIF2AK
RhoGDI, IRF
BRN – p47Phox, SRPK [386]
CD45, EIF2AK
SIIIp15
RhoGDI, IRF
CREB PKCα p47Phox, SPRK [386, 355]†
CD45, EIF2AK
SIIIp15, BLR1∗
RhoGDI, IRF
Oct1 – p47Phox, SPRK [386, 355]
CD45, EIF2AK
SIIIp15, BLR1∗
NFATc3 ERK BLR1∗ [371]
E2F – CycE, E2F [248]
AP1 ERK CycD [363]
178Table A.5: Quantiﬁcation of model training and validation error. The nor-
malized mean squared error (NMSE) or the fraction of correct
predictions was calculated over the parameter ensemble.
Species Simulation NSME or Fraction correct Purpose Citation
Figure 5.3
BLR1 mRNA Panel A 1.80 Training [355]
pRaf Panel B 0.83 Training [355]
pMek Panel C 2.31 training [355]
pErk Panel D 10.58 training [355]
Figure 5.4
BLR1 mRNA Panel A – Training [355]
BLR1 mRNA Panel B – Training [355]
pRaf Panel C – Training [355]
Figure 5.5
G1/0 Arrest Panel A – Validation [385]
Rb mRNA Panel B 0.07 Validation [385]
Rb protein Panel B 2.52 Validation this study
Table 5.1
p47Phox – 3/3 Validation [386]
SPRK2 – 3/3 Validation [386]
PRK – 2/3 Validation [386]
Cyclin D – 1/3 Validation [386]
RhoGDI – 1/3 Validation [386]
CD45 – 1/3 Validation [386]
IRF – 0/3 Validation [386]
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Figure A.1: The HL-60 network architecture exhibits scale free properties.
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Figure A.2: Correlation between parameter sets in the HL-60 ensemble. Re-
gions of red indicate high correlation, while blue regions denote
low correlation.
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Figure A.3: Schematic overview for pathways included in the ErbB signaling
network.
182Table A.6: Ligands included in the ErbB network.
Ligand
epidermal growth factor
amphiregulin
transforming growth factor alpha
betacellulin
heparin-binding growth factor
epiregulin
neuregulin1-4
Table A.7: Transcription factor regulatory mechanisms.
Transcription factor Regulation Citation
Sp1 Phosphorylation by CycA-CDK2 [101]
Phosphorylation by ERK [232]
Fos-Jun complex Phosphorylation by ERK [236]
Myc-MAX complex Phosphorylation by p-ERK [127, 300]
MAX Inhibition by MAD [395, 52]
Myc Phosphorylation by GSK leads to degradation [374, 300]
Srf Phosphorylation by ERK [22]
ETS1 Phosphorylation by ERK [358]
E2F1 Inhibition by Rb [304, 267]
Sp3 Transcriptionally by other TFs TRANSFAC
p53 Transcriptionally by other TFs TRANSFAC
STAT5B Phosphorylation by ERK [262]
ELK Phosphorylation by ERK [165]
STAT3 Phosphorylation by ERK [54]
Phosphorylation by Src [269]
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